Metabolism and Effects of Dietary Phenolic Acids. by Poquet, Laure.
UNIVERSITY O fb  SURREY
METABOLISM AND EFFECTS 
OF DIETARY PHENOLIC ACIDS
By
L aure Poquet
Subm itted  for the  Degree of Doctor of Philosophy
Faculty  of H ealth  and  M edical Sciences 
The U niversity  of Surrey, UK
in collaboration w ith 
The N estle R esearch Centre, Sw itzerland
Ja n u a ry  2008
© Laure Poquet 2008
ProQuest Number: 10085321
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10085321
Published by ProQuest LLC (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106 -  1346
Abstract
Ferulic acid is a secondary metabolite usually found as esters in plants and 
dihydrocaffeic acid results from the microbial metabolism of flavonoids and of caffeic 
acid, both widely distributed in food. Even though ferulic acid and flavonoids have 
been proposed to exert several beneficial effects on health, their in vivo activities could 
partly result from their microbial metabolites and strongly depend on their 
bioavailability.
The absorption and metabolism of phenolic acids were studied in vitro with a model for 
the colonic epithelium composed of absorptive and mucus secreting cells, ex vivo with 
everted colonic sacs and liver slices, and in vivo with rats. The photoprotective effect of 
phenolic acids was tested in vitro on the kératinocytes HaCaT.
The ferulic acid permeation was mainly by transcellular diffusion and also by a 
facilitated transport (S-MCT and MCT1). Intestinal cells conjugated ferulic acid with 
sulphate or glucuronide and reduced its unsaturated side chain. In rats, intestinal cells 
were more potent for glucuronidation of dihydrocaffeic acid, whereas the liver favoured 
sulphation, the méthylation being regio-selective. Intestinal and hepatic cells oxidized 
dihydroferulic acid into ferulic acid, which they reduced into dihydroferulic acid. 
HaCaT cells were able of sulphation, méthylation and reduction. Dihydrocaffeic acid 
decreased the cytotoxicity and the production of IL-6 and IL-8 in HaCaT cells 
following UV radiation, the minimum structure required for such effect consisting in a 
propionic side chain attached to a phenyl ring substituted with a catechol moiety.
2
Dihydrocaffeic acid also protected erythrocytes from lysis induced by a free radical 
initiator.
Phenolic acids released from food by the colonic microflora can be conjugated and 
metabolized by the intestinal epithelium, liver and other tissues, such as the epidermis, 
strongly reducing the circulating amount of the parent compound, which could be the 
most active form.
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1 The nature of dietary polyphenols
Polyphenols are secondary metabolites of plants involved in their defence against 
ultraviolet radiation and invasion of pathogens. They are classified as a function of the 
number of the phenyl rings they contain and the type of their substitutions. They are 
divided into phenolic acids, flavonoids, stilbenes and lignans (as reviewed in (Manach 
et a l,  2004)). Stilbenes, with a rrans-l,2-diphenylethylene structure, are not abundantly 
found in human food, the best known example being resveratrol (Fig. 1A), which is 
found at very low levels in red wine (Fremont et a l, 1999). The lignans, one of the 
major classes of phytoestrogens, are mainly found in linseeds and are formed of two 
phenylpropane units linked together by different types of binding. Pinoresinol (Fig. IB) 
(Kurzer & Xu, 1997) is an example of lignan. Contrary to the other members of the 
large family of polyphenols, phenolic acids possess only one phenyl ring, whereas 
flavonoids share a common structure based on an assembly of three rings.
H O
OH
H O -
'O H
H3C(
OH
Figure 1 Example o f lignan and stilbene chemical structures.
A, resveratrol (stilbene structure); B, pinoresinol (lignan structure).
1.1 Th e  FLAVONOIDS
1.1.1 The different structure-based classes
Flavonoids, the most abundant polyphenols found in food, are composed of aromatic 
rings, linked by C-C bonds and arranged as a C6-C3-C6 backbone structure (Fig. 2).
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3 '
5 4
Figure 2 The backbone of flavonoids.
Flavonoids are divided into different subclasses, as flavones, flavonols, isoflavones, 
flavanols, flavanones, anthocyanidins and proanthocyanidins, depending on the 
connection of the B-ring to the C-ring and on the presence of hydroxyl or other 
chemical groups on the phenyl rings (Ross & Kasum, 2002). The B-ring of all the 
flavonoids is linked to the C-ring at position 2 except for the isoflavones, which are 
linked at position 3 (Scalbert & Williamson, 2000). The 2-3 bond of the C ring is 
unsaturated as in flavones, isoflavones and flavonols, whereas it is saturated in 
flavanols and flavanones (Rasmussen & Breinholt, 2003). Anthocyanidins display two 
double bonds, at position 1-2 and 3-4. Some examples of flavonoids of the different 
classes are presented in Table 1.
Most of the flavonoids found in nature, except some flavanols, are linked to sugars via 
yS-glycosidic bonds with phenolic hydroxyl groups. The linked sugar is often glucose or 
rhamnose, but can also be galactose, arabinose, xylose, glucuronic acid (sugar acid) or 
other sugars (Scalbert & Williamson, 2000). Flavanols are almost always present in the 
nonglycosylated form, which has implications for their solubility and partitioning 
(Spencer et a l,  2001a). However, they can be found as acylated conjugates, gallic acid 
being the most common acyl group.
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Table 1 Examples of the different flavonoid structures.
B-ring connection unsaturation 
to C-ring of the C-ring
differences in substitution 
and binding a
flavanols 2 none (+)-catechin
(-)-epicatechin
(+)-gallocatechin OH on C5.
(-)-epigallocatechin OH on C5.
(-)-epicatechingallate gallateb on C3 in
(-)-epicatechin
(-)-epigallocatechin gallateb on C3 in
-gallate (-)-epigallocatechin
flavanones 2 none hesperetin 4-oxo, H on C3, OCH3 on C4.
naringenin 4-oxo, H on C3 and C3
flavones 2 C2-C3 apigenin 4-oxo, H on C3 C3'
luteolin 4-oxo, H on C3
isoflavones 3 C2-C3 daidzein 4-oxo, H on C5 and C3.
genistein 4-oxo, H on C3.
flavonols 2 C2-C3 kaempferol 4-oxo, H on C3
myricetin 4-oxo, OH on C5.
quercetin 4-oxo
anthocyanidins 2 0 1-C2 and cyanidin 4'-oxo, double bound C2-Ci'
C3-C4
a the substitutions of flavonoids with hydroxyl groups are on C3, C5, C7, O  and Q  with some 
exceptions
b the gallate substitution is obtained by addition of a gallic acid moiety.
1.1.2 The flavanols: structure and food source
Catechin and epicatechin are monomeric members of the flavanol class, the most 
abundant flavonoids in the human diet, which are built from one molecule, the "flavan- 
S-ol". Flavanols can also be found in food as polymers, the tannins, which are large 
molecules, synthesized by the plants themselves or resulting from food processing 
(Beecher, 2003). The tannins are divided into three subclasses: the condensed tannins or 
proanthocyanidins, the derived tannins and the hydrolysable tannins. Proanthocyanidins 
(PACs) are present in fruits, bark, leaves and seeds of many plants. The procyanidins 
(PCs), the most abundant proanthocyanidins in plants, are composed of (epi)catechin 
units (Fig. 3A) compared with the lesser common types of proanthocyanidins called 
propelargonidin and prodelphinidin, which contain respectively (epi)afzelechin or 
(epi)gallocatechin subunits (Rasmussen et al., 2005). The three forms of
16
proanthocyanidins differ in the degree of hydroxylation of their B-ring. Prodelphinidins 
possess a 3’,4’,5’-trihydroxy substitution on the B-ring, whereas procyanidins display 
hydroxyl groups on 3’ and 4 ’ positions and propelargonidin only on 4’ (Dixon et a l, 
2005). The monomeric units of PACs are usually linked by C-C and occasionally by C- 
O-C bonds (Santos-Buelga & Scalbert, 2000). The C-C bond is generally between the 4- 
position of the “upper” unit and the 8-position of the “lower” unit (Fine, 2000) (Fig. 3B), 
as in PC B1 to B4. However, an alternative linkage can be found between the C4 of the 
“upper” unit and the C6 of the “lower” one (Fig. 3C), as for the PC B5-B8. Both of 
these are called B-type linkage. Compounds with doubly linked units, by a B-linkage 
and a C2-C7 bond, or A-linkage, have also been reported in some food sources such as 
cranberry fruits (Prior et a l ,  2001) and cinnamon (Anderson et a l,  2004).
Figure 3 Structure of flavan-3-ol monomers and dimers.
A, (—)-epicatechin with R]=OH and R2 =H or (+)-catechin with R}=H and R2 =OH; B, 
procyanidin (4/3—>8)-dimer; C, procyanidin (4/3->6)-dimer.
OH
R;
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Different foods have been shown to contain proanthocyanidins, mainly fruits and 
berries, nuts, beans, some cereals (barley and sorghum), spices like curry and cinnamon 
but also beverages such as wine and beer (Gu et a l,  2004). However, attention has been 
focused on the most abundant PACs, the procyanidins. A good example of a food 
source of PCs is cocoa, which, apart from the monomeric units, contains dimeric to 
decameric (or more) forms (Hammerstone et a l,  1999). Commonly consumed food, 
like chocolate or different varieties of apples and beverages, such as wine or cranberry 
juice, contain large amounts of procyanidins (Hammerstone et a l,  2000). Dark 
chocolate contains a significantly larger amount of procyanidins by weight compared 
with the other foods and beverages investigated, cranberry juice having the lowest one.
1.2 Th e  ph e n o l ic  a cid s
1.2.1 Chemical structure and food source
Phenolic acids are divided into two classes, hydroxybenzoic and hydroxycinnamic 
derivatives (Tomâs-Barberân & Clifford, 2000; Clifford, 2000). Most of them have one 
or two substitutions of the phenyl ring, on the 3 and 4 positions (Fig. 4A). However, 
some derivatives can possess 3 substitutions, the additional one being on the 5 position 
(Fig. 4B). Phenylacetic acids are less commonly found than benzoic, propionic and 
cinnamic acids. While the content of hydroxybenzoic acids in edible plants is low, 
hydroxycinnamic acids are more abundant. The most commonly found 
hydroxycinnamic acids are p-coumaric, ferulic, sinapic and caffeic acids, the latter 
occurring the most extensively (Shahidi & Wanasundara, 1992). Hydroxycinnamic 
acids are present in a wide range of berries, fruits and beverages (Mattila et a l ,  2006), 
but also in many different vegetables (Clifford, 1999) and cereals (Kern et a l ,  2003a). 
In addition, phenolic acids are found in traditional herbal Chinese medicines and 
supplements (Cai et a l,  2006), which are receiving more and more attention.
18
AB
RI R2
COOH
COOH
COOH
b en zo ic  acid H H
4- or p-hydroxybenzoic acid OH H
3- or m -hydroxybenzoic acid H OH
protocatechuic acid OH OH
vanillic acid OH OCH,
isovanillic acid O CH, OH
R3 R4
phenylpropionic acid H H
4- or p-hydroxyphenylpropionic acid OH H
3- or m-hydroxyphenylpropionic acid H OH
3,4-dihydroxyphenylpropionic acid 
(dihydrocaffeic acid) OH OH
dihydroferulic acid OH OCH,
dihydroisoferulic acid OCH, OH
R5 R6
cinnam ic acid H H
4- or p-hydroxycinnamic acid 
(p-coumaric) OH H
3- or m-hydroxycinnamic acid 
(m-coumaric) H OH
caffeic acid OH OH
ferulic acid OH OCH,
isoferulic acid OCH, OH
gallic acid
OH
.OCH,
OH OH
HO. .OH OCH,
COOH COOHCOOH
Sinapic acid Syringic acid
Figure 4 Chemical structure o f phenolic acids.
Phenolic acids commonly found with 2 substitutions on the phenyl ring on the 3 and 4 positions 
(A) and some less commonly found with triple substitutions on the 3, 4 and 5 positions (B).
19
1.2.2 Phenolic acids forms in plants
In general, to study their presence in food, acidic hydrolysis or saponification allow the 
release of phenolic acids from the food matrix (Robbins, 2003). Indeed, phenolic acids 
are rarely present as free forms, except in processed food, but more frequently appear as 
soluble or insoluble esters. These esters are formed with polysaccharides or simple 
sugars, with quinic acid or other carboxylic acids such as tartaric or shikimic acids 
(Herrmann, 1989), with other phenolic acids, with lipids (Clifford, 2000), with sterols or 
glycerol (Clifford, 1999) or with amino acids (Clifford & Knight, 2004). To quinic acid, 
they can be conjugated as mono-, di-, tri- and tetra-esters (Clifford, 2000). The multiple- 
esters can contain the same or different hydroxycinnamic acids. Among the 
hydroxycinnamic conjugates, caffeoylquinic and di-caffeoylquinic acids are the most 
ubiquitous (Clifford, 2000). The best known quinic acid ester or chlorogenic acid is the 
5-Ocaffeoylquinic acid, a caffeic acid esterified to position 5 of a quinic acid moiety
Figure 5 Example o f chemical structure o f a chlorogenic acid: 5-O-caffeoylquinic acid.
Phenolic acids, and especially ferulic acid, which is abundantly found in cereals, can be 
found esterified to the polysaccharides present in primary and secondary cell walls of 
plants. These polysaccharides can be classified as celluloses, pectins, and 
hemicelluloses and have backbones made of different residues. Cellulose is composed 
of D-glucose residues, hemicellulose (xyloglucan, glucuronoxylan, arabinoxylan, 
glucomannan, and galactomannan) is composed of /%-D-hexosyl residues, and pectin
(Fig. 5).
OH
HOOD
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(homogalacturonans, rhamnogalacturonans, and substituted galacturonans) contains a- 
D-galacturonic acid (from Complex carbohydrate research centre. The University of Georgia; 
http://www.ccrc.uga.edu/~mao/intro/ouline.htm). Ferulic acid is the major phenolic acid 
occurring in the cells walls of monocotyledons and appears as cis- and fram-isomers, 
the latter as the most abundant form (reviewed in (Klepacka & Foma, 2006)). Ferulic 
acid is found in wheat, maize, rye, barley (Sun et a l ,  2001), oats, spinach, sugar beet, 
water chestnuts (Clifford, 1999), generally esterified, and rarely as free form, such as in 
barley (Yu et a l ,  2001). It is esterified in primary cell wall to arabinoxylans (Fig. 6 and 
7) in the aleurone layer and pericarp (Clifford, 1999), as in spinach (Fry, 1982) or in 
wheat bran (Smith & Hartley, 1983).
Figure 6 Example of feruloylated arabinoxylan.
Ferulic acid esterified to arabinoxylan, a hemicellulosic polysaccharide present in cell walls 
(from http://www. ccrc. uga. edu/~mao/intro/ouline. htm).
,4 -p ‘D-Xytp-l A - p - D - X y t H A p - D - X ^ I  . ^ D - X y t M  ,4#-D-XyIp*1 / y W X y k K l  ,4' 
2
a-L-Araf
2
HO
Figure 7 Chemical structure of 5-O-feruloyl-L-arabinofuranose.
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Ferulic acid can also be found esterified to other hydroxycinnamic acids such as in 
Mongolian medicinal plants where it is found as feruloylpodospermic acid, which is 
composed of two dihydrocaffeic acid units esterified at position 1 and 5 of a quinic acid 
moiety, with an additional feruloyl group being attached to position 3 (Tsevegsuren et 
a l, 2007). Dihydrocaffeic acid is also one of the major phenolic antioxidants 
abundantly present in black olive pericarp, and in lower amounts in brined black olive, 
with traces in brined green olives (Owen et a l ,  2003).
2 The bioavailability of polyphenols
There is evidence that diets rich in vegetables and fruits reduce the risk of cancer or 
cardiovascular diseases. Flavonoids and phenolic acids, abundant in plant-derived food, 
are in part responsible for these beneficial effects, as suggested by several in vivo and in 
vitro studies. However, bioavailability is a pre-requisite for the in vivo biological 
activity of any polyphenol.
2.1 Th e  d efin it io n  o f  “b io a v a il a b il it y ”
In pharmacology, bioavailability is a term used to describe the fraction of an 
administered dose of medication that reaches the systemic circulation. When a drug is 
administered intravenously, its bioavailability is 100 %. However, given via another 
route, such as the oral one, its bioavailability, called “absolute bioavailability”, 
decreases due to incomplete absorption and to metabolism. Before reaching the 
systemic circulation, polyphenols orally administered will transit by the gastrointestinal 
tract (GIT) where they will be submitted to different biological and physiological 
parameters, which will participate in their bioavailability, such as the pH, the digestive 
enzymes or the microflora.
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2.2 Th e  g a st r o in te st in a l  ph y sio l o g y  a n d  its r o le  in  th e
BIO AVAILABILITY OF POLYPHENOLS
The gastrointestinal tract serves as an interface between the body and the external 
environment and converts food to components which can be absorbed. In mammals, the 
GIT is divided into different sections: oesophagus, stomach, small intestine, caecum, 
large intestine, or colon, and rectum, the pancreas and the liver being parallel organs 
able to release secretions into the small intestine and participating to the bioavailability 
of polyphenols.
2.2.1 From the oral cavity to the stomach
Chewing breaks down the food into smaller particles that can further mix with GIT 
secretions. During the pre-absorption events, two principal fluids are encountered, 
saliva and gastric juice, which can potentially affect the structure and absorption of 
polyphenols. Saliva aids in bolus formation, it lubricates, protects and cleans the 
pharyngeal and oesophageal mucosa. The pH of mucous secretion by salivary glands is 
between 5.6 and 7.9 (de Freitas & Mateus, 2001). The salivary enzymes and salivary 
amylase initiate fat and starch digestion. The salivary proteins rich in proline, 
comprising about 70 % of the human salivary protein content, divided into glycosylated, 
acidic and basic classes (Schenkels et a l,  1995), strongly bind and precipitate tannins 
(Charlton et a l,  1996). The astringency phenomenon felt by drinking wine is explained 
by these interactions between proteins rich in proline and the polyphenols present in 
wine, complexes which precipitate, obstructing palate lubrication and causing an 
unpleasant sensation of roughness, dryness and constriction (Haslam & Lilley, 1986). 
Saliva has also been shown to play a role in hydrolysis of flavonoid esters with 
glycosides and other acyl groups, the hydrolysis of glycosides being limited to glucose 
conjugates, other glycosides such as rhamnosides and rhamnoglucosides being either
very slowly hydrolyzed or resistant to salivary hydrolysis (Walle et a l, 2005). Holding 
a solution of quercetin 4’-glucoside in the mouth for 5 min resulted in a loss of 60 % of 
the glucoside conjugate, one third of the resulting aglycone being counted in saliva and 
the two remainings third suggested to be absorbed by the oral epithelial cells. The 
authors proposed that some of the /%-glucosidases responsible for hydrolysis were 
coming from shed oral epithelial cells but mainly from the microflora present in saliva. 
Another report mentioned the hydrolysis of theaflavin gallates apparently by salivary 
esterases, as observed in vitro and in vivo (Lee et a l,  2004). Human whole saliva 
contains two peroxidases, salivary peroxidase (hSPO) secreted by salivary glands, and 
myeloperoxidase (hMPO) derived from polymorphonuclear leukocytes (Thomas et a l,  
1994), which are part of the innate host defence in oral cavity. The major function of 
hSPO and hMPO is to catalyze the oxidation of nitrite to nitrogen dioxide radicals, 
which participate in the nitration of tyrosine and tyrosine residues in proteins, carried 
out in the presence of hydrogen peroxide generated by some bacteria present in the oral 
cavity. Quercetin, which is able to inhibit this reaction of nitration, was also shown to 
be oxidized by peroxidases from saliva (Hirota et a l, 2005).
Swallowing is regulated by sphincter actions and allows the release of the food bolus 
into the stomach (Schneeman, 2002). In addition to the motility of the stomach, which 
mixes food by the contraction of its muscles, the glands from the wall pour gastric juice 
onto the food. The juice contains proteases (e.g. pepsin) which start digestion, 
hydrolysing large proteins into smaller ones. These enzymes work best in acidic 
conditions and so the gastric juice contains hydrochloric acid to provide the correct pH 
and also to destroy bacteria present in the food, preventing infection. Studies looking at 
their stability in solutions simulating gastric juice have suggested that polyphenols 
would be stable at the stomach pH, as demonstrated for instance for theaflavin,
relatively stable at acidic pH (5.5) compared with alkaline conditions (8.5) (Jhoo et a l,  
2005). Studies performed in rats have also shown the possible absorption of some 
phenolic compounds through the stomach epithelium. This is the case for ferulic (Zhao 
et a l,  2004), gallic, p-coumaric, caffeic and chlorogenic acids proposed to be absorbed 
as such and only further conjugated by the liver (Konishi et a l, 2006), chlorogenic acid 
being absorbed in its intact form and not metabolized into caffeic acid nor conjugated 
(Lafay et a l ,  2006a). In contrast to anthocyanins, absorbed from the stomach without 
being de-glycosylated or de-conjugated (Passamonti et a l,  2003), quercetin (Crespy et 
a l,  2002), daidzein and genistein (Piskula et a l,  1999) were absorbed only as the free 
form.
At different intervals, food is released from the stomach into the small intestine where 
the digestion and absorption continue.
2.2.2 From the small to the large intestine
The small intestine is divided into 3 segments: duodenum, jejunum and ileum, the latter 
section emptying into the large intestine. Duodenum receives secretions coming from 
the pancreas via the pancreatic duct and which contain the digestive enzymes 
precursors (proenzymes), and bile acids from the liver via common bile duct 
(Schneeman, 2002). The enzymes are of 3 different groups, the first one being the 
protease group, which contains 2 major proteases, the trypsin and chymotrypsin. These 
enzymes must be converted into their active forms once they arrive in the small 
intestine in order to digest proteins into amino acids. Enzymes from the lipase group are 
responsible for the hydrolysis of fats into fatty acids and glycerol. Finally, amylase 
digests starch into sugars. In addition to proteases, lipases and amylases, the pancreas 
produces many other digestive enzymes, including ribonuclease, deoxyribonuclease, 
gelatinase and elastase. The small intestine, due to its impressive surface area, is the
most important tissue of the body for absorption of fluids, micronutrients (vitamins, 
minerals) and macronutrients (lipids, carbohydrates, proteins). This important surface 
area is the result of three features of the small intestine luminal side: mucosal folds, 
villi and microvilli (Madara & Trier, 1987). Villi consist of a multitude of projections 
of mucosa, which protrude into the lumen and are separated by invaginations called the 
crypts (Fig. 8). Epithelial cells, which cover the surface of the intestinal mucosa, are 
supported by the lamina propria that contains lymph vessels, smooth muscle cells, 
nerves, a variety of cell types, such as lymphocytes and macrophages, as well as blood 
vessels for the nourishment of the epithelium and uptake of components from the 
intestinal cells (Doherty & Charman, 2002). Cells proliferate in the crypts and 
differentiate while they migrate in the villi. Enterocytes, which are absorptive cells, 
represent the most abundant population of the intestinal epithelium (Madara & Trier, 
1987). They are highly polarized tall columnar cells and exhibit folding of their luminal 
plasma membrane forming the microvilli. Other cells are also present in the mucosa, 
such as the Paneth cells, which provide host defence against microbes by storing a- 
defensins in zymogen granules (Ouellette, 1999), and M cells, overlying Peyer’s 
patches and transferring antigens by transcytosis (Neutra et a l ,  1996).
Interspersed between the absorptive cells is the second population, the goblet cells, 
responsible for the production of mucus, an adherent gel which lubricates and protects 
the intestinal surface from the surrounding environment. Also present in the stomach, 
the mucus gel provides a stable unstirred layer supporting surface neutralization of 
luminal acid by mucosal bicarbonate secretion (Atuma et a l ,  2001). In the rats, from 
the duodenum to the ileum, the gel forms a thin and discontinuous layer (Szentkuti & 
Lorenz, 1995). From the caecum to the colon, it increases in thickness and in continuity. 
The gel is composed of a firmly adherent mucus layer and a more loosely attached one.
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In the corpus, both layers have an equivalent thickness of about 100 pm (Atuma et ai, 
2001). In the stomach, the adherent layer is slightly thicker (~ 150 pm) than the loosely 
attached one (~ 100 pm). From the duodenum to the colon, there is a clear difference 
between the two layers, the firmly adherent layer being very thin (~ 20 pm, from the 
duodenum to the ileum) compared with the loose bound mucus whose thickness 
increases along the GIT, from ~ 200 pm in the duodenum to ~ 700 pm in the colon. 
Mucus, mainly composed of water (~ 95 %), contains salts and lipids such as fatty acids, 
phospholipids and cholesterol, but also proteins involved in the defence of the mucosa 
such as lysozymes, immunoglobulins, defensins, growth and trefoil factors (Bansil & 
Turner, 2006). Mucus is also composed of mucins, which are large glycoproteins that 
vary in size and in the composition of their oligosaccharide side chains (Madara & 
Trier, 1987).
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Figure 8 Folding of the intestinal mucosa: the villi and microvilli.
The inner surface o f  the intestinal mucosa is fo lded  forming villi and crypts. The membrane 
invaginations o f  intestinal cells form  the microvilli.
(Adapted from http://arbl.cvmbs.colostate.edu/hbooks/patliphys/digestiou/smalIgiit/lifecycle.html 
and http://www.pitt.edu/~anat/Abdomen/Smalllntestine/Small.htm).
27
The colon starts at the ileocecal junction and ends at the rectum. The caecum receives 
the solid wastes of digestion from the ileum via the ileocecal valve. The epithelium of 
the colon possesses different characteristics from the small intestine. The mucosa 
displays a large number of goblet cells but does not have any villi (Madara & Trier, 
1987). Unlike the small intestine, the colon does not produce digestive enzymes. Its 
function mainly includes the absorption of water and electrolytes and the elimination of 
faeces.
2.2.3 The gastrointestinal absorption
In the entire intestine, even though the colon and the stomach play a less important role 
in absorption than the small intestine, molecules can cross the epithelium to enter blood 
system and do so by different pathways (Fig. 9). The membrane of intestinal cells 
consists of a lipid bilayer with glycoproteins dispersed throughout. The lipidic nature of 
these membranes restricts the entry of hydrophilic molecules whereas they allow the 
entry of more hydrophobic ones. Water-soluble substrates can cross the epithelium via 
the paracellular pathway, which consists in a movement of molecules between cells, a 
passive transport restricted by one of the different junctions linking adjacent cells 
together and called tight junctions (Fig. 10). Among the tight junction proteins 
identified are transmembrane proteins (occludin and claudin) and cytoplasmic proteins 
(ZO-1, ZO-2 and ZO-3, cingulin and 7H6 (Salama et a l ,  2006)). The transcellular 
transport of hydrophilic molecules by absorptive cells can also be facilitated by some 
proteins that form pores, channels, or by energy dependent transporters, which are 
asymmetrically distributed on the apical and basolateral membranes. Macromolecules 
can be transported from one side of the cells to the other by a mechanism involving 
vesicular transport called transcytosis. In contrast to passive diffusion, which is 
independent of the concentration of the compounds to be transported, active transport
can be performed against a concentration gradient. Moreover, the transport by the 
facilitated mechanisms will depend on the affinity of the compounds for these 
transporters.
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Figure 9 Illustration o f the mechanisms of transport through the intestinal epithelium.
1, transcellular diffusion; 2, paracellular diffusion; 3, transport allow ed by proteins, which 
facilitate the flux and efflux o f  the molecules; 4, transcytosis.
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Figure 10 The different types of junctions present in the extra-cellular space and linking 
adjacent cells together.
The tightest ones regulate the paracellular transport o f  soluble molecules, (from 
http://www.biology.arizona.edu/cell_bio/problem_sets/membranes/13t.html).
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2.2.4 The gastrointestinal microflora
2.2.4.1 Composition and distribution
Each area of the GIT represents a biotope, which contains a specific population of 
micro-organisms (Ducluzeau & Raibaud, 1979). Humans and animals lodge a huge 
amount of micro-organisms, more than their own composition in eucaryotic cells. The 
weight of microflora in human is estimated to about 1 kg (B.E.Gustafsson, 1983). The 
microbial content of the human body has been estimated to 1014, while the human body 
is composed of only 1013 cells (Luckey, 1972). The gastrointestinal tract therefore 
contains 1011 microbes/g content and would be composed of 400 to 500 species of 
micro-organisms in which 40 represent about 99 % of the total population. During the 
past ten years, progress has been made in molecular biology, allowing the exploration of 
the intestinal microflora by technologies using 16S rRNA sequences PCR detection and 
revealing the presence of species, for some of them not detected by the culture 
techniques used in the past (Lay et a l ,  2005). The predominant micro-organisms are 
anaerobic bacteria, among which the Bacteroides-Prevotella group (Gram-negative) and 
the Clostridium coccoides and Clostridium leptum groups (Gram-positive) are the most 
abundant ones (Tannock, 2002). These dominant genera are followed by 
Bifidobacterium, Lactobacillus, Fusobacterium, Eubacterium and various anaerobic 
Gram-positive cocci (Guamer, 2006). In a lower amount are. found Enterococcus and 
Enterobacteriaceae.
The microflora present in the GIT can be subdivided into 2 categories of micro­
organisms, according to their ability to colonize the lumen. The autochthonous flora, or 
resident population, is able to find a niche in the GIT to develop and colonize it. By 
contrast, the allochthonous flora, which is transient, can multiply in the GIT but is not 
able to colonize it. This later population enters the digestive system via the food
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ingested, air, water or from another habitat in the gastrointestinal tract (Savage, 1981). 
The autochthonous flora has the capacity to adhere to the mucus layer or to the 
underlying epithelial cells via attachment to the glycocalix, formed by glycoconjugates 
on the apical side of the cells (Kleessen & Blaut, 2005). When the gastrointestinal 
system is perturbed, the transient microbes can also find a niche left vacant by 
autochthonous flora for some reason and multiply.
Bacteria from the oral cavity, where the pH is close to neutral, are washed with saliva 
into the stomach. In the stomach, the microbial proliferation is high but the pH between
2.5 and 3.5, and the presence of gastric juice, prevent the growth of most bacteria. This 
part of the GIT contains less than 103 colony forming units/g (Holzapfel et a l ,  1998; 
Guamer, 2006). Due to the acidic conditions in the stomach and the presence of oxygen 
coming from swallowing, surviving bacteria are acido-tolerant and facultative anaerobic. 
They are mainly Gram-positive bacteria, such as Streptococcus and Lactobacillus (109/g 
of wet tissue), and yeasts are of the genus Torulopsis (107/g of wet tissue) (Savage, 
1983). Staphylococcus have also been reported in human (Simon & Gorbach, 1986). 
Although other microbial types considered as transient have been reported to be present 
in the stomach, lactic acid bacteria and yeasts are the only ones to be able to associate 
with the epithelium of the stomach, apart from pathogens such as H elicobacter pylori. 
In rats, the microflora of the stomach is much more abundant (~ 108 bacteria/g) than in 
humans (~ lO1-!!)2 bacteria/g) (Rowland et a l ,  1985).
Whereas in rats the amount of the small intestinal microflora is relatively similar to the 
amount found in the stomach (Rowland et a l ,  1985), the small intestine represents a 
zone of transition between the low amount of micro-organisms present in the stomach 
and the abundant flora of the colon in human. Due to the short transit time and to the
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presence of aggressive intestinal fluids such as bile or pancreatic juices, the duodenum 
contains only small amounts of micro-organisms (Holzapfel et a l ,  1998). The 
microflora of the jejunum is estimated to be 104 and up to 107 cfu/g in the ileal end 
(Guamer, 2006). In general, microbial analysis in the small intestine is difficult due to 
sampling problems, which have rather been done post mortem. Lactobacilli have been 
found present in considerable amounts in the jejunum (predominantly L  gasseri and L. 
reuteri), enterobacteiia, micrococci, enterococci, yeasts and fungi occurring 
occasionally (Reuter, 2001). The ileum contained enterococci more frequently and 
bifidobacteria in some cases, Lactobacilli similarly distributed as in the ileum.
In the colon, and especially in the caecum, the population doubling time of micro­
organisms is higher than the passage rate (Savage, 1977). Caecum and colon contain the 
highest amount of bacteria of the digestive tract (1011 -  1012/g of faeces) (Hooper et a l ,
2002). The facultative anaerobes present in the caecum and colon are 10 to 100 times 
less abundant than the strict anaerobes (Holzapfel et a l ,  1998). In some European 
countries, the highest percentage detected is for the group Clostridium coccoides- 
Eubacterium rectale (28 %), followed by the Clostridium leptum group (25.2 %), 
Bacteroides representing the third group (8.5 %) (Lay et a l ,  2005). Members of the 
Atopobium  and the Bifidobacterium  are even less abundant, with 3.1 and 4.4 %, 
respectively. The difference between the amount of microflora in human and rats is less 
marked in the colon than in the upper gastrointestinal tract (Rowland et a l ,  1985).
2.2A.2 M icrobial enzymatic activities
The microflora is capable of catalysing a large number of reactions in the intestine. 
Hydrolysis of glycosidic bonds in oligosaccharides, natural sugar complexes which can 
not be metabolized by the mammalian digestive enzymes, is one of the best known
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(Goldin, 1990). Glycosides directly come from the diet or re-enter the intestine via the 
bile after a first step of detoxification by glucuronidation performed in the liver. 
Bacteria produce different glycosidases such as yS-glucosidase, yS-galactosidase and ft- 
glucuronidase (Goldin, 1986). This enzymatic activity is of importance in the field of 
polyphenols as most of the flavonoids, except flavanols and proanthocyanidins, are in 
general found glycosylated in plants (Scalbert & Williamson, 2000). The number of 
sugars is usually one but can also be two or three with different possible positions of 
substitution. It has been shown that the microbial /^-glucuronidase and /%-galactosidase 
activities are different between host species, for instance the /^-glucuronidase activity 
being much higher in rat than in human (Rowland et al., 1986). This difference could 
have a significant effect on the bioavailability profile of polyphenols if studied in one or 
the other species. Indeed, removal of the sugar, which represents a hydrophilic moiety 
for the polyphenol, will be necessary for passive diffusion across intestinal barrier. As 
an example of bacterial metabolism of flavonoids is the deglycosylation of quercetin-3- 
glucoside by Enterococcus casselifavus into quercetin (Blaut et a l ,  2003). Microbial 
metabolism has also been shown to be critical for the bioavailability and as a 
consequence for the bioactivity of isoflavones (daidzein, genistin and glycitein). They 
release the aglycone from the corresponding glycoside and further metabolize it, leading 
to activation or de-activation of the isoflavone, as reviewed in (Turner et a l ,  2003). 
Indeed, the microflora plays a major role in the bioavailability of some polyphenols in 
terms of type of circulating forms. By comparing germ-free rats and germ-free rats 
associated with human microflora, it has been shown that the profile of urinary excreted 
metabolites after ingestion of an isoflavone-rich diet was different and linked to the 
presence of microflora (Bowey et a l ,  2003). Moreover, the production of equol, the 
reduced form of daidzein, was subject dependent, the microbial unit responsible for this 
conversion present only in some human microflora. The microflora is also able to
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extensively metabolize polyphenols into various aromatic acids by opening their 
backbone at different points depending on their structure, generating a wide range of 
metabolites (developed in the § 3.1). In return, metabolites derived from microbial 
metabolism of polyphenols can exert an effect on the microflora as already shown for 
tea or red wine polyphenols modulating the intestinal bacterial population, probably by 
acting as prebiotics (Dolara et a l ,  2005; Lee et a l ,  2006).
2.2.5 The mammalian enzymatic activities participating in the bioavailability of 
polyphenols
2.2.5.I. Deglycosylation
Contrary to microflora, human liver and small intestinal tissue do not possess any 
rhamnosidase activity (Day et a l ,  1998). Rhamnosidase activity has been investigated 
in the rat small intestine using quercetin-3-O-rutinoside (rutin), the rutinoside moiety 
being a disaccharide of glucose and rhamnose (loku et a l ,  1998). The authors could 
detect a low glycosidase activity in the rat small intestine, by measuring appearance of 
quercetin. However, only quercetin was measured. As rhamnose is attached to glucose, 
itself linked to quercetin, the enzymatic activity might be glucosidase, removing the 
disaccharide from the quercetin, rather than a rhamnosidase activity, hydrolysing the 
bond between the glucose and the rhamnose and releasing quercetin-glucoside. Thus, in 
human, and probably also in rats, removal of rhamnose must be performed by gut 
microflora. The use of germ free rats compared with germ-free rats colonized by human 
microflora showed the presence of a glucosidase activity allowing the production of 
aglycones from daidzin and genistin in both models (Bowey et a l ,  2003). The 
deglycosylation of polyphenols by intestinal mucosa has been proposed to be 
performed by 2 types of enzymes, which act either inside or outside the cells.
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Glycosidase activity of the lactase phlorizin hydrolase (LPH), a ^-glucosidase present 
in the small intestinal brush-border membrane, does not require a pre-absorption event 
of the molecules for hydrolase activity (Day et a l ,  2000). The physiological 
specificities of this enzyme are glucosylceramides and lactosylceramides, lactose being 
also a substrate for LPH (Leese & Semenza, 1973). In addition to lactose and phlorizin, 
LPH has also been shown to degly cosy late dietary flavonoid glucosides (Nemeth et a l ,
2003). However, the soluble cytosolic ^-glucosidase (CBG) requires a pre-absorption 
by the cells of the tissues in which it is expressed, such as liver, where the enzyme is 
the most abundant, or intestine (Lambert et a l ,  1999). The absorption of the glycoside 
conjugate could be by the glucose carrier SGLT1, as shown for quercetin-3-glucoside 
(Wolffram et a l ,  2002). CBG catalyses hydrolysis of a wide variety of xenobiotic 
glycosides, including glucosides, galactosides, xylosides, arabinosides and fucosides.
2.2.S.2. The detoxification system
All the compounds ingested from food, drugs and air or produced by intestinal 
microflora, and considered as toxic for the body, are presented to the first-pass 
clearance system, which involves the biotransformation and clearance of a compound 
from the body before it reaches the systemic circulation. This clearance takes place in 
several organ tissues including the intestinal mucosal wall and the liver. Liver is the 
primary detoxifying organ of the body. It filters circulating blood and produces bile that 
serves as a carrier in which many toxic substances are dumped back into the intestine. 
The detoxification role of the liver involves two processes known as Phase I and II 
(Grant, 1991).
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2.2.5.2.1 Phase I
Phase I serves to transform substances through oxidation, reduction or hydrolysis. This 
system either neutralizes a toxin, or modifies it to form activated intermediates, which 
are then neutralized by one or more of the several Phase II enzyme systems. Although 
there is a range of metabolic enzymes involved in Phase I reactions (alcohol and 
aldehyde dehydrogenases, xanthine and amine oxidases, aromatases and different 
enzymes initiating hydrolysis reactions), the super family of CYP enzymes 
(Cytochrome P450) is the most representative one (Doherty & Charman, 2002). These 
enzymes are highly expressed in the endoplasmic reticulum (microsomes) of the liver 
and less concentrated in the intestine, lungs, kidneys, brain and placenta. Cytochrome 
P450 ratio livenintestine was estimated in rat and human and the results suggested that 
the biotransformations in intestine may be of some importance in the rat but are 
unlikely to contribute substantially to the metabolism of drugs in human (Back & 
Rogers, 1987). Because the intestine is the first organ able of detoxification 
encountered by food derived compounds or orally taken drugs, its detoxification system 
plays a major role in the neutralization of orally ingested xenobiotics. However, 
molecules absorbed through the intestinal wall via the paracellular pathway are less 
likely to undergo metabolism by intestinal cells. Human gastrointestinal mucosa is 
capable of different metabolic reactions of Phase I. Oxidation reactions are performed 
by Cytochrome P450, alcohol dehydrogenase and monoamine oxidase and hydrolyses 
by non-specific esterases (Back & Rogers, 1987). The highest concentration of mucosal 
enzymes is in the upper small intestine, decreasing from the tip of the villi to the crypts 
(Shen et a l ,  1997). 3 subfamillies of CYP enzymes are found in human small intestine: 
CYP1, CYP2 and CYP3. However, the predominant cytochrome P450 iso-enzyme in 
human adult liver and intestine was shown to be the CYP3A4, in which it represents 
respectively 60 and 70 % of the total CYP450 amount (Kolars et a l ,  1994; Shimada et
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a l ,  1994). Even though, RNAs from CYP1A1, 1B1, 2C, 2D6, 2E1, 3A4 and 3A5 were 
detected in enterocyte microsomes of several human small intestine samples (Zhang et 
a l ,  1999), only CYP2C and 3A4 were detected by Western immunoblotting suggesting 
that only these 2 forms can play a role in CYP detoxification by enterocytes.
2.2.5.2.2 Phase II
In Phase II, conjugation reactions add a polar hydrophilic molecule to the intermediate 
metabolite generated from Phase I reaction or directly to the xenobiotic, converting 
lipophilic substances to more water-soluble forms for their excretion and elimination. 
These polar hydrophilic molecules are glutathione, sulphate, glycine, methyl and 
glucuronide, respectively added to xenobiotics by glutathione-S-transferases, 
sulphotransferases, acyl-CoA glycine transferases, methyltransferase and UDP- 
glucuronosyltransferases. Phase II reactions may follow Phase I or act directly on the 
toxin or metabolite. Whereas the Phase I activities of the intestinal mucosa are 
considerably lower than that of the liver, the conjugation reactions of Phase II in the gut 
may be close to that of the liver. Human intestinal tissues have been reported to express 
high levels of Phase II enzymes such as glucuronosyltransferase, N-acetyltransferase, 
sulphotransferase and glutathione-S-transferase (Prueksaritanont et a l ,  1996).
Among the different enzymatic activities of the Phase II system, glucuronidation, 
sulphation and méthylation are the most studied enzymatic reactions in the field of 
polyphenol metabolism. The UDP glucuronosyltransferase (UDP-GT), an enzyme 
situated in the endoplasmic reticulum, catalyses the conjugation of polyphenols with 
glucuronic acid (Fig. 11) (Scalbert & Williamson, 2000). Glucuronidation uses UDP- 
glucuronic acid (glucuronic acid linked via a glycosidic bond to uridine diphosphate).
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formed in the liver, as an intermediate. The UDP-GT enzymes exist as a large family of 
related enzymes. UGT1A is the one that predominantly glucuronidates polyphenols and 
occurs in intestine, liver and kidney (Scalbert & Williamson, 2000).
The sulphotransferases (SULTs) are a group of cytosolic enzymes widely distributed, 
which transfer an S 0 3_ group from the universal sulphonate donor T-phosphoadenosine 
5'-phosphosulphate (PAPS) to molecules possessing phenols, enols, alcohols or amines 
(Strott, 2002). The SULTs constitute a multi-gene family, and based on their amino 
acid sequences, the cytosolic SULTs in mammals have been classified as the phenol 
sulphotransferase (P-ST) family, known as form SULT1, and the hydroxysteroid SULT 
(US-ST) family, better known as SULT2. SULT1A1 is the predominant form of phenol 
sulphotransferase in the liver, whereas catechol sulphotransferase, the SULT 1 A3 form, 
is the predominant one in the intestine (Cappiello et a l ,  1990).
Méthylation is also an important enzymatic activity, especially regarding polyphenols 
possessing a catechol moiety. Catechol-O-methyl transferase (COMT) catalyzes the 
transfer of a methyl group from the methyl donor S-adenosyl methionine to one 
hydroxyl group of the ring catechol of a substrate to eliminate the potentially active or 
toxic catechol structures of endogenous and exogenous compounds (Axelrod & 
Tomchick, 1958). COMT is present in both soluble and membrane-bound forms in 
mammals, with the soluble form being predominant in most tissues.
OH
OH
OHHO
OH
Figure 11 Glucuronic acid structure.
The arrow indicates the hydroxyl group to which the xenobiotic to be detoxified will be attached 
by a f-glycosidic bond.
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2.2.5.23 Other systems involved in detoxification
Additionally to the Phase I and II detoxification systems, the antiporter activity (p- 
glycoprotein or multi-drug resistance) has been defined as the Phase III system. The 
antiporter m drl P-glycoprotein is an ATP-binding cassette transporter (ABC 
transporter), an energy-dependent efflux pump, which pumps xenobiotics out of a cell, 
thereby decreasing their intracellular concentration (Chin et a l ,  1993). Antiporter 
activity in the intestine appears to be expressed at the brush border of the enterocytes 
and co-regulated with intestinal Phase I CYP3A4 enzyme, indicating that the antiporter 
may support detoxification (Nakamura et a l ,  2002). Its function of pumping non­
metabolized xenobiotics out of the cell back to the intestinal lumen could give another 
chance to the Phase I activity to metabolize the xenobiotic before it enters into blood 
circulation. Two genes encoding antiporter activity have been described: the multi-drug 
resistance gene 1 (MDR1) and multi-drug resistance gene 2 (MDR2) (Chin et a l ,  
1993). The MDR1 gene product is normally found in cells of the liver, kidney, 
pancreas, small and large intestine, brain, and testes. MDR2 activity is expressed 
primarily in the liver and may play a role similar to MDRL The Multidrug Resistance 
Proteins (MRPs) are also ATP-dependent transporters belonging to the ABC transporter 
superfamily. Multidrug resistance protein 2 (MRP2, ABCC2) is present predominantly 
at the biliary pole of hepatocytes and is also expressed in the kidney and intestine 
(Dietrich et a l ,  2003). It plays a major role in hepato-biliary elimination of many 
structurally diverse xenobiotics, including organic anions and drug conjugates. The 
contribution of MRP2 form to polyphenol export has been demonstrated using Caco-2 
cells (Walle e ta l ,  1999).
Absorption of polyphenols is determined by their chemical structure, molecular size, 
degree of polymerisation and solubility (Wollgast & Anklam, 2000). The polyphenol
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structure will also influence its conjugation with methyl, sulphate or glucuronide 
groups but also its metabolism by microflora and finally the amount of its absorbed 
forms, which represents the potential active molecules.
2.3 B e h a v io u r  o f  m o n o m e r ic  to  o l ig o m e r ic  p r o c y a n id in s  in  t h e
GIT, AS AN ILLUSTRATION OF FLAVONOIDS BIO AVAILABILITY
2.3.1 Stability from the mouth to the small intestine
The first fluid encountered by ingested procyanidins is saliva. Interaction between 
salivary proteins and flavan-3-ols has been investigated and demonstrated to be 
dependent on the chemical structure of the tested compounds, a gallate substitution on 
the position 3 on (-)-epicatechin or (-)-epigallocatechin increasing their affinity to 
salivary proteins (Bacon & Rhodes, 1998). Moreover, an extra hydroxyl group on the 
5’-position of (-)-epicatechin gallate ((-)-epigallocatechin gallate) also favoured 
interaction. However, epimerization of the hydroxyl group in position 3 seemed to have 
a less marked effect. The interactions between procyanidins and proline-rich proteins, 
optimum at pH 3.5 and 5, were shown to lead to their precipitation (de Freitas & 
Mateus, 2001), the intra-flavanol linkage and the structural monomeric units composing 
procyanidins influencing this precipitation, the degree of polymerization having only a 
slight effect.
Different studies have investigated the effects of saliva and gastric fluid on the stability 
and, as a consequence, on the behaviour of procyanidins during the first steps following 
their ingestion. Unpublished data, observed and mentioned by Spencer et a l  in a review 
(Spencer et a l ,  2001a), showed that, incubated in human saliva for up to 30 min, 
procyanidins, from dimeric to hexameric forms, were not altered, 99 % of the initial 
quantity being recovered at the end of the incubation period. Oligomeric procyanidins
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isolated from Theobroma cacao incubated in a phosphate buffer at pH 2 were degraded 
into monomeric and mainly into dimeric forms (Spencer et a l ,  2000). After 2.5 hours at 
pH 2, 70 % of the trimeric to hexameric forms were degraded compared with only 15 % 
for the dimeric form during the same period of time. No difference being observed 
between the use of a phosphate buffer at pH 2 and a commercially available simulated 
gastric juice at the same pH without pepsin, the authors suggested that the pH was the 
only parameter responsible for the cleavage of oligomers. Another report mentioned 
that (-)-epicatechin and (+)-catechin are stable in simulated gastric juice (0.24 % 
hydrochloric acid - 0.2 % sodium chloride solution, pH 1.8), whereas PC dimers B2 
(two epicatechin units linked by C4-C8 bond) and B5 (two epicatechin units linked by 
C4-C6 bond) are unstable, producing epicatechin units and their respective isomers B5 
and B2 (Zhu et a l ,  2002a). These results are in contradiction with data obtained from 
an in vivo study investigating the stability of procyanidins from a chocolate beverage 
during stomach transit (Rios et a l ,  2002). The pH of the stomach was at about 5.4 ± 0.2 
after intake of the cocoa beverage and not at 2, which corresponds more to the pH of 
empty stomach. The percentage of each oligomer among the total amount of flavonoids 
present in the beverage was the same after stomach transit and the components were not 
degraded during the stay in the stomach. This report supports the idea that all the 
ingested procyanidins should reach the small intestine without any pre­
depolymerisation in the stomach. However, the pH of the GIT from stomach to jejunum 
varies from 2 to 8.5. It is known that polyphenols such as flavanols oxidize rapidly at 
alkaline pH at the level of the catechol moiety present on the B-ring (Spencer et a l ,  
2001a). Thus, oxidation of procyanidins could occur in the first part of the small 
intestine. In simulated intestinal juice (1.5 % sodium hydrogen carbonate solution, pH 
8.5), monomers, as well as dimers, degraded almost completely within several hours, 
however neither epicatechin/catechin nor isomers were found from the dimers (Zhu et
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a l ,  2002a). At higher pH, monomers and dimers degraded within minutes. Studies have 
also shown that (epi)catechins are much more stable than the corresponding 
gallocatechins under digestive conditions (gastric or small intestinal), whereas the 
gallate substitutes had an intermediate stability (Neilson et a l ,  2007). However, 
catechins were more stable in gastric phase than in intestinal phase, stability which was 
more linked to pH than to enzymatic activity, the sensitivity being for rather neutral or 
basic pH. The instability of epigallocatechin gallate, epicatechin and epigallocatechin 
resulted in the formation of homodimers.
2.3.2 Absorption from the small intestine
Unlike some classes of polyphenols such as flavonols and flavones, flavanols are 
almost always present in the non-glycosylated form. Removal of glycoside from 
flavonoids, usually necessary before the transport across the intestinal barrier, is not 
required in the case of flavanols (Scalbert & Williamson, 2000). The absorption of 
procyanidins at the level of the small intestine was investigated by studying 14C-(+)- 
catechin, dimer, trimer and PCs polymers permeation through Caco-2 cell cultures 
(Deprez et a l ,  2001). There was not much difference in permeability between monomer, 
dimer and trimer, based on the measurement of radioactivity present on the basal side 
of the cultures, whereas the permeability of the polymers was 10 times lower. The 
authors reported the absence of catechin metabolism but did not mention if they 
checked whether the radioactivity measured on the basal side of the cultures was from 
the parent dimers to polymers or from their products of degradation or metabolites, 
which could have resulted from the un-stability of the parent compounds in the culture 
medium or from their metabolism by mammalian enzymes. From the results obtained, 
the authors suggested that procyanidins, from monomers to polymers, are poorly 
absorbed, transported via the paracellular pathway. The paracellular permeation of
monomers does not fully support other studies reported in the literature, which rather 
suggested an absorption by intestinal cells of (epi)catechin in order to allow 
conjugation. For example, catechin glucuronide and 3'-0-methyl-catechin were found 
in the mesenteric vein after in situ perfusion of rat jejunum and ileum with catechin, 
indicating the intestinal origin of these conjugates (Donovan et a l ,  2001). After 
epicatechin oral administration by direct stomach intubation of rats, its free as well as 
its methylated forms were found in plasma of blood collected from the tail in addition 
to sulphated, glucuronidated and sulpho-glucuronidated forms (Piskula & Terao, 1998). 
The blood being taken from the tail 2h after the intake, conjugation could not be 
concluded to take place in the intestinal cells. However, with isolated tissues, the 
authors reported a glucuronosyltransferase activity higher in the small and large 
intestinal mucosa than in the liver, kidney and lung. The different studies listed above 
investigated absorption and conjugation of procyanidins but it is only more recently 
that the mechanism of transport involved in catechin and epicatechin absorption was 
studied. It was suggested that an active transport, Na+-independent but stimulated by an 
outwardly directed gradient of protons, could be used by the flavan-3-ols monomers 
(-)-epicatechin and (+)-catechin to cross the intestinal barrier (Starp et al., 2005). 
Based on their results, the authors also proposed that free diffusion would be favoured 
by high concentrations of flavan-3-ols whereas carrier mediated uptake would occur for 
lower amounts.
If the mechanisms of absorption of monomeric forms of flavanols are now better 
understood, the results obtained from the studies investigating the absorption of dimers 
are contradictory and make the understanding of their permeation mechanism more 
difficult. The absorption of dimers has been suggested from in vivo data showing 
procyanidin B1 detected in human serum after intake of procyanidin-rich grape seed
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extract (Sano et a l ,  2003). After oral administration of procyanidin dimer B-2 to rats, 
0.34 % of the provided dose was detected in urine (Baba et a l ,  2002). Besides dimer B- 
2, the presence of epicatechin and its 3’-0-methylated product were also excreted in 
urine. All the compounds found in urine were present in plasma, peaking at 30 - 60 min 
following the intake of procyanidin dimer. The absorption of pure dimers B2 and B5 
from the perfusion of rat jejunum was also shown, with six different components 
having flavanol-like spectral characteristics detected on the serosal side of the intestinal 
epithelium, which represented a transfer of flavanol of 23 % (Spencer et a l ,  2001b). In 
addition to catechin, dimer and 0-methylated dimer, the major compound (95.8 %) 
obtained on the serosal side had the characteristics of epicatechin, with no evidence for 
the presence of its glucuronides or 3’-0-methyl and 4 ’-0-methyl conjugates. The 
authors also suggested that the cleavage of the dimer into monomeric form would be 
energy dependent, taking place in the intestinal cells. More recently, tetramethylated 
dimeric procyanidins were detected in rat plasma and liver 1 h after intake of synthetic 
dimeric procyanidins (Garcia-Ramirez et a l ,  2006). Appearance of procyanidin B-2 
and B-3, purified from Cinnamonomic cortex, has been measured in plasma, peaking 
respectively at 20 and 40 min after their oral administration to rats (Tanaka et a l ,  2003). 
According to the chemical structure drawn and the mass reported in the paper, the 
compound called dimer B-3 would be a trimer. This would be the first time that a trimer, 
found under the form of parent compound in plasma, is reported in literature, which is 
unexpected due to its molecular weight.
Even if dimers and trimers are stable under GIT conditions and absorbed under their 
native form as for the monomers, the amount crossing the epithelial barrier of the small 
intestine and being further excreted in urine must be very low, the major part of the 
ingested procyanidins reaching the colon where an abundant microflora can metabolize
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them into smaller molecules, more potent for absorption. The general behaviour of 
procyanidin monomers to oligomers in the GIT, from their ingestion to microbial 
metabolism, is summarized on Figure 12.
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Figure 12 Summary of the procyanidin behaviour in the GIT.
^  , precipitation; 9 ,  phenolic acid; CH3, methyl conjugate; G, glucuronide; 0~, oxidized  
hydroxyl group; S, sulphate; S+G, sulphoglucuronide conjugate.
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3 Phenolic acids as metabolites of plant-derived compounds
Gut microflora accounts for a major part of the production of phenolic acids excreted in 
urine (Goodwin et a l ,  1994). In addition, mammalian enzymes can also participate in 
the structure modification of these phenolic acids. The following paragraphs will mainly 
focus on hydroxycinnamic rather than on hydroxybenzoic acid derivatives, since they 
were purpose of investigation during the present PhD work, with a particular interest for 
ferulic and dihydrocaffeic acids.
3.1 P r o d u c t i o n  o f  p h e n o l i c  a c i d s  in  t h e  c o l o n  f r o m  f l a v o n o i d s
MICROBIAL DEGRADATION
Several studies have shown the presence of phenolic acids in plasma and/or urine after 
intake of different types of flavonoid-rich food, such as artichoke extract, apple cider, 
breakfast cereals, tomatoes, coffee or beer, chlorogenic, caffeic and ferulic acids being 
the most studied ones (as reviewed in (Manach et a l ,  2005)) but also after chocolate 
intake (Rios et a l ,  2003) or red wine consumption (Caccetta et a l ,  2000). Several 
phenolic acids were identified in human urine after intake of a polyphenol-rich meal 
based on fruits and vegetables and comprising tomato and onion pasta sauce, pasta, 
cooked broccoli, cherry tomatoes, cucumber, continental leaf salad, pepper salad 
dressing, raspberries, red grape juice and apple juice (Rechner et a l ,  2002). Ferulic, 
isoferulic, sinapic and 3-hydroxyphenylacetic acids were found glucuronidated, 
whereas vanillic and homovanillic acids were found as both free and glucuronidated 
forms. In plasma, dihydroferulic and 3-hydroxyphenyIpropionic acids were present as 
free and glucuronidated forms with ferulic, isoferulic, p-coumaric, hydroxybenzoic and 
vanillic acids as glucuronide conjugates only. The authors proposed the 3,4- 
dihydroxyphenylpropionic acid (dihydrocaffeic acid) as the first hydroxycinnamic acid
46
in the cascade of microbial metabolism of dietary flavonoids, based on their work and 
reports from the literature. Indeed, monomeric units of procyanidins, which have not 
been absorbed through the small intestinal epithelium, can reach the colon to be 
metabolized by the intestinal microflora. 3-hy droxypheny Ipropionic acid has been 
proposed to be the major metabolite found in urine of rats after ingestion of (+)- 
catechin (Griffiths, 1962), in the free form but also conjugated (Griffiths, 1964), 
together with 4-hy droxypheny Ipropionic acid, 5-(3-hydroxyphenyl)-^valerolactone, 5- 
(3,4-dihydroxyphenyl)-^valerolactone and hydroxyphenylvaleiic acids, as minor 
metabolites (Scheline, 1970). In urine of rats, 5-(3,4-dihydroxyphenyl)-^valerolactone 
was detected, resulting from the ring fission of (-)-epicatechin by microflora (Meng et 
a l ,  2002; Unno et a l ,  2003), and in human urine, it was found together with 3,5- 
dihydroxyphenyl-y-valerolactone after ingestion of green tea, epigallocatechingallate or 
epigallocatechin (Meng e ta l ,  2002).
Benzoic, 2, 3 and 4-hydroxybenzoic, phenylacetic, 4-hydroxyphenylacetic,
phenylpropionic, 2, 3, 4-hydroxyphenylpropionic, 3,4-dihy droxypheny Ipropionic acids, 
but also £(3-hydroxyphenyl)-^valerolactone and l-(3-hydroxyphenyl)-3-(2,4,6- 
trihydroxyphenyl)-propan-2-ol have been detected after 5 days incubation of 
proanthoyanidin dimer B3 with rat-cecal microflora (Groenewoud & Hundt, 1986). In a 
more recent study, also investigating the in vitro microbial metabolism of a 14C-labeled 
procyanidins fraction, which did not contain monomer, dimer and trimer, low- 
molecular-weight aromatic acids, differing by their hydroxylation status and the length 
of their aliphatic side chain, were detected (Deprez et a l ,  2000). The 6 different 
compounds found were m-hydroxyphenylacetic acid and m-hydroxyphenylpropionic 
acid, their isomers p-hydroxyphenylacetic acid and p-hydroxyphenylpropionic acid, m- 
hydroxyphenylvaleric acid and phenylpropionic acid. Phenylacetic and benzoic acids
were also detected but their source was not clearly identified. In vivo work on rats or in 
human have also supported the results found in vitro showing the presence of phenolic 
acids in plasma and urine after intake of isolated procyanidins, extracts or food 
containing procyanidins. In vivo investigation of the metabolism of catechin monomer, 
dimer B3, trimer C2 and purified polymers using a rat model suggested that 
procyanidin degradation could start by a depolymerization into (epi)catechin monomers, 
due to similarities in the degradation products obtained from catechin and procyanidins, 
before the further metabolism leading to the production of phenolic acids (Gonthier et 
a l ,  2003b). Phenolic acids recovered in urine were also detected in human after 
chocolate intake (Rios et a l ,  2003) and of rats after intake of red wine polyphenols 
(Gonthier et a l ,  2003a), food sources known to contain procyanidins. Phenolic acids 
can be expected to be found in plasma and urine after different food intake, since 
oligomers of procyanidins are found in grape seed extracts (Ward et a l ,  2004), in 
apples, cranberries, chocolate and wine (Hammerstone et a l ,  2000). The stability, as 
well as the microbial metabolism of monomeric and oligomeric/polymeric procyanidins 
and the generation of the first forms of hydroxycinnamic acids, are summarized in 
Figure 12. A non-exhaustive list of the different phenolic acids found in plasma or urine 
in vivo after ingestion of flavonoid-rich foods or pure flavonoids is presented in Table 2.
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Table 2 Summary o f the phenolic acids found in vivo and in vitro from different food sources 
and flavonoids.
BA, benzoic acid; C, conjugated; CA, caffeic acid; m or p-CA, m or p-coumaric acid; DHFA, 
dihydroferulic acid; 3,4-DHPAA, 3,4-dihydroxyphenylacetic acid; 3,4-DHPPA, 3,4- 
dihydroxyphenylpropionic acid; 3,4-DHPVA, 3,4-dihydroxyphenylvaleric acid; FA, ferulic acid; G, 
glucuronide; HA, hippuric acid; 2-, 3- or 4-HBA, 2-, 3- or 4-hydroxybenzoic acid; 3- or 4-HHA, 3- or 4- 
hydroxyhippuric acid; 3- or 4-HPAA, 3- or 4-hydroxyphenylacetic acid; 3- or 4-HPPA, 3- or 4- 
hydroxyphenylpropionic acid; 3- or 4-HPVA, 3- or 4-hydroxyphenylvaleric acid; HVA, homovanillic 
acid; isoFA, isoferulic acid; nd, not detected; PAA, phenylacetic acid; PCA, protocatechuic acid; PPA, 
phenylpropionic acid; SA, sinapic acid; VA, vanillic acid.
Diet Model Phenolic acids References
Plasma t Urine
(+)-catechin rats Ï major metabolites: 3-HPPA, 
i free and C
(Griffiths, 1962) 
(Griffiths, 1964)
(+)-catechin rats | •  major metabolite: 3-HPFA 
i •  minor metabolites: 4-HPIA  
| 5-(3-hydroxyphenyl)-7 
[ valerolactone, 5-(3,4- 
! dihydroxyphenyl)- y  
! valerolactone and HPVA
(Scheline, 1970)
(-)-epicatechin rats ; 5-(3,4-dihydroxyphenyl)-y- 
valerolactone
(Meng et a i ,  
2002; Unno et 
a i ,  2003)
•  8 days of diet 
supplemented with 0.12 
g/100 g catechin,
• 0.25 or 0.50 g/100 g red 
wine powder
rats
• phenolic acids affected by 
the diet (represent 4.7g/100g 
catechin ingested): 3-HPPA 
(major), 3-HBA, 4-HBA, 3- 
HHA, 4-HBA, FA, 3,4- 
DHPAA, 3,4-DHPPA, 3-HPA.
•  3-HBA, 4-HBA, HA, 3- 
HHA, 4-HHA, VA, PAA, 3- 
HPA, 3,4-DHPAA, 3-HPPA, 
3,4-DHPPA, p-CA, CA, FA.
(Gonthier et a i ,  
2003a)
phenolic acids from dimer trimer polymer
catechin, dimer B3, trimer 
C2 and purified polymers
rats
3.4-DHPVA nd 
3-HPVA x
3.4-DHPPA x 
3-HPPA x
m-CA x 
p-CA  same as Ctrl 
FA x
3.4-dHPAA x 
3-HPAA almost
PCA same as Ctrl
3-HBA x
4-HBA x 
VA x
3-HHA x
4-HHA x 
HA x
nd nd 
x nd 
nd nd
X X 
X X
same as Ctrl same as Ctrl
X X
same as Ctrl same as Ctrl 
same as Ctrl same as Ctrl 
same as Ctrl same as Ctrl 
nd nd 
same as Ctrl same as Ctrl
X X
nd nd 
same as Ctrl same as Ctrl 
same as Ctrl x
(Gonthier et a i ,  
2003b)
green tea, 
epigallocatechingallate or 
epigallocatechin
human 5-(3,4-dihydroxyphenyl)-y- 
valerolactone and 3,5- 
dihydroxyphenyl-y- 
i  valerolactone
(Meng et a i ,  
2002)
polyphenol-rich meal based 
on fruits and vegetables
human • DHFA and 3-HPPA: free 
and G forms 
•  FA, isoFA, p-C A, HBA and 
VA: G forms
•  FA, isoFA, SA and 3- 
HPAA: G forms 
•  VA and HVA: free and G 
forms
(Rechner et a i ,  
2002)
chocolate intake human 3,4-DHPPA, 3-HPPA, FA,
1 3,4-dHPAA, 3-HPAA, PAA, 
VA, 3-HBA, 4-HBA, 4-HHA, 
HA
(Rios et a i ,  
2003)
proanthoyanidin dimer B3 5 days 
incubation 
with rat- 
cecal 
microflora
BA, 2 ,3  and 4-HBA, PA, 4-HPAA, phenylpropionic, 2, 3 ,4 -  
HPPA, 3,4-diHPPA, 8-(3-hydroxyphenyl)-y-valerolactone and 
l-(3-hydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)-propan-2-ol
(Groenewoud & 
Hundt, 1986)
14C-labeled procyanidins human 3-HPAA and 3-HPPA acid, 4-HPAA and 4-HPPA, 3-HPVA, (Deprez et a i ,  
fraction, without monomer, colonic PPA, PA, BA 2000)
dimer and trimer microflora
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Phenolic acids can come from the metabolism of different polyphenols than catechins 
and procyanidins. The degradation of flavonoid aglycones by microflora can be more or 
less rapid, the presence of a methoxyl group on the A or B ring of the flavonoid being 
protective against the bacterial degradation by C-ring cleavage (Lin et a l ,  2003). Ring 
fission of quercetin followed by water elimination and dehydroxylation resulted in the 
formation of 3-hydroxyphenyIpropionic acid (Schoefer et a l ,  2003; Rechner et a l ,
2004), which itself resulted from the deglycosylation of rutin. However, quercetin has 
also been reported to be metabolized by C-ring fission into 3,4-dihydroxyphenylacetic 
acid (coming from the B-ring) and phloroglucinol (three hydroxyl groups on a phenyl 
ring, coming from the A-ring) (Winter et a l ,  1989). Moreover, 3- 
hydroxyphenylpropionic acid resulted from the ring fission of naringenin, itself the 
aglycone obtained by microbial deglycosylation of naringin, and could be further 
dehydroxylated to give phenyIpropionic acid (Rechner et a l ,  2004).
Dihydrocaffeic acid, the metabolite of dihydroxyphenylvaleric acid in the cascade of 
microbial degradation of catechins and procyanidins (Fig. 13), is one of the major 
phenolic acids found in human faecal water (Jenner et a l ,  2005). It was detected in the 
plasma of coffee drinkers (Goldstein et a l ,  1984), in urine as the free form and mainly 
conjugated in human plasma after ingestion of artichoke leaf extracts, which contain 
monocaffeoylquinic, dicaffeoylquinic and caffeic acids as well as flavonoids (Wittemer 
et a l ,  2005), in human urine after chocolate intake (Rios et a l ,  2003), in rat urine after 
ingestion of polyphenol-rich red wine extract (Gonthier et a l ,  2003a) and produced by 
bacteria from luteolin and apigenin (Schoefer et a l ,  2003). Due to the abundance of its 
precursors in food and its central appearance in the cascade of microbial metabolism of 
flavonoids, dihydrocaffeic acid, in addition to all the other phenolic acids generated in 
the colon by microbial metabolism of flavonoids, could play a significant role in the
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biological activities of these polyphenols in vivo and as a consequence was considered 
in the present thesis for studying its absorption and beneficial effects.
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Figure 13 Summary o f the microbial metabolism leading to hydroxycinnamic acids from  
monomeric and oligomeric/polymeric units o f procyanidins.
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3.2 P h e n o l i c  a c i d s  f r o m  p l a n t  e s t e r s
As mentioned in paragraph 1.2, phenolic acids, and most particularly ferulic acid, are 
mainly found in food as soluble or insoluble esters. For most of the insoluble esters, a 
preliminary hydrolysis and a release of the free form will be required before absorption. 
In the gastrointestinal tract, the insoluble wheat bran fibre is first hydrolysed by 
xylanase, releasing feruloylated oligosaccharides to the soluble phase, where cinnamoyl 
esterase can hydrolyse the ester bond and release ferulic acid (Kroon et a l ,  1997). A 
small proportion of ferulic acid, as free form and esterified groups, has been shown to 
be released from wheat bran by in vitro gastric and small intestinal incubation, 
indicating the presence of enzymatic activities in the upper part of the GIT, able to 
hydrolyze the xylan backbone and the ester bond of ferulic acid from the xylan 
backbone. However, 95 % of the total release of the feruloyl groups appear to take place 
in the colon where xylanase and cinnamoyl esterases activities of microbial origin have 
been detected (Couteau et a l ,  2001). Small amounts of cinnamoyl esterases of 
mammalian origin have also been identified in the mucosa of the small intestine, which 
could possibly also come from pancreatic secretions (Andreasen et a l ,  2001a; 
Andreasen et a l ,  2001b). The enterocyte-like cells Caco-2 also exhibited hydrolase 
activity towards esters of hydroxycinnamic acids and diferulates, part of the esterases 
produced by the cells being secreted in the culture medium (Kern et a l ,  2003b). The 
release of hydroxycinnamic acids by the intestinal esterases appeared however to be 
dependent on the substitution of the phenyl ring of the substrate, the activity decreasing 
with the number of substitutions and the substrate specificity being not as marked with 
microbial esterases (Andreasen et a l ,  2001a). Interestingly, intestinal esterases are not 
active towards chlorogenic acid whereas microbial ones are able to produce caffeic acid, 
as already proposed (Plumb et a l ,  1999; Rechner et a l ,  2004). Very low amounts of 
caffeic acid have been detected in gastric and small intestinal content after ingestion by
rats of a chlorogenic acid supplemented diet, appearance of the free form being much 
more significant in the caecum (Lafay et a l ,  2006a). From coffee consumption, 
chlorogenic acid was not found in human plasma but high amounts of caffeic acid were 
detected, suggesting no absorption of the ester and a requirement of pre-cleavage of the 
ester bond before absorption in the gastrointestinal tract (Nardini et a l ,  2002). It can be 
extrapolated that ferulic acid, found esterified with carboxylic acids such as quinic acid 
in food (Herrmann, 1989) or with polysaccharides in cereals for instance, could also 
reach the caecum almost intact and be released by the action of xylanases and 
cinnamoyl esterases, mainly in the caecum and colon.
4 The bioavailability of phenolic acids
Once ingested or released in the gastrointestinal tract, phenolic acids can be further 
metabolized by the microflora and/or by mammalian enzymes to produce new 
compounds.
4.1 M a m m a l ia n  a n d  m ic r o b ia l  m e t a b o l ism  o f  ph e n o l ic  ac id s
One of the first papers presenting microbial metabolism of phenolic acids was the report 
of Scheline who used rat intestinal microflora (Scheline, 1968). This paper, covering 
most of the interconversions possible between phenolic acids by microflora, reported 
the reduction of the unsaturated side chain in o-, m- and p-coumaric, caffeic, isoferulic 
and ferulic acids. Microflora was also capable of dehydroxylation on position 4 of 
protocatechuic and dihydrocaffeic acids into their respective m-hydroxy acid forms. 
Dehydroxylation of hydroxycinnamic acids has also been demonstrated for human 
microflora, phenylpropionic acid obtained from m-hydroxyphenylpropionic acid, itself 
resulting from dehydroxylation of dihydrocaffeic acid (Rechner et a l ,  2004).
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Déméthylation of the 3-hydoxy-4-methoxy- and 3-methoxy-4-hydroxy-phenylacetic, 
phenylpropionic and cinnamic acids also occurred with rat intestinal microflora 
(Scheline, 1968). In addition, the author showed decarboxylation of phenylacetic and 
cinnamic, but not phenylpropionic, acids which possessed a p-hydroxyl group. 
Dihydrocaffeic and caffeic acids were later shown to be decarboxylated by ^-oxidation 
to form respectively 4-vinyl-catechol and 4-ethylcatechol in vitro (Peppercorn & 
Goldman, 1971). Vinyl-catechol was formed by Lactobacillus sp. 1 in vitro but not in 
vivo, in germ free rats colonized by this strain (Peppercorn & Goldman, 1972). The 
appearance of propionic and benzoic acids would be the result of progressive loss of 
carbons through ^-oxidation from the phenyl valeric compounds (Deprez et a l ,  2000). 
Beta-oxidation, taking place in the liver by mammalian enzymes, was responsible for 
the production of vanillic acid from dihydroferulic acid, itself coming from the 
hydrogenation of ferulic acid (Rechner et a l ,  2002). However, another report mentioned 
the production of vanillic acid from caffeic acid metabolism, with the detection of 
ferulic and isoferulic acid but not dihydroferulic acid, suggesting that vanillic acid could 
also directly come from ferulic acid instead of dihydroferulic acid (Jacobson et a l ,  
1983). This hydroxycinnamic metabolism seems to be similar to the /^-oxidation of fatty 
acids. Indeed, vanillic acid has been proposed to result from ferulic acid via its 
reduction through the formation of feruloyl-SCoA, which is hydrated into 4-hydroxy-3- 
methoxyphenyl-y&hydroxypropionyl-SCoA further converted to vanillic acid and 
acetyl-SCoA by an enoyl-SCoA hydratase/lyase enzyme (Gasson et a l ,  1998). This 
enzyme belongs to a superfamily, which includes bacterial, mitochondrial, peroxisomal 
and glyoxysomal enzymes of the fatty acid oxidation pathway, suggesting that this 
enzymatic reaction can happen through bacterial or mammalian metabolism. The 
reduction, which has been shown to give dihydrocaffeic acid from caffeic acid by 
microflora (Peppercorn & Goldman, 1971; Rechner et a l ,  2004), could be an
intermediate step in the /2-oxidation. This reduction, which could also take place with 
mammalian enzymes due to the presence of the enzymes in mammalian cells, has never 
been clearly demonstrated. Indeed, gnotobiotic rats, germ free rats harbouring a strain of 
Streptococcus, were able to reduce caffeic into dihydrocaffeic acid, whereas germ free 
rats were not able (Peppercorn & Goldman, 1972). It has also been shown more recently 
that hepatocytes reduced ferulic acid to dihydroferulic acid (Moridani et a l ,  2002).
If intestinal microflora is capable of de-methlylation, it is not responsible for the 
méthylation of phenolic acids, since dihydroferulic and ferulic acids were excreted in 
urine of germ free rats after ingestion of respectively dihydrocaffeic and caffeic acids 
(Peppercorn & Goldman, 1972). The mammalian enzyme catechol-O-methyl transferase 
realises the méthylation of hydroxyl groups. Ferulic acid was an in vivo metabolite of 
caffeic acid (Azuma et a l ,  2000), such as its isomer isoferulic acid (Rechner et a l ,  
2002), secreted back into the lumen by intestinal cells, as shown after caffeic acid 
perfusion of rat small intestine (Lafay et a l ,  2006b). Ferulic and isoferulic acids, absent 
from the plasma samples, were detected in urine of rats, together with caffeic and 5 - 0  
caffeoylquinic acids, 1.5 h after the beginning of a meal containing chlorogenic acid 
(Lafay et a l ,  2006a). Usually, ferulic acid is found in nature as the trans-isomer. 
However, c/s-ferulic acid, found in biological samples (Zhao et a l ,  2004), was 
attributed to an isomerization of the trans- form taking place during the storage of the 
samples, as already hypothesized (Graf, 1992).
In addition to different hydroxyl derivatives of cinnamic, phenylacetic and benzoic 
acids, hydroxyl derivatives of hippuric acid are found as metabolites of flavonoids and 
phenolic acids. Hippuric acids come from the glycination, conjugation with glycine 
moiety, of benzoic acid derivatives in the liver and kidneys. The first step of this
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conjugation is the activation of benzoic acid by benzoyl-CoA ligase to form benzoyl- 
CoA, similarly to the first step of y9-oxidation (Schwab et a l ,  2001). However, benzoic 
acid, because of its short side chain, is not degraded by /^-oxidation but CoA is rather 
substituted by the amino acid glycine to form the hippuric conjugate. Hippuric acid 
derivatives are the end products of metabolism of phenolic acids and consequently of 
flavonoids. Indeed, they were detected in human urine after intake of a polyphenol-rich 
meal (Rechner et a l ,  2002), 3-hydroxyhippuric, 4-hydroxyhippuric and hippuric acids 
present as both free and glucuronidated forms. Hippuric acid and/or its hydroxy 
derivatives were also detected in rat urine after intake of chlorogenic acid (Gonthier et 
a l ,  2003c), dimer, trimer and polymers of procyanidins (Gonthier et a l ,  2003b), of a 
diet supplemented with catechin or red wine powder (Gonthier et a l ,  2003a) and in 
human urine after chocolate intake (Rios et a l ,  2003). The figure 14 summarizes most 
of the possible inter-conversions of the commonly found phenolic acids.
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Figure 14 Summary of the main possible inter-conversions between the different phenolic 
acids by microbial and mammalian enzymes, starting from dihydrocaffeic acid, the microbial 
metabolite o f 3,4-dihydroxyphenylvaleric acid.
4.2 A b s o r p t io n  o f  t h e  s o l u b l e  e s t e r s  a n d  f r e e  f o r m s
It is supposed that the soluble esters of phenolic acids with carboxylic acids or sugars 
will be stable through their passage in the stomach, since acidic gastric juice was not 
sufficient to cleave the ester linkage in 5-0-caffeoylquinic acid (Rechner et al ,  2001a), 
nor was an incubation in HCl-NaOH (0.9 %) aqueous solution (pH 2.5) of the 5-0- 
feruloyl-L-arabinofuranose (Zhao et a l ,  2004). In a study involving healthy ileostomy 
subjects, it was shown that 5-0-caffeoylquinic acid is absorbed as such and further 
metabolized in the liver, rather than hydrolyzed into caffeic acid before absorption in 
the stomach or in the small intestine, since it was fairly stable when incubated in 
gastrointestinal fluids (Olthof et a l ,  2001). However, the absorption of the ester was 
lower (33 % of the ingested dose) than the free form (95 %). Other reports have also 
mentioned the absorption of the soluble esters 5-O-caffeoylquinic acid (Lafay et al ,  
2006a; Lafay et al ,  2006b) or diferulic acids (Andreasen et a l ,  2001b), without a pre­
lysis of the ester bond. Indeed, 5-O-caffeoylquinic acid was detected in urine (Gonthier 
et al ,  2003c) or plasma (Lafay et al ,  2006a) of rats after intake of a semi-purified diet 
containing chlorogenic acid. In a more recent study performed in human, 3-, 4-, and 5- 
caffeoylquinic acids, as well as 3,4-, 3,5- and 4,5-di-caffeoylquinic acids were identified 
in plasma, peaking at 1 or 3h following ingestion of brewed coffee, depending on the 
subjects (Monteiro et al ,  2007), one subject showing the additional presence of 4- and 
5-feruloylquinic acid. Results on 5-0-caffeoylquinic acid absorption (summarized in 
Table 3) are however contradictory since some reports also mentioned no detection of 
this ester in plasma of rat after direct stomach administration of a solution containing 5- 
0-caffeoylquinic acid (Azuma et a l ,  2000) or human after coffee consumption (Nardini 
et al ,  2002). These discrepancies could result from the methods used to detect 
chlorogenic acid in plasma, LC-MS with electrospray ionization appearing to be the 
most adapted one (Matsui et a l ,  2007). They could also result from the instability of
chlorogenic acids towards the methods of purification used to process plasma or urine, 
leading to the lysis of the ester bond and to the release of the free form.
Ferulic acid has often been reported as a model compound for the investigation of 
phenolic acids bioavailability, as free or esterified forms (Table 4), since it is 
abundantly present in food. A scheme of digestion and absorption of ferulic acid has 
been proposed, based on the study performed on rats fed ferulic acid sugar esters, 5-0- 
feruloyl-L-arabinofuranose and feruloyl-arabinoxylan (Zhao et a l ,  2003a). Released 
from the ester, it would be more absorbed by the small intestine and the caecum. The 
authors also proposed that 5-0-feruloyl-L-arabinofuranose could be absorbed as such 
and further hydrolysed in the mucosa or in the circulation. The absorption of free 
phenolic acids is mainly expected to occur in the small and large intestine. However, a 
possible permeation of phenolic acids already in the stomach has been proposed in 
addition to the small intestine, such as for ferulic acid and its sugar ester, based on its 
rapid absorption observed with rats (Zhao et al ,  2003a). This hypothesis was later 
supported by a study using a rat in situ gastric perfusion model in which the pylorus was 
ligatured, followed by an injection of a solution of ferulic acid free or 5-0-feruloyl-L- 
arabinofuranose in the stomach before the ligature of the cardia (Zhao et a l ,  2004). The 
authors showed a high absorption rate of ferulic acid from the stomach (74 ± 1 1  % of 
the administered dose), much higher than the absorption of its sugar ester (19 ± 4 % of 
the administered dose). Uptake by the gastric cells was confirmed in vitro, ferulic acid 
and 5-0-feruloyl-L-arabinofuranose shown to be present in the gastric mucosa, only as 
un-conjugated forms, after incubation in an excised stomach, even though the 
experiment was performed on ice. This suggests that the uptake by the gastric cells did 
not require any energy and was probably carrier independent. If the uptake was by a 
transcellular route, the incubation on ice must have lowered the amount up-taken by the
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cells, since the fluidity of the phospholipidic membranes will be reduced by lowering 
the temperature. Whereas ferulic acid was found in the gastric mucosa only as free form, 
it was also present as glucuronide, sulphate and sulphoglucuronide in plasma, bile and 
urine, in the portal vein after its perfusion in the stomach in situ, even though free 
ferulic acid was the major form. A further in vivo investigation confirmed the results 
obtained by Zhao et a l  and allowed the detection of metabolites of ferulic acid in the 
portal vein and abdominal artery, by using a more sensitive method of detection 
(Coulometric instead of UV) (Konishi et al ,  2006). Based on their previous report 
(Zhao et al ,  2004), the authors suggested that these metabolites would come from a 
further metabolism by the liver of the free form absorbed by the stomach, and/or re­
absorption by the enterohepatic circulation rather than from a direct metabolism by the 
gastric cells. Ferulic acid and its sugar ester are not the only phenolic acids shown to be 
absorbed by the stomach. Chlorogenic (Lafay et al ,  2006a), but also gallic, caffeic and 
p-coumaric acids could also be absorbed at the gastric level, their absorption being 
dependent on their structure in the following order: chlorogenic = gallic < caffeic < p- 
coumaric acids (Konishi et al ,  2006). Indeed, caffeic acid has been shown to be three 
times better absorbed (95 % of the ingested dose) than chlorogenic acid (33 %) (Olthof 
et al ,  2001).
The behaviour of phenolic acid esters and free forms in the GIT is summarized in the 
figure 15.
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Figure 15 Summary of the behaviour of phenolic acid esters and free forms in the GIT and 
the liver.
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4.3 Th e  m e c h a n ism s  of  ph e n o l ic  a c id s  u pt a k e
The partition coefficient (log P or log octanol/water) which reflects the lipophilicity of a 
molecule will determine its affinity for a biological membrane and its partitioning 
through this membrane. This coefficient has been shown to govern the capacity of 
different flavonoids to be absorbed by cells (Crespy et al ,  2003), suggesting a passive 
diffusion as a main mechanism of flavonoid transport. The percentage of ferulic acid 
absorbed after perfusion of the rat small intestine was independent of the concentration 
perfused, indicating that there was no saturation of the permeation system involved 
(Silberberg et al ,  2006), findings which do not support the existence of a specific 
transport system. However, some studies have attempted to discover other permeation 
mechanisms of phenolic acids.
Various drug transporters have been identified and characterized, among which are the 
monocarboxylate transporters (MCTs). The physiological role of these transporters is to 
co-transport the endogenous monocarboxylates such as pyruvate, lactate, acetoacetate 
and /?-hydroxybutyrate together with equimolar protons by a symport mechanism (as 
reviewed in (Enerson & Drewes, 2003)). MCTs may also have an important role in the 
transport of some exogenous compounds, which consist of weak organic acids that are 
monovalent, with the carboxyl group attached to a relatively small alkyl group having 
either hydrophobic or hydrophilic properties. These transporters are expressed by 
various tissues such as the intestine, heart, liver, kidney and brain (Halestrap & Price,
1999). Different isoforms of MCTs have recently been localized in the different regions 
of the human intestine and on the membrane of intestinal cells (Gill et al ,  2005). MCT1 
expression is restricted to the luminal membranes of human intestinal cells, whereas 
MCT4 and MCT5 are present on the basolateral side. The isoform 3 is also expressed on 
the basolateral side but at a very low level compared with MCT4 and 5. However, no
MCT6 is detected on either the basolateral or apical side of small intestinal or colonic 
cells. Expression of the transporters increases along the length of the intestine, being 
maximal in the distal colon and even absent in the jejunum for MCT4 and 5. MCT1, 
expressed on the luminal side of intestinal cells, is a potential candidate for the transport 
of phenolic acids.
An in vitro model of Caco-2 cells grown on semi-permeable membranes was used to 
investigate the potential involvement of the MCTs in the transport of phenolic acids 
(Konishi et a l ,  2002). The study was based on competition for transport between 
fluorescein, an MCT substrate (Kuwayama et al ,  2002), and phenolic acids. Ferulic, 
cinnamic, p-coumaric and vanillic acids competitively inhibited the transport of 
fluorescein, with the following order of inhibition cinnamic > ferulic > vanillic > p- 
coumaric acids, suggesting the transport of these phenolic acids via MCTs. Caffeic acid 
had no effect, whereas ferulic and vanillic acids had a very similar effect (respectively 
49 and 45 % of inhibition). However, it must be mentioned that the concentrations of 
phenolic acids used as competitors in this study were high (10 mM) and one could 
wonder, even though not mentioned by the authors, if  phenolic acids used at such 
concentrations could have been toxic for the cells, the resulting percentage of inhibition 
influenced by the toxicity. Further studies aimed to better understand the mechanisms of 
phenolic acid transport. Using the same model, transport of p-coumaric acid was shown 
to be pH dependent, higher, but saturable, in the presence of a proton gradient (apical 
side, pH 6; basal side, pH 7.4), and ten times higher from the apical to the basal side 
compared with the opposite direction (Konishi et al ,  2003b). According to these results, 
the authors suggested that the permeation of p-coumaric acid in the presence of a proton 
gradient would be dependent on an active transport mechanism, whereas in absence of 
proton gradient, it must be restricted by tight junctions. The active transport was
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proposed to be MCT mediated, since benzoic and acetic acids, substrates of MCTs, 
inhibited p-coumaric acid permeation, although lactic acid, a good substrate for MCT1- 
MCT4, had no effect, suggesting the involvement of a different isoform. However, no 
metabolite of p-coumaric acid could be detected on the basal side of the Caco-2 cell 
model. This model also served to study the permeation of ferulic acid, shown to be Na+- 
independent (Konishi & Shimizu, 2003), contrary to what has been proposed earlier for 
cinnamic acid (Wolffram et al ,  1995). As for p-coumaric acid, ferulic acid was 
absorbed via an MCT system and was not conjugated by the in vitro model. The authors 
also proposed that tea polyphenols shared the same MCT transporter(s) with ferulic 
acid, since its permeation was inhibited by (+)-catechin, (-)-epicatechin, (-)- 
epicatechin-gallate, (-)-epigallocatechin and (-)-epigallocatechingallate (Konishi et a i ,  
2003a). Transport of caffeic, m-coumaric and m-hydroxyphenylpropionic acids (Konishi 
& Kobayashi, 2004b), as well as dihydrocaffeic acid (Konishi & Kobayashi, 2004a), 
were also proposed to happen via MCTs, as shown using Caco-2 cells. A more recent 
report clarified the identity of the MCT responsible for the transport of 
hydroxycinnamic acids and proposed that an isoform, different from the MCT1, is 
involved in the transport of hydroxycinnamic acids and derivatives (Konishi et al ,  
2006).
4.4 Th e  c ir c u l a tin g  m e ta b o l it e s  a n d  c o n ju g a tes
Free ferulic acid and its glucuronide were the forms excreted in human urine over the 7-
9 h following ingestion of a meal based on fresh tomatoes, a source of ferulic,
chlorogenic, caffeic and p-coumaric acids (Bourne & Rice-Evans, 1998). They
represented 11-25 % of the ingested amount, a considerable proportion as the
glucuronide. Ferulic acid and its conjugates, glucuronide, sulphate and
sulphoglucuronide, peaked in rat plasma between 0 and 1 h, and lasted for at least 24 h
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after ingestion of a 26 % bran-rich diet, which contained 95.8 and 4.2 % respectively of 
bound and free ferulic acid (Rondini et al ,  2004). They also started to appear in urine 
only 30 min after the ingestion of bran, reaching a plateau after 4.5 h. In plasma, over 
the 24 h following intake of bran, the sulphate and sulphoglucuronide were the main 
metabolites (72 % of total ferulic acid), followed by the glucuronide (19 %) and the free 
form (9 %). The free form was more abundant (25 %) when animals received pure 
ferulic acid instead of the bran based diet. Conjugated ferulic acid was also detected in 
the intestinal contents, suggesting a metabolism in the mucosa and a secretion back into 
the lumen via the bile duct. Free ferulic and its glucuronide, sulphate and 
sulphoglucuronide conjugates were detected in plasma after intake of ferulic acid or of 
5-O-feruloyl-L-arabinofuranose (Zhao et a l ,  2003b). Given as free form in a diet, the 
amount of ferulic acid in plasma peaked 30 min after ingestion of the meal and quickly 
decreased between 0.5 and 1.5 h and more slowly until 4.5 h (Rondini et a l ,  2002). 
Ferulic acid was present in plasma and urine as the free form but also conjugated with 
glucuronide, sulphate or both, the major form being the feruloyl-sulphate and feruloyl- 
sulphoglucuronide. Another study showed that, after oral administration of pure ferulic 
acid (1 mmol) to rats, three metabolites, in addition to the parent compound which was 
the main form excreted, were detected in urine 0-12 h after the intake (Zhang et al ,
2005). Two of the metabolites were identified as mono-glucuronides of ferulic acid, the 
conjugation taking place on the 4-OH group or on the carboxylic function, as suggested 
by the authors. The third conjugate was proposed to be a di-glucuronide, with one 
glucuronide on the free hydroxyl of the phenyl ring and the other one on the carboxylic 
function. This study also investigated the tissue distribution of ferulic acid in rats, found 
in the liver, spleen, kidney and lungs, but not in the heart, 2 h after the oral 
administration. Free caffeic acid, together with ferulic acid, and their respective sulphate, 
glucuronide and sulphoglucuronides were found in rat plasma following the oral
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administration of caffeic acid (Plumb et a l ,  1999; Azuma et al ,  2000). However, only 
caffeoyl-glucuronide, caffeoyl-sulphoglucuronide and feruloyl-sulphoglucuronide were 
detected with a peak at 0.5-lh  in rat plasma after oral administration of chlorogenic acid 
(Azuma et a l ,  2000). In this study, interestingly, when caffeic acid was orally 
administered, caffeoyl-glucuronide, caffeoyl-sulphoglucuronide and feruloyl- 
sulphoglucuronide peaked after 2 h instead of 0.5 h when chlorogenic acid was 
administered. It is surprising to see that metabolites, which require microbial 
metabolism to be generated, appear quicker in plasma from chlorogenic acid than when 
caffeic acid is absorbed. The authors did not discuss this point in their paper. The results 
suggest that caffeic acid could be absorbed from the stomach but also in the lower part 
of the intestine, with a better absorption rate from the small intestine than from the 
stomach, explaining the delay of the peak of absorption. Even though not detected by 
the authors in plasma, chlorogenic acid could be absorbed as such by the stomach, better 
than caffeic acid, and quickly hydrolysed by gastric cells, intestinal cells or liver, 
allowing the rapid presence of caffeic acid in plasma (0.5 h). Konishi et a l  
demonstrated that caffeic acid is better absorbed than chlorogenic acid by the stomach, 
which does not support the above mentioned hypothesis (Konishi et a l ,  2006). 
Chlorogenic acid may be better absorbed than caffeic acid but, due to instability, its 
amount in biological fluids could be under-estimated.
In situ perfusion of ferulic acid showed that ferulic acid could be absorbed from the 
small intestine and that the forms circulating in plasma were glucuronide and sulphate 
conjugates, ferulic acid being rapidly excreted in urine (Adam et a l ,  2002). Caco-2 cells 
have also been used to study the metabolism of phenolic acids. Contrary to the transport 
studies, which usually use the cells grown on semi-permeable filters (2 compartments), 
the cultures used to study metabolism are prepared with cells grown and partially
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differentiated on dishes (one compartment). The Caco-2 cell model could perform 
sulphation, glucuronidation and méthylation of various hydroxycinnamic acids (Kern et 
al ,  2003b). Ferulic, sinapic and p-coumaric acids could enter the cells, be sulphated, but 
not glucuronidated, and then be effluxed back into the medium. However, the 
corresponding methyl-esters were both sulphated and glucuronidated. The authors 
proposed that methyl esters could be more hydrophobic and as a consequence better 
access to the UGTs localized in the membrane of the endoplasmic reticulum whereas 
the more polar corresponding hydroxycinnamic acids would remain in the cytosol 
where the sulphotransferases are located.
Apart from sulphation, méthylation or glucuronidation, a report mentioned the possible 
formation of mono- or bi-glutathione conjugates of caffeic, chlorogenic and 
dihydrocaffeic acids by rat hepatocyte microsomes, the reaction taking place during 
peroxidase/H202-catalysed oxidation of the phenolic acids (Moridani et a l ,  2001).
All these studies suggest that the metabolic pathway is the same for free and bound 
forms of ferulic acid. Whereas the free form is rapidly absorbed, metabolized and 
excreted in urine, the bound form allows a long lasting appearance (free and conjugated) 
in plasma, as already suggested by the absence of free ferulic acid in rat plasma 18 h 
after intake from an enriched diet whereas its metabolites were still present (Adam et a l ,
2002). Even though its bioavailability, in terms of lasting in plasma and low excretion 
in urine, was improved when esterified, the absorption of ferulic acid from a wheat 
source was lower than if present as free form in a diet (Rondini et a l ,  2004). This 
indicates that the amounts of ferulic acid circulating in plasma as well as its circulating 
metabolites are dependent on its form present in the food source.
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Depending on the food source, the model used, the time points, the method of analysis 
and the reports, phenolic acids, and especially ferulic acid, can be detected under 
different forms in the biological samples. However, there is a common tendency to 
suggest that phenolic acids can be absorbed through the gastrointestinal epithelium and 
be metabolized to circulate and be excreted as free and/or conjugated forms.
5 Beneficial effects on health of flavonoids and phenolic acids
As shown in the above paragraphs, monomeric units of flavonoids can be absorbed as 
such or reach the colon and be further metabolised by the intestinal microflora. The 
oligomeric and polymeric forms of procyanidins, because of their high molecular 
weight, are not absorbed as such but metabolized by the microflora. It can be 
hypothesized that a significant part of the beneficial effects observed in vivo, after 
intake of flavonoid-rich foods, especially the ones that contain high molecular weight 
flavonoids, could be due to phenolic acids. Indeed, phenolic acids themselves, and 
phenolic acids containing food, have been shown to possess beneficial activities for 
health.
5.1 A n t io x id a n t  a c t iv it y
The beneficial effect for health of flavonoids and phenolic acids is usually proposed to 
result from their antioxidant properties. An antioxidant property is fulfilled when a 
compound significantly delays or prevents oxidation of a substrate and when the 
resulting radical formed is stable, in order to prevent it from acting as a chain- 
propagating radical. The stabilization is usually obtained by delocalization of the 
electrons (Fig. 16A), hydrogen intra-molecular bounding (Fig. 16B) or further oxidation 
by another radical, forming for instance a quinone (Fig. 16C), if the compound 
possesses a catechol moiety (Shahidi & Wanasundara, 1992; Croft, 1998). The
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examples described in the following paragraphs for flavonoids and phenolic acids 
represent a non-exhaustive list of the in vivo studies having shown the beneficial effects 
on health of these compounds.
5.2 E x a m p le s  o f  i n  v iv o  b e n e f i c i a l  e f f e c t s  o f  f la v o n o i d s  a n d
FLAVONOID-RICH FOODS
Consumption of flavonoid-rich foods has been linked to many beneficial effects on 
health (as reviewed in (Williamson & Manach, 2005)). Among all these effects, 
epidemiological studies have largely examined the relation between consumption of 
flavonoids-rich foods (cocoa, wine, berries or tea) and the risk of cardiovascular 
diseases (as reviewed in (Arts & Hollman, 2005)), measured by the lowering of 
coronary heart disease, myocardial infarction, atherosclerosis but also up-regulation of 
endothelial nitric oxide synthase (eNOS) expression and production of endothelial cell 
NO (Erdman et al ,  2007). Cocoa is one of the richest flavonoid-containing foods, 
flavonoids representing more than 10 % of the weight of cocoa powder used to prepare 
beverages (Hammerstone et al ,  2000). Cocoa and chocolate contain substantial 
amounts of fiavan-3-ols, with catechin, epicatechin, procyanidin B2 and procyanidin C l, 
representing respectively 2.5, 5.9, 3.9 and 2.6 % of the total polyphenols (Natsume et al ,  
2000). In cocoa powder, the presence of compounds other than procyanidins, such as 
luteolin and its glucosides luteolin-6, -7 and -8-C-glucoside, apigenin and its glucosides 
apigenin-6 and -8-C-glucoside, quercetin-3-O-galactoside, -glucoside and -arabinoside, 
naringenin and naringenin-7-0-glucoside has been detected (Sanchez-Rabaneda et a l ,
2003). A recent review reported a wide range of human studies linking cocoa and health 
benefits, such as increase of plasma antioxidant activity, decrease of LDL oxidation, 
decrease of platelet activation or improved vasodilation (Cooper et a l ,  2007).
73
Protection of flavonoids against cancer has also been extensively investigated (as 
reviewed in (Arts & Hollman, 2005)). Green tea, in addition to effects against 
cardiovascular diseases, is probably the food source the most linked to cancer 
prevention, through the intake of green tea extract or of its individual flavonoid type 
components, (epi)-catechin, (epi)gallocatechin or (epi)gallocatechin-gallate, which 
protect against oral, gastrointestinal, liver, lung, prostate or mammary cancer (as 
reviewed in (Crespy & Williamson, 2004) and (Cabrera et a l ,  2006)). Cocoa also 
displays chemopreventive effects (as reviewed in (Weisburger, 2001)). Interestingly, 
cocoa also prevented obesity induced by a high-fat diet, by regulating expression of 
genes involved in the metabolism or transport of fatty acids, lowering the body-weight 
gain, the presence of mesenteric white adipose tissue and the serum triacylglycerol 
accumulation in rats (Matsui et a l ,  2005).
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Figure 16 Structural features o f the antioxidant activity offlavonoids and phenolic acids.
A, stabilization of the radical by delocalization of unpaired electrons around the aromatic ring;
B, stabilization of the radical by intramolecular hydrogen bond; C, example of quinone 
formation from oxidation of a molecule containing a catechol moiety, such as catechin or 
caffeic acid.
5.3 E ffec ts  o f  p h e n o l ic  acid s
5.3.1 In vitro demonstration
The antioxidant activity of phenolic acids mainly depends on the number and position
of hydroxyl groups present in the molecules. Total antioxidant activity relative to
Trolox was in the following order p-coumaric > m-coumaric or caffeic > o-coumaric
acids (as reviewed in (Rice-Evans et a l ,  1996)). As shown for cinnamic acids, p-
hydroxyphenylpropionic acid had a higher Trolox equivalent activity (TEAC) than m-
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hydroxyphenylpropionic acid (Pietta et a l ,  2000). However, dihydroxy substitutions on 
benzoic and phenylpropionic derivatives (m and p) lead to a higher TEAC value than 
the mono p-substituted derivatives. Moreover, the type of phenyl ring substitution may 
play a role in the antioxidant activity. The radical scavenging activity towards DPPH 
(1,1 -diphenyl-2-picrylhydrazyl) decreased in the following order caffeic > sinapic > 
ferulic > ferulic esters > p-coumaric acids, the length of the ester having no major effect 
on this scavenging activity (Kikuzaki et a l ,  2002). The catechol moiety of caffeic acid 
was more efficient than the 3-methoxy-4-hydroxy substitution of ferulic acid, in terms 
of Trolox equivalent, however less efficient than the 4-hydroxy-dimethoxy of sinapic 
acid (Natella et a l ,  1999). Most of the antioxidant potential of ferulic acid resides in its 
ability to terminate radical chain reaction, since the unpaired electron of the radical 
formed from ferulic acid after loss of a hydrogen atom can delocalize across the entire 
molecule (Graf, 1992). However, the radical scavenging activity of ferulic acid is 
enhanced by the replacement of the methoxyl by a hydroxyl group to obtain caffeic acid. 
Indeed, the loss of a hydrogen atom by caffeic acid forms a stable phenoxyl radical, 
which can donate a second atom and form a quinone (Fig. 16C). Caffeic acid was 1000- 
fold more efficient than ferulic acid in inhibiting in vitro lipid peroxidation in rat brain 
homogenate (Sharma, 1976). In addition to antioxidant activity, caffeic and ferulic acids 
exerted activity against colon and breast cancer cells (Hudson et a l ,  2000), in a 
clonogenic assay. Moreover, in an assay involving the measurement of mitochondrial 
function to reflect cell viability, ferulic and caffeic acids reduced the number of viable 
colon but not breast cancer cells.
In addition to the number of hydroxyl groups available on the phenolic acids and their 
position in the molecule, the structure and length of the side chain may have some 
importance. The antioxidant activity relative to Trolox of cinnamic acid derivatives was
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more efficient than the TEAC of the corresponding benzoic acids, the unsaturated side 
chain probably participating in the stabilization of the radical by resonance (Rice-Evans 
et al ,  1996; Natella et a l ,  1999). However, towards the inhibition of LDL oxidation, 
there was a significant difference between cinnamic and benzoic acids derivatives, but 
only in the presence of a catechol moiety (caffeic and protocatechuic acids) or of a p-  
hydroxy-dimethoxy substitution on the phenyl ring (sinapic and syringic acids), the p- 
hydroxy (p-hydroxybenzoic and p-coumaric acids) and p-hydroxy-m-methoxy (vanillic 
and ferulic acids) substitutions rendering the activity of cinnamic and benzoic acids 
derivatives identical. From the investigation of their activity against the peroxidation of 
phosphatidylcholine liposomes, it was also proposed that these phenolic acids, in 
addition to their radical scavenging activity, their polarity and three-dimensional 
interaction with lipid bilayers might also participate in the antioxidant activity towards 
lipid membrane oxidation (Rice-Evans et a l ,  1996).
Dihydrocaffeic acid antioxidant properties are also of interest since it is a central 
compound in the metabolism of flavonoids. Towards the free radical DPPH, 
dihydrocaffeic acid had a higher scavenging effect than (±)-a-tocopherol (Silva et a l ,  
2000) and was even more efficient than caffeic acid (Roche et al ,  2005). Using a FRAP 
assay, its antioxidant power was shown to be similar to caffeic and 5-Ocaffeolylquinic 
acid in PBS and in plasma (Lekse et al,  2001). Unlike chlorogenic acid, dihydrocaffeic 
and caffeic acids could also enter erythrocytes and enhance their ability to reduce the 
transmembrane oxidant stress generated by extracellular ferricyanide, the best effect 
seen with dihydrocaffeic acid. Moreover, chlorogenic acid was shown to spare cc- 
tocopherol, but not ascorbic acid, in the presence of the water-soluble free radical 
initiator AAPH, and to prevent lipid peroxidation. From these results, the authors 
suggested that the antioxidant potential resides solely in the catechol moiety, with little
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effect of the unsaturated side chain. Protection against a-tocopherol consumption was 
also shown for 3,4-dihydroxyphenylacetic acid, reinforcing the catechol moiety 
efficiency, independently of the side chain structure (Raneva et a l ,  2001). Cellular 
incorporation of dihydrocaffeic acid was also demonstrated with endothelial cells, 
which were consequently protected against oxidative stress and exhibited a slightly 
increased endothelial nitric oxide synthase activity (Huang et a l ,  2004).
5.3.2 In vivo benefits
In addition to lipids, the antioxidant properties of phenolic acids also allow them to be 
protective for DNA, as shown for p-coumaric acid in vivo against DNA oxidative 
damage of rat colonic mucosa (Guglielmi et a l ,  2003). Because abundant in food, 
ferulic acid has been studied for its potential to exert several beneficial effects on health. 
For example, in skin, it inhibited tumour promotion in mice (Huang et a l ,  1988; Kaul & 
Khanduja, 1998), significantly protected against UVB-induced erythema in humans 
(Saija et a l ,  2000) and reinforced the topical photo-protective effect of the antioxidants 
vitamins C and E by stabilizing them (Lin et a l ,  2005). Ferulic acid also inhibited lipid 
peroxidation (Toda et a l ,  1991), acted as a peroxyl radical scavenger and increased the 
resistance of LDL to oxidation (Castelluccio et al ,  1995). Ferulic acid and its isomer 
isoferulic acid had inhibitory effects on murine IL-8 production in response to influenza 
virus infections of macrophages in vitro, as well as in vivo (Hirabayashi et a l ,  1995), 
suggesting a potential activity of ferulic acid as an anti-inflammatory compound. 
Plasma of rats fed with a diet enriched with 26 % bran showed a better antioxidant 
activity than the rats fed with a standard diet enriched with pure ferulic acid (Rondini et 
al ,  2004). Ferulic acid may also protect against some diseases such as diabetes 
(Balasubashini et al ,  2004), enhancing the antioxidant capacity of diabetic rats by 
neutralizing the free radicals formed. Indeed, supplementation of diabetic rats with
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ferulic acid resulted in a decrease in the levels of glucose, TEARS, hydroperoxides, free 
fatty acids and in an increase in reduced glutathione, superoxide dismutase, catalase and 
glutathione peroxidase activities. Ferulic acid decreased the glucose and increased the 
insulin levels in plasma of mice developing obesity, insulin resistance, hyperglycemia 
and leptine resistance by feeding the animals a diet enriched with ferulic acid (Jung et 
al ,  2007). Ferulic acid was proposed to work by improving utilization of plasma 
glucose through the elevation of glycogen production and activation of hepatic 
glucokinase activity. Recently, feruloyl oligosaccharides were demonstrated to be 
efficient in mitigating oxidative damage in diabetic rats, even more than sodium ferulate 
and vitamin C, by increasing total antioxidant activity, glutathione peroxidase and 
superoxide dismutase activities of the serum (Ou et a l ,  2007). Ferulic acid may also 
protect against Alzheimer’s disease, since its long-term administration protected against 
the toxicity of A/%-42 which, when injected intracerebroventricularly in mice, induces 
some aspects of Alzheimer’s disease such as learning and memory behaviour 
impairment (Yan et al ,  2001). Ferulic acid could also be protective against cancer, 
since it was a strong inhibitor of aberrant crypt foci formation, which are preneoplastic 
lesions formed in the rat colon after ingestion of a carcinogen (Wargovich et a l ,  2000).
Dihydrocaffeic acid had interesting effects in rats fed with a high cholesterol diet (Lee 
et al ,  2001). As for caffeic acid, it significantly reduced the hepatic cholesterol and 
triglyceride levels, but not the plasma levels, and also the activity of the hepatic HMG- 
CoA reductase, the first enzyme of the HMG-CoA reductase pathway, which produces 
cholesterol among various other biomolecules. This suggests that caffeic and 
dihydrocaffeic acids are potential candidates for reducing the risk of atherosclerosis 
since they also increased the HDL/total cholesterol ratio in plasma.
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5.4 Fl a v o n o id s  a n d  p h e n o l ic  a c id s  f o r  sk in  ph o t o pr o t e c t io n  
5.4.1 The structure of the skin
The skin is the first line of defence of the body against environmental challenges. It is 
composed of an outer epithelium, the epidermis, an underlying connective tissue, the 
dermis, and a subcutaneous tissue (Fig. 17) (Kanitakis, 2002). Some accessory 
structures are also part of skin: the hair, thin filaments of keratin that develop in the 
dermis from invaginations of the epidermis, the sebaceous glands, dermal exocrine 
glands associated with hairs and which secrete an oily substance (sebum) on the 
growing hair, the exocrine glands that secrete sweat, and the Pacinian corpuscles, which 
are mechanoreceptors. Skin contains several cell types including Langerhans cells, 
melanocytes and kératinocytes (Eckert & Rorke, 1989). Langerhans cells function as 
antigen-presenting cells of the immune system in skin and melanocytes produce a 
pigment called melanin, which absorbs some of the ultraviolet (UV) radiation from 
sunlight. By far, the most abundant cells are the kératinocytes. In epidermis, 
kératinocytes represent 85 % of the cells (Suter et a l ,  1997). Epidermis is a stratified 
squamous epithelium distributed into different layers, from the inner to the outer most 
(Fig. 18): the basal layer (stratum basale), the spinous layer (stratum spinosum), the 
granular layer (stratum granulosum), a layer of transitional cells (stratum lucidum) and 
the comified layer (stratum comeum) (Eckert & Rorke, 1989). Epithelial stem cells 
remain in the basal layer where they proliferate, generating new stem cells and transit 
amplifying cells, which will undergo some divisions before they start differentiation, 
leaving the basal layer and migrating to the upper ones (Parkinson, 1992). Kératinocytes 
leaving the stratum basale will undergo a series of morphological and biochemical 
changes during their migration through the epidermis to end as dead, flattened, 
enucleated squames, which will be shed from the surface of the stratum comeum. The 
epidermis plays different roles, preventing water and electrolytes loss, acting as a
physical barrier to micro-organisms penetration, exerting sensory functions but also 
absorbing one of the most challenging components of the environment, the UV 
radiation.
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Figure 17 The skin structure.
(from http://www. enchantedlearning. com/subjects/anatomy/skin/)
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Figure 18 The different layers composing the epidermis.
(from http .-//upload, wikimedia. org/wikipedia/commons/2/20/Skinlayers.png )
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5.4.2 Skin damage and inflammatory response caused by UV radiation
The solar UV radiation is divided into three main regions of wavelengths: UVC (100- 
290 nm), UVB (290-320 nm) and UVA (320-400 nm). Whereas UVC are almost 
completely absorbed by the ozone layer, UVA and UVB both reach the Earth’s surface 
in sufficient amounts to have damaging effects on skin. Molecular oxygen (0 2), within 
the kératinocytes, is a primary target for UV light waves that penetrate the skin. The 
outer orbits of 0 2 are not completely filled with electrons, and thus 0 2has a tendency to 
absorb additional electrons to fill up these two vacant orbits. Following UV exposure, 
an electron can be given to 0 2, which then has a single unpaired electron in its outer 
orbit and becomes an unstable, aggressive free radical known as the superoxide anion 
(0 2*-) (Pugliese, 1995). To stabilize itself, the superoxide anion will randomly steal an 
electron from a nearby molecule, damaging this molecule and converting it into a free 
radical. This free radical will also try to stabilize by stealing an electron to another 
molecule, propagating the oxidative reaction. In skin, ROS, in particular superoxide 
anion, hydroxyl radical (’OH) and hydrogen peroxide (H20 2), are the key mediators of 
many of the UV-light induced biological effects (as reviewed in (Heck et a l ,  2004)). 
They are responsible for the peroxidation of lipids, the alteration of enzymes, the 
degradation or stimulation of the synthesis of collagen, the increase of protease 
activities, the carbohydrates oxidation and DNA damage (base modification, strand 
breaks or cross-linking) (as reviewed in (Pugliese, 1995)). Peroxynitrite (ONOCT), 
formed when nitric oxide (’NO) and superoxide anion (0 2*~) react, has been also 
reported to be a potent inducer of cell death, by directly undergoing reactions with 
biomolecules or by generating new radicals (as reviewed in (Szabo et a l ,  2007)). 
Peroxynitrite can result from the UV irradiation in skin, since 0 2*- and ’NO production 
increase after UV irradiation.
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With a longer wavelength than UVB, UVA deeply penetrates into the skin, to the 
dermis, causing damages to collagen and to fibroblasts, leading to ageing and wrinkling 
of the skin (Scharffetter et al ,  1991). UVB affects more the epidermis and the upper 
part of the dermis and are responsible for erythema, sunburns and skin cancers. Whereas 
DNA is not a chromophore for UVA, it absorbs UVB, causing the formation of dimeric 
photoproducts between adjacent pyrimidine bases. Shortly after UV exposure, 
keratinocyte mitosis and DNA synthesis are interrupted in order to allow the cells to 
repair the damages by nucleotide excision repair before replication, or synthesize DNA 
using post-replication repair specific DNA polymerase, which is free from error. The 
interruption phase is followed by a recovery phase during which RNA and protein 
synthesis are back to normal with an acceleration of DNA synthesis, which peaks 48-72 
h after exposure and can persist, to a lesser degree, for 7 days (Epstein et a l ,  1970). 
Kératinocytes, which have accumulated too much damage and too many mutations, are 
eliminated by apoptosis, due to an accumulation of p53, in order to prevent such DNA 
damage to lead to skin carcinogenesis in case of chronic UV exposure (Matsumura & 
Ananthaswamy, 2002).
In parallel to oxidation and damage, UV irradiation initiates immune response and 
inflammation. The cytokine IL-1 is produced constitutively by kératinocytes and 
retained in the cells (Kupper, 1988). When kératinocytes are damaged, IL-1 is released, 
stimulating neighbouring kératinocytes and amplifying the response (McKenzie & 
Sander, 1990). TN F-a has also been shown to be produced by kératinocytes in response 
to UV irradiation (Kock et a l ,  1990), through their stimulation partly by IL-1 and partly 
by ROS (Corsini et a l ,  1995). IL-1 and TN F-a auto-induce their production by 
kératinocytes (Barker et al ,  1991) and also stimulate production of pro-inflammatory
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cytokines such as IL-6 (Li et a l ,  1996) and IL-8 (Larsen et a l ,  1989), even working 
synergistically (Fujisawa et a l ,  1997).
5.4.3 Photoprotective effect of flavonoids and phenolic acids
Flavonoids have been shown to have protective effects on skin in vivo suggesting that 
their microbial metabolites could participate in these effects. Cocoa beverage rich in 
flavanols has been shown to decrease the sensitivity of human skin to UV light, the skin 
response being lowered by 15 and 25 % after 6 and 12 weeks of intake (Heinrich et a l ,  
2006). Orally administered, quercetin prevented UVB-induced immunosuppression in 
SKH-1 hairless mice, apigenin was effective in the prevention of UVA/UVB-induced 
skin carcinogenesis in SKH-1 mice and genistein inhibited UVB-induced proto­
oncogene expression and skin tumourigenesis in hairless mice (as reviewed in 
(Svobodova et a l ,  2003)). In addition, long term feeding of mice chronically exposed to 
UV with a polyphenolic fraction prepared from green tea resulted in a lower tumour 
burden compared with animals fed with a control diet (reviewed in (Afaq & Mukhtar,
2006)).
Ferulic and caffeic acids appear to be interesting candidates for topical in vivo 
protection against UV light-induced skin damage since they were able to permeate the 
stratum comeum of excised human skin, to protect phosphatidylcholine liposomes from 
UV-induced peroxidation and to react with nitrogen oxides (Saija et a l ,  1999). 
Topically applied, ferulic acid, even though to a lesser extent than caffeic acid, 
significantly protected skin against UVB-induced erythema in human (Saija et a l ,
2000). Despite its capacity to absorb UV radiation with a maximum at 307 nm (Graf, 
1992), ferulic acid is expected to act more as an antioxidant, interacting with pro­
oxidant intermediates, rather than acting as a sun screen. Indeed, it improved the
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stability of vitamins C and E in a topical solution, doubling their protection against 
solar-simulated irradiation of pig skin (Lin et a l ,  2005).
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6 Purpose of investigation
As presented in the previous paragraphs, dihydrocaffeic acid is one of the first 
hydroxycinnamic acids appearing in the cascade of microbial metabolism of flavonoids, 
mainly (epi)catechin and procyanidins. Ferulic acid, as free or esterified forms, is also 
present in many plant-derived foods or beverages, especially in coffee and cereals. 
Moreover, these two phenolic acids have been shown, directly or indirectly, via their 
precursors or their food source, to possess biological activities, which could be 
beneficial for human health. However, to exert these effects, they need to be 
bioavailable.
Because ferulic and dihydrocaffeic acids are expected to appear in the gastrointestinal 
tract, mainly in the colon, after microbial metabolism of esters or flavonoid precursors, 
it is of interest to understand their absorption and metabolism at the level of the colonic 
epithelium. To date, studies have mainly focused on absorption and/or metabolism of 
phenolic acids by the small intestinal epithelium. However, the colon presents different 
structural features compared with the small intestine, especially the presence of a thick 
mucus layer, which could play a role in the permeation of hydroxycinnamic acids 
through the colonic epithelium. The studies reported in the literature are often based on 
in vivo experiments consisting of animals or human fed with phenolic acids, either food 
sources or pure compounds. Blood and urine are usually collected and analysed for the 
presence of phenolic acids and their metabolites. An alternative to in vivo studies is the 
in situ perfusion experiment. The advantage of the technique, compared with the in vivo 
studies, is the isolation of a segment of intestine, in general the small intestine rather 
than the colon, or of the stomach, which are perfused with a solution containing a 
purified phenolic acid at a known concentration. The analysis of the effluent and of the
blood allows the estimation of the absorption of the perfused compound. From in vivo 
and in situ perfusion studies, the absorption of phenolic acids from the intestine and the 
stomach has been demonstrated and the circulating metabolites identified, proposed to 
be sulphate, glucuronide and sometimes sulpho-glucuronide, but also methyl conjugates, 
or reduced form, depending on the study reported, on the phenolic acid investigated and 
on the concentration used. However, because these techniques involve the whole body, 
the detection of the metabolites in the circulating blood or excreted in urine do not allow 
the determination of their tissue source and the sequence of their appearance. Moreover, 
it is not clear, from the discrepancies of the literature, if the free form can be effluxed on 
the serosal side of the intestine or if only conjugates and metabolites are. Culture of 
isolated cells from the intestine, such as the enterocyte-like Caco-2 cells, have been also 
used and shown to produce some metabolites of hydroxycinnamic acids (Kern et a l ,  
2003b), mainly sulphate conjugates from caffeic and ferulic acids and methyl 
conjugates from caffeic acid. Even though they were described by the authors as 
differentiated, because they were cultured in dishes, the cells were most probably not 
fully polarized and the cultures contained only one compartment. Other studies used 
Caco-2 cells grown on inserts, for the compartmentalisation of the cultures, but no 
metabolites could be detected (Konishi & Shimizu, 2003; Konishi et a l ,  2003b; Konishi 
& Kobayashi, 2004b). Using this model, the authors studied the mechanism of phenolic 
acid transport and proposed it to be mainly by MCTs, especially for ferulic acid. 
However, the conclusions on the transport mechanisms of phenolic acids in general 
were not clear.
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The purpose of investigation of this thesis was a better understanding of phenolic acids 
bioavailability and potential beneficial effects by:
■ Clarifying the mechanism of transport from the luminal side to the serosal side 
of the intestinal epithelium, especially in the colon, using more physiological 
concentrations of substrate than reported in the literature
■ Studying the efflux of metabolites from enterocytes
■ Determining which tissues could produce each circulating metabolite, by using 
isolated organs or cells (intestine and liver)
■ Identifying the possible circulating metabolites
■ Investigating the effect of phenolic acids, parent compounds and metabolites, on 
a target tissue
To answer these questions, models needed to be set up:
■ in  v itr o  models for the colonic epithelium by co-culture of mucus secreting cells 
(HT29-MTX) and enterocyte-like cells (Caco-2):
>  on inserts for permeation studies
>  on dishes for metabolism studies
■ ex v iv o  models:
>  Everted sacs of colon and small intestine from rat to study permeation 
and metabolism
>  Liver slices from rat to study hepatic metabolism
■ in  v iv o  model: in rat to study the metabolic fate
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Once the mechanisms of phenolic acid absorption were better understood and the nature 
of their circulating metabolites determined, it was of interest to:
■ investigate their effect on target cells that they could reach and protect against a 
harmful challenge:
>  HaCaT keratinocyte cell line challenged with UV and investigated for:
- cytotoxicity
- production of pro-inflammatory cytokines
>  Erythrocytes challenged with oxidative reagent:
- cytotoxicity
■ determine the minimal structural features necessary for a phenolic acid to be 
efficient
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1 Materials
Dulbelcco’s Modified Eagle’s medium (DMEM), Hanks’ Balanced Salt solution 
(HBSS), fetal calf serum (ECS), penicillin-streptomycin, amphotericin B, trypsin IX 
(0.5 g trypsin/0.2g EDTA in 1 L of HBSS) and L-glutamine were purchased from 
Sigma (Buchs, Switzerland). Plastic dishes and Transwell® Polycarbonate semi- 
permeable membranes of 0.4 pm pore size and 4.7 cm2 surface area were obtained from 
Coming (Wohlen, Switzerland).
2 General method for the culture of Caco-2 and HT29-MTX cells
The human colorectal adenocarcinoma cell line Caco-2 (HTB-37) at passage 21 was 
obtained from the American Type of Culture Collection (ATCC, LGC Promochem, 
Molcheim, France). The HT29-MTX cells at passage 7 were elaborated and provided by 
Dr T. Lesuffleur (Villejuif, France). Caco-2 and HT29-MTX cells were used between 
passage 10 and 50.
Caco-2 and HT29-MTX cells were maintained separately in culture in flasks (75 cm2, 
Costar GmbH, Bodenheim, Germany) at 37 °C under a humidified 5 % CO2 atmosphere 
in DMEM supplemented with 584 mg/L of L-glutamine, 1 % MEM, 100 U/ml of 
penicillin-streptomycin and heat inactivated ECS (15 % for Caco-2 and 10 % for HT29- 
MTX). To expand the cells, 90 % confluent monolayers were washed twice with HBSS 
free of calcium and magnesium. The cells were removed from the flasks by incubation 
with 1.5 ml of trypsin IX for 5-6 min at 37 °C. The reaction was stopped using an equal 
volume of DMEM-15 % ECS and resulting cell suspensions were centrifuged at 210 g 
for 5 min. Cells were counted and seeded for amplification at 12 000 and 10 000
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cells/cm2, respectively for Caco-2 and HT29-MTX cells. Medium was changed every 
other day. Co-cultures were prepared seeding a total of 6.104 cells per cm2 with 24 and 
76 % respectively of HT29-MTX and Caco-2 cells. Mixed cultures were grown in 
DMEM containing 10 % PCS.
3 Co-cultures for the transport studies
HT29-MTX and Caco-2 cells were seeded at 6.104 cells/cm2 on 4.7 cm2 Trans well0 
Polycarbonate semi-permeable membranes (0.4 pm) and grown in DMEM-10 % ECS 
for 21 days, with fresh medium added every other day. On the day of the transport 
experiment, medium was replaced by fresh one at least 5 hours before treatment.
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1 Abstract
In vitro models have been designed to re-create the intestinal barrier and to allow rapid 
evaluation of the mechanisms involved in the transport of molecules such as drugs 
across the intestinal epithelium. One of the most widely used is the Caco-2 cell line, 
enterocyte like cells, which spontaneously differentiate and exhibit properties of the 
small intestinal absorptive cells. However, they do not produce mucus, which is present 
in the intestinal tract and especially thick in the colon. A model of co-culture of Caco-2 
and HT29-MTX cells, which produce mucus, was set up. The model was characterized 
for the production of mucus, the integrity of the tight junctions and the presence and 
functionality of monocarboxylic acid transporters (MCTs), especially MCT1. The 
optimal experimental conditions to study phenolic acid permeation through this model 
for colonic epithelium were determined and preliminary experiments performed for the 
understanding of dihydrocaffeic acid permeation.
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2 Introduction
Because phenolic acids are mainly expected to appear in the colon after microbial 
metabolism of phenolic acid esters and flavonoids, it was of interest to set up a 
convenient model allowing the understanding of the absorption mechanisms and 
metabolism of phenolic acids by the colonic epithelium.
In vitro models have been designed to mimic the intestinal barrier and to allow a rapid 
evaluation of the mechanisms involved in the transport of molecules across the 
intestinal epithelium. Different types of cell lines isolated from the intestine are 
available and have been described in the literature. One of the cell lines the most widely 
used as an in vitro model of absorptive enterocytes is the Caco-2 cell line, derived from 
a human colorectal adenocarcinoma. These cells have been well characterized as a 
model system to study permeability of drugs through the intestinal epithelium (Hidalgo 
et a l ,  1989; Hilgers et a l ,  1990; Artursson et a l ,  2001). When grown on semi- 
permeable filters, Caco-2 cells spontaneously differentiate after they reach confluence 
to form monolayers exhibiting several morphological and biological properties of 
enterocytes such as the microvilli (Pinto et a l ,  1983), which express the small intestinal 
hydrolases, sucrase-isomaltase, lactase phlorizin-hydrolase, however at very low levels, 
aminopeptidase N and dipeptidylpeptidase IV (Hauri et a l ,  1985). Caco-2 cells have the 
property to form dense intercellular junctional complexes resulting in a tight epithelium 
displaying a resistance from 200 to 1300 Ohm.cm2, depending on the culture conditions 
(Delie & Rubas, 1997). Thus, Caco-2 cultures present a unique paracellular as well as 
transcellular barrier. Even though different from the in vivo situation, they resemble 
more the colon than the small intestine, with a resistance respectively of 100-275 and 
20-50 Ohm.cm2 in the rat (Sutton et a l ,  1992). Drug-metabolism activities of phase I 
and II involved in the clearance of xenobiotics are also present in Caco-2 cells, which
express several CYP genes, but not CYP3A4 and CYP2B6/7, although these enzymes 
are the most abundant ones in the intestine (Borlak & Zwadlo, 2003). In parallel, they 
also express sulphotransferases (Tamura et a l ,  2001) and UDP- 
glucuronosyltransferases (Paine & Fisher, 2000). Caco-2 cells are usually used as a 
model for the absorptive cells (enterocytes). However, the intestinal epithelium is 
composed of different cell types, enterocytes, endocrine cells, M cells but also goblet 
cells, which produce mucus, especially abundant in the colon. Indeed, the goblet cells 
represent the second most frequent cell type, accounting for 10 to 24 % of the total cells 
present respectively in the duodenal epithelium and in the distal colon (Walter et a l ,  
1996).
HT-29 cells, mostly undifferentiated in standard cultures, are able to differentiate into a 
population of absorptive and goblet-like cells producing mucus when adapted to 
methotrexate (MTX). HT29-MTX cells were developed by Dr T. Lesuffleur by 
adaptation of the HT-29 cells to high concentrations of MTX in order to select a 
population containing a high proportion of goblet-like cells (Lesuffleur et a l ,  1990; 
Lesuffleur et a l ,  1991). Compared with Caco-2, the HT29-MTX cells develop on their 
apical side only sparse and shorter microvilli but also secrete gastric-type mucins 
(Pontier et a l ,  2001).
The model of colonic epithelium used to study the transport mechanisms of 
dihydrocaffeic acid was a co-culture of Caco-2 and HT29-MTX cells seeded 
respectively at 76 and 24 % of the total cells, this ratio representing more the distal 
colon in terms of goblet cells population. The culture medium was supplemented with 
10 % serum in order to allow the two cell types to grow with comparable doubling times 
(Hilgendorf et a l ,  2000). Grown together, Caco-2 and HT29-MTX cells develop tight 
junctions resulting in a monolayer with an electrical resistance which increases over
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time, being dependent on the proportion of HT29-MTX cells and forming a significant 
barrier to xenobiotic transport (Walter et a l ,  1996). The culture on semi-permeable 
membranes immersed in culture medium allows cell differentiation and the culture 
separation into an apical chamber, which represents the luminal side of the intestine, 
and a basal chamber, mimicking the blood circulation (Fig. 19). By incubating the 
apical chamber, with the compound of interest and studying its appearance in the basal 
chamber allows the understanding of its mechanisms of absorption by the intestinal 
epithelium.
A co-culture of Caco-2 and HT29-MTX cells, as a model for colonic epithelium, was 
first set up, characterized and further used for preliminary test for the understanding of 
dihydrocaffeic acid permeation. The role of monocarboxylic acid transporters (MCTs), 
suggested to be involved in the transport of different phenolic acids by Caco-2 cells 
(Konishi & Shimizu, 2003; Konishi et a l ,  2003a; Konishi et a l ,  2003b; Konishi et a l ,  
2003c) was particularly investigated.
C om pound Apical cham ber
Cell m onolayer
S em i-p erm eab le m em brane  
B asal cham ber
Figure 19 In vitro model o f intestinal epithelium.
C ells a re  grow n  on sem i-perm eable m em branes, a llow in g  the access  to  the cu ltures fr o m  the 
a p ica l an d  the ba sa l sides.
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3 Materials and methods
3.1 M a t e r ia l s
Hanks’ Balanced Salt solution (HBSS), calcium chloride, periodic acid, 
paraformaldehyde, phosphate buffered saline 1 X (PBS IX), polyethylene glycol 2000, 
Schiffs reagent, Alcian Blue, glutaraldehyde, neutral red and fluorescein 
isothiocyanate-dextran 4000 (FD4) were purchased from Sigma (Buchs, Switzerland). 
Lab-Tek® glass Chamber Slides™ were obtained from Nalge Nunc (Hereford, UK). 
HPLC grade water, acetonitrile, ethanol, methanol, xylol, HC1, NaOH and glacial acetic 
acid were purchased from Merck (Dietikon, Switzerland). Aqueous and fluorescent 
mounting media were obtained from DakoCytomation AG (Baar, Switzerland). 
Dihydrocaffeic acid was obtained from Extrasynthese (Genay, France). Osmium 
tetroxide was from Electron Microscopy Sciences (USA).
3.2 P r o c e d u r e  f o r  t h e  s t a in in g  o f  m u cin s u s in g  p e r io d ic  a c id -  
S c h i f f ’s /A lc ia n  B lu e
HT29-MTX at passage 10-12, alone or in culture together with Caco-2 at passage 35-38, 
were grown in 4-wells Lab-Tek® glass Chamber Slide™ (Nalge Nunc International, 
Milian SA, Geneva, Switzerland) for different periods of time and slides were processed 
as follows to be stained:
1- rinsed twice with HBSS
2- fixed overnight at 4 °C with 4 % paraformaldehyde in PBS I X
3- hydrated by successive bathes of 3 min in water containing decreasing 
concentrations of ethanol (100, 95, 90, 85,70, and 50 %)
4- rinsed 5 min in PBS and 5 min in distilled water
99
5- immersed 2 min in 3 % acetic acid
6- incubated for 10 min in a solution of 1 % Alcian Blue in 3 % acetic acid
7- quickly washed twice in tap water and twice in distilled water
8- treated with 1 % aqueous periodic acid for 5 min
9- rinsed 1 min in distilled water
10- treated with Schiff s reagent for 5 min
11- washed in running tap water for 5 to 10 min
12- dehydrated by ascending concentrations of ethanol (50, 70, 85, 90, 95, 100 % in 
water), 1 min each bath, cleared by 1 min in Xylol
13-mounted with aqueous mounting medium
3.3 St a in in g  of  M u cSAC b y  im m u n o flu o r e sc e n c e
For the immunofluorescent staining of MUC5AC, HT29-MTX and Caco-2 cells were 
seeded in 4-wells Lab-Tek® glass Chamber Slide™ and grown for 7 days. TNP buffer 
was prepared in water with 1 M Tris pH 8.6, 1.8 % NaCl and 0.2 % polyethylene glycol 
2000. TNP-BSA was obtained by addition of 0.5 % BSA to TNP buffer. Slides on 
which cells had been grown were first fixed in 80 % methanol at 4 °C followed by 100 
% acetone at -  20 °C, for 2 min each. They were then washed 1 min in HBSS and 1 min 
in TNP Buffer. The slides were blocked for 30 min in TNP-BSA and incubated with the 
first antibody diluted in TNP-BSA at 1/300, for 1 h 30 in a humidified chamber. In 
order to detect the HT29-MTX population, a mouse monoclonal IgGl anti-MUC5AC 
(Santa Cruz Biotechnology, Heidelberg, Germany) served as the first antibody. A 
purified mouse IgG anti-TNP (Becton Dickinson AG, Basel, Switzerland) was used as 
negative control of the first antibody. At the end of the incubation, slides were rinsed 
three times for 5 min by immersions in TNP followed by TNP-BSA. Slides were 
incubated for 1 hour with the second antibody, a goat anti-mouse IgG FITC (Santa Cruz
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product, mixed with 1 pi of loading buffer (0.25 % bromophenol blue and 30 % 
glycerol in water), were loaded on the gel.
3.6 Tr a n spo r t  st u d ie s
3.6.1 Integrity of the monolayers
3.6.1.1 Transport o f  Phenol R ed
To test the integrity of monolayers, co-cultures prepared on inserts were used. After 21 
days of culture, 2 ml of DMEM-10 % PCS containing 45 pM  phenol red were added on 
the top of the cultures, whereas 2 ml of DMEM-10 % ECS without phenol red were 
added on the basal side. The amount of phenol red having diffused to the basal side after 
1 hour of incubation at 37 °C was determined spectrophotometrically (at 560 nm) after 
addition to the samples of 10 % (v/v) 0.1 N NaOH. The number of moles corresponding 
to the optical density measured was determined using a standard curve established for 
different concentrations of phenol red in the medium.
3.6.1.2 Evaluation o f  the Transepithelial E lectrical Resistance (TEER)
The permeability of the cell monolayers grown on inserts was determined using a 
Millicell®-ERS (Millipore, AG, Zug, Switzerland), device which measures the 
resistance of epithelial cells in culture (Ohm). The TEER, expressed in Ohm.cm2, 
represents the macroscopic expression of ion transport (Na+, K+, CF) via the 
paracellular pathway.
3.6.1.3 Cytotoxicity
After incubation of the cultures in the test conditions, cytotoxicity was assessed by 
incubating for 2 hours at 37 °C the apical chambers of the cultures with medium
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(DMEM-10 % PCS) containing 50 pg/ml neutral red. Then, cells were rinsed 3 times 
with 0.9 % NaCl and dried at room temperature. Neutral red was extracted from the 
cells by incubating them with 500 jil 2 % acetic acid/methanol (1:1) for 15-30 min and 
reading the absorbance of the resulting supernatant at 590 nm. The cytotoxicity of the 
treatments was calculated relatively to the control condition consisting of the cells 
incubated in DMEM.
3.6.2 Dihydrocaffeic acid uptake
At the beginning of the transport studies, medium was replaced by transport solution, 
which was freshly prepared by dissolving dihydrocaffeic acid at the desired 
concentration in HBSS. The pH of the solutions was adjusted after dissolution of the 
phenolic acid and the other test compounds in HBSS using 1 N HC1 or NaOH. The 
stability of dihydrocaffeic acid in HBSS was tested for 2 h at 37 °C in absence of cells. 
TEER was measured at the beginning and at the end of the experiment. After the 
appropriate time of incubation at 37 °C, samples were harvested from the apical and 
basal sides of the cultures, acidified with 0.1% formic acid (final concentration) and 
stored at -  20 °C until analysis.
As the vehicle chosen for the transport experiments was a saline solution, the method of 
dihydrocaffeic acid purification was simple, consisting of a step of quick centrifugation 
of the de-frosted samples, in order to precipitate large fragments of cells, which would 
be present in the supernatant of the culture, followed by a step of filtration on 0.45 pm 
nylon filters (Millex®-HN, Millipore AG, Zug, Switzerland). A test of reproducibility of 
the filtration was carried out to detect possible adhesion of dihydrocaffeic acid (3 mM) 
to the filters. The recovery was of 106 ± 4 % (n = 10), suggesting no adhesion of 
dihydrocaffeic acid to the filter.
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3.6.3 HPLC-DAD analysis of the samples
The samples were analysed by reverse-phase HPLC-DAD using an Atlantis TM dC18 
column (4.6 x 100 mm, 3 pm; Waters, Rupperswil, Switzerland). Solvent A (5 % 
acetonitrile/0.1 % formic acid) and B (40 % acetonitrile/0.1 % formic acid) were run 
with an HPLC Hewlett Packard 1090 (Agilent Technologies, Basel, Switzerland) at a 
flow rate of 1.2 ml/min using the following gradient: solvent B increased from 0 to 100 
% over a 15 min period. This gradient was maintained for 5 min before a decrease of 
solvent B back to 0 % over a period of 5 min and solvent A maintained at 100 % for 10 
min. The eluent was monitored with a diode array detector Agilent 1100 (Agilent 
Technologies, Basel, Switzerland) at 280 nm, maximum of absorption for 
dihydrocaffeic acid. The concentration of the identified compounds was estimated with 
reference to calibration curves made using known amounts of pure compounds.
3.7 D a ta  a n a ly sis
Data are shown as mean ± SD. Differences between test and control conditions were 
assessed by Student’s f-test and differences with value of P < 0.05 were considered as 
significant.
For the transport of phenol red and FD4 the apparent permeability (Papp in cm/sec) was 
also determined using the following equation: Papp = P/(A x Co) where P is the 
permeability rate of the compound (mol/sec), Co is the initial concentration in the upper 
chamber (mol/103 cm3) and A is the surface of the monolayer in cm2.
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4 Results
4.1 P r o d u c t io n  o f  m u c u s  b y  HT29-MTX c e l l s  a n d  c h a r a c t e r iz a t io n
OF THE CO-CULTURES
Cryo-preserved HT29-MTX cells at passage 7 (7 passages after adaptation of HT29 to 
MTX) were available at the Nestlé Research Centre (Lausanne, Switzerland), stored in 
liquid nitrogen for a long and unknown time. Before initiating the experiments on 
transport and metabolism using the co-culture model, it was of importance to first 
confirm that HT29-MTX cells had maintained their ability to produce mucus after a 
culture for different passages followed by a long storage period at -  196 °C. Mucins can 
be detected using a staining method with Periodic acid-Schiff’s reagent and Alcian blue 
(PAS/AB), distinguishing between acidic and neutral mucins respectively stained in 
blue and pink. A purple colour indicates a mixture of acid and neutral mucins. HT29- 
MTX cells were grown for 8, 15 and 22 days and stained using the PAS/AB procedure. 
As shown in Figure 20, a pink staining was visible on the monolayers observed under 
the microscope, staining which increased with the time of culture, covering a larger 
surface after 22 days compared with only some isolated staining visible after 8 days and 
indicating that the number of mucus secreting cells increased.
Co-cultures were prepared by seeding 76 % Caco-2 and 24 % HT29-MTX cells, which 
were grown for 7 days. HT29-MTX cells were smaller in size than Caco-2 cells and 
formed clusters embedded between the Caco-2 cells, as shown in Figure 21 (white 
arrows). Electron microscopy analysis of the apical side of cultures showed the presence 
of dense microvilli on Caco-2 cells grown alone (Fig. 22) and cells with less dense and 
shorter microvilli detected in the co-cultures, which could be the HT29-MTX (Fig. 23, 
white arrows).
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Figure 20 HT29-MTX cultures are covered by a discontinuous mucus layer.
Periodic acid-Schiff’s/Alcian Blue staining procedure shows that mucus is secreted by HT29- 
MTX cells in a time dependent manner. A, 8 days; B, 15 days; C, 22 days.
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Figure 21 HT29-MTX cells form clusters among Caco-2 cells when grown as co-cultures.
The white arrows indicate the presence o f clusters o f  sm aller cells form ed by HT29-MTX cells 
among the larger Caco-2 cells, 7 days after the seeding o f  60 000 cells/cm2 (76 % Caco-2 and 
24 % #T29- M7XJ.
Figure 22 Electron microscopy of the apical side of Caco-2 cell cultures.
Caco-2 cells were grown on semi-permeable membranes fo r  21 days and processed  fo r  electron  
microscopy analysis.
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Figure 23 Electron microscopy analysis of the apical side of co-cultures.
Caco-2 and HT29-MTX cells were grown together on semi-penneable membranes fo r  21 days 
and processed fo r  electron m icroscopy observation. The white arrows indicate the potential 
presence o f  HT29-MTX cells among Caco-2 cells.
In the co-cultures, the mucus covered a larger surface than the area occupied by the 
HT29-MTX, suggesting that the mucus spreads also over the Caco-2 cells (Fig. 24). In 
order to confirm the presence of HT29-MTX clusters among the Caco-2 cells, another 
technique based on immunofluorescence was used. Seven-day-old mixed cultures were 
stained using an antibody directed against a specific marker expressed by HT29-MTX, 
MUCSAC, a gastric-type mucin (Lesuffleur et al, 1995). 2 ratios of cells were seeded: 
50 %/50 % and 76 %/24 % respectively of Caco-2 and HT29-MTX cells. The staining 
obtained was proportional to the quantity of HT29-MTX present in the culture (Fig. 25). 
Absence of staining in the controls, obtained by performing the staining with a control 
primary antibody or without a secondary antibody, allowed the validation of a specific 
staining.
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Figure 24 Mucus produced by HT29-MTX spreads almost over the entire co-culture.
Co-cultures made o f  76 % Caco-2 and 24 % HT29-MTX cells were grown fo r  21 days and  
mucus was detected by Periodic acid-Schiff’s/Alcian Blue staining procedure.
Figure 25 MUCSAC expression is proportional to the amount o f HT29-MTX seeded in the 
co-cultures.
HT29-MTX are localized in the co-culture by their expression o f  M UCSAC detected by 
immunofluorescent staining, 7  days after the seeding o f  60 000 cells/cm 2 containing 50  % o f  
Caco-2 and HT29-MTX (A) and 76 % Caco-2 and 24 % HT29-MTX (B).
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4.2 D e t e c t i o n  o f  H M C T I g e n e  e x p r e s s i o n  i n  H T 29-M T X  c e l l s
Caco-2 cells have been proposed to transport hydroxycinnamic acids via the 
monocarboxylic acid transporter 1 (MCT1). Because the co-cultures further used to 
study the transport of phenolic acids would contain a non-negligible quantity of HT29- 
MTX, it was of interest to determine if these cells were also able to express the hMCTI 
gene. Analysis of RT-PCR products obtained using specific primers for this gene 
showed a band corresponding to a size of 544 bp, its quantity increasing with the 
number of PCR cycles (Fig. 26).
Number of cycles 
18 21 24 27 30 33 36 39 42
hMCTI m R N A  (544  pb)
Figure 26 RT-PCR detection o f hMCTI mRNA in HT29-MTX cells.
RNA was extracted from  one week old cultures o f HT29-MTX cells and analyzed by RT-PCR fo r  the 
presence o f  hMCTI mRNA.
4.3 I n t e g r i t y  o f  t h e  p a r a c e l l u l a r  p a t h w a y  i n  t h e  c o - c u l t u r e s
The integrity of the tight junctions between Caco-2 and HT29-MTX cells grown 
together for 21 days on a semi-permeable membrane was determined by measuring the 
transport of phenol red, a low molecular weight compound used as a paracellular marker.
If the percentage of phenol red transported per hour is less than 5 % of the initial 
concentration, integrity of the monolayer is considered as preserved (Martel et ai,  
2003). Transepithelial permeation of 45 pM phenol red, determined using a standard 
curve (Fig. 27), represented 2.3 ± 0.4 % (n = 3) of the initial number of moles
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transported over two hours, confirming the presence of an appropriate barrier function. 
The apparent permeability was 1.3 ± 0.2 x 10”6 em.see '. In addition, the TEER 
obtained for the monolayers of Caco-2 and HT29-MTX cells on semi-permeable 
membranes after 21 days of culture was 699 ± 51 Ohm.cm2 (n = 9).
0.6  -
c 0. 4 
o
ID
Q 0-2
o
0.0
0 1 2  3 4
P h en o l red  a m o u n t (x 10 '9 mol)
Figure 27 Standard curve of phenol red.
Absorbance o f  culture medium containing different known amounts o f  phenol red was measured  
at 560 nm. The equation o f  the regression is y  =  0.106 x +  0.043 with r2 = 0.999. The values are 
the mean o f  three values ± SD.
4 .4  S e t  u p  o f  t h e  e x p e r i m e n t a l  c o n d i t i o n s  t o  s t u d y  p h e n o l i c  a c i d s
TRA N SPO RT
For the transport experiments with Caco-2 cells, HBSS-like buffered salt solutions are 
commonly used. Compared with culture media, the use of these saline solutions allows 
the detection of compounds without interference with proteins and phenol red present in 
culture media. They also favour the stability of these compounds over incubation and 
enable the adjustment of the transport solution to the desired pH. HBSS free of Ca2+ and 
Mg2+, usually used in cell culture to wash monolayers before trypsination, was first 
chosen as transport solution. Incubation of the monolayers in Ca2+/Mg2+ free HBSS had
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the effect of disrupting the tight junctions, as indicated by a drastic decrease of TEER, 
which was, after 2 hours, equivalent to the TEER measured for the control conditions 
consisting of membranes with no cells. Electron microscopy analysis showed that the 
shape of the cells was completely changed to spheres after 30 min of incubation in 
Ca27Mg2+ free HBSS (Fig. 28).
Figure 28 Electron microscopy of co-cultures after 30 min of incubation in HBSS.
Caco-2 cells were grown on semi-perm eable membranes fo r  21 days, incubated in Ca2+/M g2+ 
free  HBSS fo r  30 min at 37  °C and analyzed by electron microscopy.
Other transport solutions have been tested in order to obtain conditions able to maintain 
the integrity of the monolayers. Some studies using the Caco-2 cell model have reported 
the use of HBSS supplemented with Hepes (10 mM). Supplementation of HBSS with 
0.1 % ECS was also tested as serum is known to contain many compounds, which could 
be necessary and sufficient at a low concentration to maintain the tight junctions 
without impairing subsequent HPLC-DAD analyses. A study reported in the literature 
showed that calcium is required for the regulation of intestinal epithelial tight junction 
permeability, absence of calcium inducing a separation of the cytoplasmic and 
transmembrane tight junction proteins, ZO-1 and occludin, and a formation of large
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intercellular openings between the adjacent cells (Ma et a l ,  2000). In culture medium 
such as DMEM, calcium is present at a concentration of 1.8 mM. Thus, another 
condition tested was HBSS supplemented with 1.8 mM calcium. TEER values of the 
co-cultures incubated in the different transport solutions were evaluated, using complete 
DMEM as a positive control. Figure 29 shows that calcium is necessary to maintain the 
integrity of the monolayers. Moreover, addition of 10 mM Hepes is not sufficient to 
sustain the tight junctions assembly. 0.1 % ECS supplementation could be used but the 
amount of unknown compounds contained by ECS would complicate the HPLC-DAD 
analyses of the samples as well as the adjustment of pH in the transport solution. Thus, 
HBSS supplemented with 1.8 mM calcium was chosen to perform the further transport 
studies.
In order to study the involvement of a transport in the permeation of molecules, the 
effect of the presence of a proton gradient is often investigated. To create the proton 
gradient, the apical side of the cultures was adjusted to pH 6 whereas the basal side was 
adjusted to pH 7.4. The integrity of the cultures was tested by studying the transport of 
the macromolecule FD4, which consists of a dextran-4000 molecule coupled to a 
fluorescein isothiocyanate moiety. The apparent permeability of FD4 (1 mg/ml) 
incubated for 1 h with the co-cultures was 0.11 ± 0.05 and 0.09 ± 0.01 x 10*6 cm/sec in 
calcium supplemented HBSS when adjusted to respectively pH 6 and 7.4, indicating 
that permeation of molecules via the paracellular pathway is not significantly affected 
by the presence of a proton gradient (P > 0.05).
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Figure 29 TEER values o f the co-cultures incubated in different transport solutions.
Values are the average o f  3 measurements o f  TEER values perform ed after 0, 30, 60, 90 and  
120 min incubation o f  the 21 days old co-cultures o f  Caco-2 and HT29-MTX in different 
transport solutions ± S D  (n = 3).
Because the analytical method was based on LC separation in tandem with UV 
detection (DAD), the minimum amount of dihydrocaffeic acid detected was not high, 
about 5xl0~n mol for 100 pi injected. To enable the detection and quantification of 
dihydrocaffeic acid in the basal compartment after transport, the use of a concentration 
of substrate higher than would be present in vivo in contact with the colonic epithelium 
was required. The concentration administered to the apical compartment of the co­
cultures was in the range of the millimolar (3 mM). Because of the high concentration 
of substrate used, a cytotoxicity test, based on neutral red uptake, was performed to 
determine if the treatments with dihydrocaffeic acid had a toxic effect on the cells. 
Neutral red is a dye which enters and is retained by living cells. Incubation of the 
cultures for 2 hours with 3 mM dihydrocaffeic acid, in the presence or absence of a 
proton gradient had no significant cytotoxic effect (P > 0.05), the percentage of living 
cells representing respectively 103.1 ± 5.1 and 100.4 + 13.1 % (n = 3) of the control 
condition (cells in DMEM).
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4.5 T r a n spo r t  stud ies
Because an MCT system has been proposed to be involved in the transport of some 
phenolic acids, the presence of an active MCT1 system in the co-culture was assessed. 
The most studied aromatic acid substrate of MCT1 is benzoic acid. It is transported by 
Caco-2 cells (Tsuji et a l ,  1994) and used as a competitor for absorption of 
monocarboxylic acids by these cells (Tamai et a l ,  1995; Konishi et a l ,  2002; Konishi 
et a l ,  2003a). Capacity of the present in vitro model to transport benzoic acid was 
tested. Because the MCT1 system is coupled to a proton pump, the effect of a proton 
gradient was also investigated. After 2 hours of incubation, 35.2 ± 2.7 and 26.6 ± 1.0 % 
(n = 3) of the initial quantity of benzoic acid present on the apical side (3 mM) were 
transported to the basal side respectively in the presence and absence of a proton 
gradient. These results confirm the presence of a functional MCT1 system in the co­
cultures. Compared with benzoic acid, dihydrocaffeic acid was much less efficiently 
transported, with only 2.3 ± 0.2 and 1.8 ± 0.1 % of the initial concentration transported 
over 2 hours of incubation respectively in the presence and absence of a proton 
gradient. The effect of the proton gradient was less obvious than for benzoic acid, 
however reproducible between the experiments, suggesting a possible but not obvious 
involvement of a transport mechanism dependent on protons.
As for benzoic acid, lactic acid is known to be transported across cell membranes by an 
MCT mediated system (Bracht et a l ,  1981). Lactic and benzoic acids were tested for 
their possible inhibitory effect on the transport of dihydrocaffeic acid by co-incubation 
of the substrate and its potential competitors. Neither benzoic nor lactic acid 
significantly competed with dihydrocaffeic acid transport (P > 0.05), which in their 
presence was transported respectively at 89 ± 14 and 118 ± 13 %, relatively to the 
control condition (absence of competitor). These results suggest that if dihydrocaffeic
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acid is transported by an MCT system, it is a different isoform than the one transporting 
benzoic and lactic acid. Caffeic acid was reported to be primarily absorbed by a 
paracellular pathway but also by a proton polarized transport system, which was 
hypothesized to be an MCT (Konishi & Kobayashi, 2004b). However, the authors of 
this study showed that lactic acid had no inhibitory effect on caffeic acid transport, 
indicating that caffeic acid would be transported by a MCT isoform different from 
MCT1, 2, 3 or 4 used by lactic acid. Accordingly, permeation of 3 mM dihydrocaffeic 
acid was investigated in the presence of 3 mM caffeic acid. As shown with benzoic and 
lactic acids, caffeic acid did not significantly compete with dihydrocaffeic acid, 
transported at 86 ± 13 % of the amount transported in absence of caffeic acid. Carriers 
and transporters are often asymmetrically distributed on the cell surface of polarized 
cells such as enterocytes. To better understand if a carrier was involved in the 
mechanism of dihydrocaffeic acid transport, its permeation was studied from the basal 
to the apical side. However, the amount transported from B to A was not significantly 
different from the amount transported from A to B in presence or absence of a proton 
gradient (P > 0.05; data not shown), reinforcing the possible independence of the 
dihydrocaffeic acid permeation from a carrier mediated system.
The effect of mucus on the absorption of dihydrocaffeic acid was evaluated using 
monolayers grown for 21 days and successively washed 3 times with HBSS just before 
the transport study. The increase of the amount of dihydrocaffeic acid was 35 ± 10 % (P 
< 0.01) of the control after removal of the loosely mucus layer. These results suggest 
that transport of dihydrocaffeic acid is partially restricted by the presence of the mucins 
spread on the cultures, which probably physically impair the access of the phenolic acid 
to the cells.
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In order to evaluate if taurocholic acid could have an effect on the transport of 
dihydrocaffeic acid, as shown for other poorly water soluble molecules, co-cultures 
were incubated with 3 mM of dihydrocaffeic acid in the presence of 5 mM of 
taurocholic acid, which did not significantly improve the transport of dihydrocaffeic 
acid (P > 0.05; data not shown). The possible interaction between dihydrocaffeic acid 
and BSA present on the serosal side was addressed. Addition of 4.5 % BSA in the basal 
compartment did not increase its permeability, suggesting that plasma proteins may not 
work as a reservoir towards dihydrocaffeic acid in vivo.
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5 Discussion
5.1 Ch a r a c t e r iz a t io n  o f  th e  m o d e l
As for Caco-2 cells, the characterization and the use of co-cultures of Caco-2 and 
HT29-MTX cells for the understanding of xenobiotics transport has already been 
reported in the literature (Walter et a l ,  1996; Hilgendorf et a l ,  2000). However, since 
discrepancies in the culturing of Caco-2 cells and in the experimental approach to study 
transport of compounds using these cells have been identified in the literature, 
discrepancies leading sometimes to differences in the results reported, it was of interest 
to set up and characterize the model and the experimental conditions before studying the 
permeation of dihydrocaffeic acid.
The Periodic acid-Schiff s/Alcian Blue staining of the HT29-MTX cultures showed that 
even after a long cryo-storage, the goblet like cells were able to produce mucus, a 
mucus layer starting to be visible at the surface of the HT29-MTX culture after 14 days 
and becoming thicker over the following days, in agreement with what has already been 
reported (Lesuffleur et a l ,  1993). Moreover, the mucus layer spread on the co-cultures, 
beyond the surface area covered by the HT29-MTX cells, which formed clusters among 
the Caco-2 cells. Although some mucins are membrane bound due to the presence of a 
hydrophobic membrane-spanning domain that favours their retention in the plasma 
membrane, other mucins are secreted on the cell surface forming a gel. Indeed, part of 
the mucus gel, the un-anchored mucins, may spread on the Caco-2 cells. The HT29- 
MTX cells have been shown to secrete mucins with gastric immunoreactivity 
(Lesuffleur et a l ,  1990), rather neutral, according to the pink staining obtained.
A critical function of the intestinal mucosa is to form a barrier that regulates the 
transport of molecules and host defence mechanisms at the interface with the luminal
119
content. Tight junctions form narrow belts that surround the upper part of the lateral 
surfaces of adjacent epithelial cells to create fusion points that participate to this barrier 
by regulating the paracellular diffusion of hydrophilic compounds. Tight junctions are 
formed by the assembly of different proteins, which are connected to the cytoskeleton. 
HT29-MTX and Caco-2 cells have already been shown to form monolayers with tight 
junctions when grown together in culture (Walter et a l ,  1996). The measurement of 
TEER and the study of phenol red transport suggest that, in the present experimental 
conditions, Caco-2 and HT29-MTX cells effectively form tight junctions which 
preserve a functional and not impaired paracellular pathway. The apparent permeability 
of phenol red, a marker for paracellular permeability, was 1.3 ± 0.2 x 10'6 cm/sec. It is 
difficult to compare this result to data reported in the literature, since, from one 
laboratory to another, the Papp of mannitol (paracellular permeation marker) varied from 
0.18 to 22.1 x 10"6 cm/sec (as reviewed in (Hidalgo, 2001)). The Papp of different model 
compounds that use the paracellular pathway has been determined using a co-culture of 
Caco-2 and HT29-MTX cells with different ratio of the two cell types. For a culture 
with 30 % HT29-MTX cells, values between 1.05 ± 0.14 to 0.25 ± 0.05 x 10"6 cm/sec 
have been obtained, the variation being dependent on the type of compound tested 
(Hilgendorf et a l ,  2000).
To maintain the integrity of the tight junctions during the study of phenolic acid 
transport in the saline solution HBSS, the presence of calcium at a concentration of 1.8 
mM was necessary, as indicated by the measurement of TEER. The integrity of the co­
cultures was not impaired by 1 h of incubation in calcium supplemented HBSS, as 
indicated by the apparent permeability of FD4, which was similar to what has been 
previously reported for Macrogol 4000, a molecule with identical molecular size to
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dextran 4000, with a Papp of 0.40 ± 0.04 x 10"6 cm/sec through Caco-2 cultures (Pontier 
et a l ,  2001).
As shown for Caco-2 cells (Hadjiagapiou et a l ,  2000), the HT29-MTX cells expressed 
an MCT1 mRNA. Moreover, the co-culture model was able to transport benzoic acid, 
an MCT1 substrate, in a proton gradient-dependent manner, indicating that the protein 
was also expressed and functional. The involvement of an MCT1 in the transport of 
dihydrocaffeic acid could be studied with the co-cultures.
5 .2  P r e l im in a r y  e x p e r im e n t s  o n  d ih y d r o c a f f e ic  a c id  t r a n s p o r t
Evaluating the permeation of different phenolic acids through Caco-2 cultures, previous 
studies have shown that some of them are transported via the MCT transporters 
(Konishi & Shimizu, 2003; Konishi et a l ,  2003a; Konishi et a l ,  2003b; Konishi et a l ,  
2003c; Konishi & Kobayashi, 2004b). Thus, the hypothetical involvement of MCT 
transporters in the permeation of dihydrocaffeic acid was investigated. The data 
reported here show that the transport of dihydrocaffeic acid, from the apical to the basal 
compartment (A to B), was about 10 times lower than the transport of the MCT1 
substrate benzoic acid, however higher in the presence than in the absence of a proton 
gradient and equal to its transport in the opposite direction (B to A). Moreover, 
competition studies performed in the presence of MCT substrates (benzoic, lactic and 
caffeic acids) suggest that the permeation of dihydrocaffeic acid, apparently dependent 
on a proton gradient, may happen via a system different from MCTs. These results are 
not in agreement with reports published while I was performing these experiments. The 
involvement of an MCT transporter has been investigated for dihydrocaffeic acid by 
measuring its inhibitory effect in the transport of fluorescein, a known substrate of MCT 
other than MCT1 (Konishi & Kobayashi, 2004b). The results showed that
dihydrocaffeic acid transport was pH dependent even though it did not compete with the 
transport of fluorescein, suggesting that these molecules do not share the same carrier. 
A further report showed that dihydrocaffeic acid permeation was strongly inhibited by 
substrates for MCT (20 mM) such as benzoic and acetic acids. Lactic acid, even though 
a good substrate of MCT1-MCT4, had no effect (Konishi & Kobayashi, 2004a). 
However, the flux of dihydrocaffeic acid was also shown to be inversely correlated with 
the TEER of the monolayers, independently of the proton gradient, suggesting that the 
permeation was restricted by the tight junctions and leading the authors to conclude that 
dihydrocaffeic acid was mainly transported by the paracellular pathway and to a lesser 
extent by an MCT system. According to the results presented in this thesis, I conclude 
that dihydrocaffeic acid permeation is pH dependent. However, nothing indicates 
clearly that the transport of dihydrocaffeic acid is via an MCT system but the results 
rather suggest permeation mainly by passive diffusion.
The addition of bile salts in the apical chamber of in vitro models used to study 
absorption of drugs has been proposed to increase the solubility of poorly soluble 
molecules but also to have experimental conditions closer to the physiological ones. The 
low permeation rate of dihydrocaffeic acid compared with benzoic acid could also result 
from low water solubility due to relative hydrophobic properties of the phenolic acid. In 
vivo, the presence of bile acids in the intestinal lumen sometimes facilitates the transport 
of compounds through the intestinal barrier. Indeed, bile acids, originating from the 
liver, are stored in the gallbladder and are transported via bile to the duodenum, where 
they are known to perform an important role in the absorption of lipids and lipid-soluble 
nutrients. Most of the bile acids are reclaimed from the terminal ileum and returned to 
the liver via portal blood for reuse. Taurocholic acid is a crystalline acid involved in the 
émulsification of fats and occurs as a sodium salt in the bile of humans and other
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mammals. Sodium taurocholate has been shown to increase the permeability of poorly 
water-soluble molecules when added at 5 mM on the apical side of Caco-2 monolayers 
and considered to be effective at mimicking in vivo conditions of intestinal drug 
absorption (Kataoka et a l ,  2003). However, addition of taurocholic acid did not 
improve the permeation of dihydrocaffeic acid, indicating that, in vivo, dihydrocaffeic 
acid will probably not require bile acids for absorption because is water-soluble enough 
to dissolve and permeate through the intestinal epithelium, if its permeation is done via 
the paracellular pathway.
Once xenobiotics with high lipophilicity have entered the blood circulation after the 
permeation through the intestinal epithelium, they can bind serum proteins such as 
albumin, enhancing their solubility and their concentration in the serum by exerting a 
driving force. Even though it has already been demonstrated that addition of BSA in the 
basal compartment of in vitro models facilitates the permeability of some drugs through 
Caco-2 cells monolayers (Kataoka et a i ,  2003), BSA did not improve dihydrocaffeic 
acid permeation.
The mucus layer, thicker at the surface of the colonic epithelium, seems to impair, to 
some extent, the permeation of dihydrocaffeic acid in vitro. Mucus could simply act as a 
physical barrier and/or interact with the phenolic acid, through its components, resulting 
in both cases in a slow down of the flux of dihydrocaffeic acid through the epithelium. 
This suggests that, if the permeation of dihydrocaffeic acid is passive and independent 
of a transporter, which could be expected to be differently expressed along the length of 
the intestine, dihydrocaffeic acid permeation could be lower in the colon, where the 
mucus layer is more abundant than in the small intestine.
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6 Conclusion
Even though useful, the in vitro model described here, such as many in vitro models 
reported in the literature, presents limitations compared with the in vivo situation. First 
of all, the ratio between the amounts of substrate used to the number of cells in the 
cultures is much higher than what could be found in vivo. The use of a high dose of 
dihydrocaffeic acid, in the range of the millimolar, has been often reported in the 
literature and was required for the present study because of the low sensitivity of the 
detection method used (DAD analysis of the LC effluent). However, such experimental 
conditions may hide weak changes in dihydrocaffeic acid permeation challenged by the 
use of competitors or of a proton gradient. Moreover, the presence of a blood flow and 
the higher volume of the serosal compartment in vivo allow the dilution of the absorbed 
compound and preserves the concentration gradient as a driving force for drug transport. 
The removal by the intestinal flow of the possibly effluxed molecules to the luminal 
side by the enterocytes also influences the permeation in vivo. In such in vitro model, 
absence of blood and intestinal flows as well as proteins from the serum, but also the 
small size of the serosal and luminal volumes, will influence the absorption of the 
studied compound. The results obtained could be consequently impaired and 
discrepancies generated when compared with data reported in the literature, especially 
from in vivo studies. Nevertheless, the present in vitro co-culture model remains a 
useful tool for preliminary investigation of the mechanisms of transport of molecules 
such as the phenolic acids, closer to in vivo situation owing to the presence of mucus, 
compared with the mucus free cultures of Caco-2 cells only.
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1 Abstract
Ferulic acid is an important antioxidant found in food, beverages, supplements and 
herbal medicines. However, its mechanism of absorption in the colon has never been 
examined, even though this is its main site of in vivo absorption. Ferulic acid was 
efficiently transported as free form through an in vitro model for the colonic epithelium 
consisting of co-cultured Caco-2 (absorptive) and HT29-MTX (mucus-producing) cells, 
with only a small amount transported as feruloyl-glucuronide or sulphate, together with 
some free dihydroferulic acid. This pattern of metabolism and permeation was also seen 
using rat everted ascending and descending colon sacs. In the cell model, free ferulic 
acid permeated by passive diffusion, as judged by the linearity of the uptake over time 
and the non-saturable concentration dependence. The permeation was independent of 
tight junctions but strongly linked to the hydrophobicity of the different phenolic acids 
tested, suggesting a transcellular rather than a paracellular transport. The use of 
inhibitors showed that only a small proportion (< 20 %) of the free ferulic acid transport 
was carrier-mediated. The production of metabolites in the basal chamber was lowered 
by MK571 and increased by cyclosporine A, implying an involvement of MRP and P- 
gp transporters in the efflux of metabolites, respectively to the serosal and luminal sides. 
These results show that the form of ferulic acid available to the blood after passage 
across the colonic barrier would be mainly the free form, together with only a small 
percentage of conjugated and reduced ferulic acid.
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2 Introduction
Ferulic acid has been shown to exert beneficial effects on health as shown by different 
in vitro studies. However, the in vivo activity of ferulic acid strongly depends on its 
absorption, further metabolism and tissue distribution. Ferulic acid absorption has been 
studied in vivo after its ingestion by animals or humans, purified or contained in food 
(Bourne & Rice-Evans, 1998; Rondini et a l ,  2002; Adam et a l ,  2002; Kern et a l ,  
2003a; Zhao et a l ,  2003a; Zhao et a l ,  2003b; Rondini et a l ,  2004; Zhang et a l ,  2005; 
Nardini et a l ,  2006), by in situ perfusion of small intestinal segments (Spencer et a l ,  
1999; Adam et a l ,  2002; Silberberg et a l ,  2006) and by perfusion of rat stomach (Zhao 
et a l ,  2004; Konishi et a l ,  2006). Cultures of Caco-2 cells, as an in vitro model for the 
small intestinal epithelium, have also been used for studying bioavailability of ferulic 
acid (Konishi & Shimizu, 2003; Kern et a l ,  2003b). However, the major and most 
potentially important site for ferulic acid absorption is the colon.
The mechanisms of phenolic acid uptake and their mammalian metabolism in the colon, 
where the mucus layer is the thickest (Atuma et a l ,  2001), have not yet been 
investigated. The in vitro model used was a co-culture of enterocyte (Caco-2) and 
goblet-like (HT29-MTX) cells and was compared with rat everted ascending and 
descending colonic sacs; the sample analysis was performed by LC-MS, which allowed 
direct identification and quantification of both the free form and metabolites.
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3 Materials and methods
3.1 M a t e r ia l s
Hanks’ Balanced Salt solution (HBSS), T C I99 medium, Krebs-Ringer bicarbonate 
buffer, sodium bicarbonate, calcium chloride, DL-dithiothreitol, cyclosporine A, ct- 
cyano-4-hydroxycinnamic acid (CHC), ibuprofen and fluorescein isothiocyanate- 
dextran 4000 (FD4) were purchased from Sigma (Buchs, Switzerland). Ethyl acetate, 
sodium acetate anhydrous, HPLC grade water, acetonitrile and glacial acetic acid were 
purchased from Merck (Dietikon, Switzerland). Ferulic, caffeic and dihydrocaffeic acids 
were obtained from Extrasynthese (Genay, France). Dihydroferulic acid was provided 
by Alfa Aesar (Karlsruhe, Germany). Feruloyl-4-0-|3-D-glucuronide, as a HPLC 
standard, was from NRC collection of standard compounds. MK571 was purchased 
from Biomol Int. (Zurich, Switzerland).
3.2 P r e p a r a t io n  o f  t r a n s p o r t  a n d  m e t a b o l is m  s o l u t io n s
Ferulic acid in powder form was weighed and dissolved in HBSS for 10 min under 
stirring at room temperature. The solutions were then adjusted to pH 6 or 7.4 and 
centrifuged for 5 min at 5 000g. The amount of ferulic acid present in solution was 
determined by measuring the optical density at 310 nm using a UV/Vis 
Spectrophotometer (Uvikon, Kontron, Basel, Switzerland), after further dilution if 
necessary. Ferulic acid stock solutions were prepared in EtOH or DMSO, depending on 
the intended concentration.
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3.3 In  v it r o  t r a n s e p i t h e l i a l  t r a n s p o r t  s t u d i e s
Caco-2 and HT29-MTX were prepared for transport studies as detailed in Chapter II. 
The integrity of the monolayers was evaluated by measurement of the transepithelial 
electrical resistance (TEER) using a Millicell®-ERS device (Millipore, Zug, Switzerland) 
before and after the treatments. To evaluate transepithelial permeability, medium was 
removed from the apical and basal sides of the cultures and replaced by 2 ml of the 
transport solution consisting of HBSS containing 1.8 mM calcium (calcium 
concentration required for maintaining integrity of the tight junctions) and phenolic 
acids and/or inhibitors, and pH was adjusted to 6 or 7.4. After an incubation of a desired 
period of time at 37 °C, apical and basal contents were collected, acetic acid added to 
obtain a final concentration of 10 mM and samples stored at -2 0  °C until further 
analysis. To investigate the effect of mucus, permeation was evaluated after removal of 
the mucus layer by a pre-incubation of 10 min at 37 °C with 1 mM DL-dithiothreitol 
(DTT) solubilized into HBSS followed by two successive washes in HBSS. To study the 
effect of sodium azide on transport, cells were pre-incubated with 10 mM NaNg for 30 
min and then co-incubated with 10 mM NaNg and 30 pM ferulic acid for 1 h.
Different transport solutions, which could be used for the transport studies using everted 
sacs, were compared. The permeation of FD4 (1.25 mg/ml) was investigated on co­
cultures immersed in T C I99 medium, supplemented with sodium bicarbonate (44 
mg/ml) and L-glutamine (10 mg/ml), and compared with permeation obtained when 
cultures were immersed in Krebs-Ringer bicarbonate buffer supplemented with Ca2+ or 
not.
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3.4 M e t a b o l is m  e x p e r im e n t s
Cells were seeded at 6 x 104 cells/cm2 in 3.8 cm2 wells and grown over a period of 6 
days in 10 % FCS supplemented DMEM, the medium being changed every second day. 
Metabolism of ferulic acid was studied by incubating each well with 100 pM ferulic 
acid. After 3 h at 37 °C, supernatant was collected, acidified with acetic acid to obtain a 
final concentration of 10 mM and stored at -2 0  °C until analysis.
3.5 T r a n s p o r t  s t u d y  u s in g  e v e r t e d  s a c s
Six week old male Sprague Dawley rats were adapted to the laboratory conditions 
(normal 12 h dark/12 h light cycles) with free access to tap water and to a conventional 
diet for one week and then to a polyphenol-free semi-synthetic diet of AIN 93M type 
(composition in Annex 3) for another week. Rats were randomly sacrificed by 
decapitation. The ascending and descending parts of the colon were quickly excised, 
everted and rinsed in room temperature Krebs-Ringer bicarbonate buffer, prepared 
according to the manufacturer’s recommendations and gassed with 95 % CVS % CO2 
for 60 min prior to use. The segments were then mounted at one extremity on a 1 ml 
plastic syringe which contained 0.7 ml of Krebs-Ringer bicarbonate buffer, pre-warmed 
to 37 °C and supplemented with 1.25 mg/ml FD4, while the other extremity was sealed 
with surgical linen. The content of the syringes was emptied into the sacs, which were 
then incubated in chambers filled with 30 ml of Krebs-Ringer bicarbonate buffer, 
containing ferulic acid at a concentration of 500 pM  and pre-warmed to 37 °C. The 
everted sacs were incubated for 30 min in the chambers maintained at 37 °C and 
continuously gassed with 95 % 0 2/5 % C 0 2. At the end of the incubation, the content of 
the sacs was recovered by filling back the syringe, further acidified with acetic acid to a 
final concentration of 20 mM and stored at -2 0  °C until analysis. The content of the
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chambers was recovered in order to monitor the sacs integrity by measuring the FD4 
concentration by fluorescence spectrophotometry (excitation at 490 nm and emission at 
520 nm).
3.6 S a m p l e  p r e p a r a t io n  a n d  LC-MS a n a l y s is
Room temperature defrosted samples (150 pi) were mixed with an equal volume of 0.1 
mM sodium acetate buffer pH 5. HPLC grade water (150 pi) and 300 pi 200 mM 
HCl/methanol were added. After 30 sec of sonication, the mixture was vortexed and 
extracted three times with ethyl acetate. After each centrifugation at 5000 g for 5 min, 
organic phases were collected, pooled and dried under nitrogen. The dried extracts were 
re-suspended into 5 % acetonitrile in water containing 0.1 % formic acid and injected 
onto an Acquity UPLC™ BEH Shield RP i8 column (2.1 x 100 mm, 1.7 pm; Waters, 
Rupperswil, Switzerland). Elution was performed with a flow rate of 0.3 ml/min and a 
gradient of solvent A (water) and B (acetonitrile), both acidified with 0.1 % formic acid. 
HPLC analysis was started with 3 % of solvent B. This condition was maintained for 1 
min and then the percentage of solvent B was linearly increased to 5 within 1 min, to 10 
within 18 min, to 15 within 10 min and finally to 100 within 1 min. 100 % solvent B 
was maintained for 3 min, then initial conditions were reached within 1 min and the 
column equilibrated in 3 % solvent B for 5 min.
The HPLC system (Acquity UPLC system, Waters, Rupperswil, Switzerland) was 
connected to a triple Quadrupole Micromass Quattro micro API mass spectrometer 
(Waters, Rupperswil, Switzerland), with an electrospray ionization (ESI) interface. The 
LC eluent was introduced directly from the absorbance monitor (Photo Diode Array, 
PDA) into the ESI probe without flow splitting. A nebulizing gas flow of 150 L/h and a 
drying gas flow of 550 L/h were applied for ionization using nitrogen in both cases.
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Samples were analyzed using the negative ion mode. ESI-MS parameters were as 
follows: voltage, 3 kV; capillary temperature, 90 °C.
3.7 D a t a  a n a l y s is
The results obtained for the quantification of the phenolic acids were normalized using 
an internal standard, syringic acid, added at a known concentration to the samples to be 
extracted. The percentage of recovery for the different phenolic acids relatively to 
syringic acid has been preliminarily determined and used for the corrections of the 
quantifications after each run of extraction.
Data are shown as mean ± SD. Differences between test and control conditions were 
assessed by Student’s r-test and differences with value of P < 0.05 were considered as 
significant.
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4 Results
4.1 D isso l u t io n  of  fer u lic  a c id  in  t r a n spo r t  so l u tio n s
The procedure to prepare transport solutions and the concentrations of ferulic acid to 
use were investigated, since several papers have reported the use of millimolar 
concentrations to study permeation of different compounds. Transport solutions were 
firstly prepared by dissolving ferulic acid in powder form directly into HBSS. In some 
experiments, when the pH was adjusted to 6, the concentration of ferulic acid measured 
corresponded to the intended concentration, up to 50 pM. Over 50 pM, the measured 
concentration corresponded only to a certain percentage of the intended concentration 
(from 100 % for 50 pM to 76 % for 3 mM). The measured concentrations decreased to 
70 % of the intended concentrations in the range of 3 to 10 mM. In other experiments, 
when the pH was adjusted to 7.4, the measured concentration was between 100 and 80 
% of the intended concentration in the range of 50 pM  to 10 mM. As a consequence, 
ferulic acid was pre-dissolved as stock solutions in ethanol (up to 100 mM) which were 
further dissolved into HBSS to obtain concentrations from 10 to 100 pM. However, 
stock solutions above 100 mM were prepared in DMSO and further dissolved into 
HBSS for concentrations from 100 pM to 2 mM. The maximum solvent concentration 
in the cultures during treatments never exceeded 0.1 %.
4.2 T im e -d e pe n d e n t  tr a n spo r t  o f  f e r u l ic  a c id
Quantification of ferulic acid was performed using LC-MS by detection of the 
corresponding negative ion {m/z = 193), without any pre-treatment of the samples with 
de-conjugating enzymes. The transport of ferulic acid by Caco-2/HT29-MTX co­
cultures was rapid and linear up to 3 h at 30 pM (Fig. 30), and was linear up to at least 2
h for the other concentrations (data not shown). For further experiments investigating
1 3 4
the mechanisms of ferulic acid transport, an incubation time of 60 min was chosen, as 
this time was well within the linear phase.
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F igu re 30  T im e-depen den t p erm ea b ility  o f  fe ru lic  acid.
Caco-2/HT29-MTX co-cultures grown on inserts were incubated in HBSS (pH 7.4) and the 
apical side supplemented with ferulic acid (30 pM). Permeation o f ferulic acid was evaluated by 
measuring the amount transported to the basal compartment after different times o f incubation 
at 37  ° C  Values are mean +  SD o f 3 independent cultures.
4.3 C o n c e n t r a t i o n  a n d  d i r e c t i o n - d e p e n d e n t  p e r m e a t i o n  o f  f e r u l i c  
a c i d
The relationship between the amount of ferulic acid transported and its initial 
concentration in the donor compartment was determined. Permeation from the apical to 
the basal side (A to B) was compared with the transport in the opposite direction (B to 
A). Figure 31A shows that ferulic acid transport in the absence of a proton gradient (A 
and B at pH 7.4) was linear in both directions over the range of concentrations tested 
(from 2 pM to 2 mM), without any saturation for the highest concentration, and being a 
little faster from B to A. The transport of ferulic acid was also linear (Fig. 3 IB) in the 
presence of a proton gradient (A, pH 6 and B, pH 7.4), over the range of the 
concentrations tested, and almost twice as high compared with transport in the absence
135
of a proton gradient, pH 6 being close to the immediate surface of the rat and human 
colon measured at around 6.4 (McNeil et a l, 1987). For all the conditions tested, the 
transport displayed on a normal or log/log scale was linear over the range of 
concentrations tested (R2 = 1 ; data not shown).
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Figure 31 Concentration and direction dependence of ferulic acid permeation.
Permeation o f ferulic acid (2 mM, 200, 20 and 2 pM ) was measured after 60 min incubation at 
37  °C; (A) the basal and apical chambers were at pH  7.4 and permeation from  apical to basal 
( ♦ )  and from  basal to apical side (m) was determined; (B) the apical chamber was at pH  6 and  
the basal one at 7.4, recording permeation from  apical to based side. Values are mean ±  SD o f  3 
different cultures.
4 .4  E f f e c t  o f  p H  a n d  m i c r o -e n v i r o n m e n t  c r e a t e d  b y  t h e  m u c u s
LAYER ON FERULIC ACID TRANSPORT
Permeation of 30 pM ferulic acid through the co-cultures was higher in the presence 
(3.8 ± 0.2 x 10 2 nmol/cm2.min) than in the absence (1.6 + 0.4 x 10 2 nmol/cm2.min) of a 
proton gradient. This permeation in the presence of a proton gradient was slightly but 
significantly higher after removal of the mucus layer by DTT treatment (123 ± 11 % of 
the ferulic acid transported in control condition; P < 0.05), whereas it was unchanged in 
the absence of a proton gradient.
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4.5  T h e  r o l e  o f  t ig h t  ju n c t io n s  o n  f e r u l ic  a c id  p e r m e a t io n
Tightness of the intercellular junctions was monitored by measuring the transepithelial 
electrical resistance (TEER) of the cultures. When transport studies were performed at 
low calcium concentrations (18 pM), the TEER measured was 495 ± 55 Ohm.cm2 (n=3) 
lower than when studies were preformed at 1.8 mM, as extracellular calcium plays a 
role in the maintenance of tight junction integrity (Ma et a l ,  2000). However, TEER 
was 520 ± 1 0 0  Ohm.cm2 (n = 3) higher when the HT29-MTX cell population was 
decreased from 24 to 10 % in the co-culture, as shown previously (Hilgendorf et a l ,  
2000). None of these treatments affecting TEER had a significant effect on ferulic acid 
permeation. Moreover, cultures of Caco-2 cells transported ferulic acid similarly to 
mixed cultures, even if displayed a TEER value 1.8 times higher than that of mixed 
cultures (data not shown).
4.6  I n h ib it io n  o f  f e r u l ic  a c id  t r a n s p o r t
Sodium azide, a metabolic inhibitor, was used to test for the involvement of an active 
transport mechanism in ferulic acid permeation. Sodium azide (10 mM) reduced the 
permeation of ferulic acid to 80 ± 4 % (P < 0.05) of the control only in the presence of a 
proton gradient. In addition, isoferulic acid did not compete for transport with the 
closely related compound ferulic acid, even if used at a concentration ten times higher. 
Ferulic acid transport in the presence of isoferulic acid was 106 + 8 and 94 ± 10 % of 
the transport of ferulic acid in absence of its isomer, respectively, in the presence and 
absence of a proton gradient (P > 0.05). Since possibly up to ~ 15-20 % of transport of 
ferulic acid is carrier-mediated, based on the results obtained with sodium azide and 
albeit only in the presence of a proton gradient, transport was studied in the presence of 
inhibitors (150 pM): a-cyano-4-hydroxycinnamic acid (CHC), an inhibitor of the
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monocarboxylic acid transporter 1 (MCT1), which binds to MCT1 without being 
translocated, or ibuprofen, a strong ligand of the sodium-dependent monocarboxylic 
acid transporters (S-MCTs). Both compounds showed a small inhibitory effect on free 
ferulic acid permeation, which was 90.1 ± 3 .1  and 89.5 ± 2.6 % of the control in the 
presence of ibuprofen and CHC respectively (P < 0.05).
4.7 R e l a t io n s h ip  b e t w e e n  HPLC r e t e n t io n  t im e  o f  p h e n o l ic  a c id s
AND THEIR PERMEATION RATE
Since about 80 % of ferulic acid transport is by a passive mechanism, we explored this 
further. Paracellular transport was ruled out (see above), so permeation of ferulic acid 
was compared with transport of other phenolic acids with a similar chemical structure 
and used at the same concentration (30 pM). The results, summarized in Table 5, show 
that permeation of phenolic acids was dependent on pH, and strongly proportional to 
their retention time on a reverse phase HPLC column. As seen for ferulic acid, the 
permeation rate of the other phenolic acids tested was higher in the presence of a proton 
gradient. Table 5 also shows that there is no direct relationship between the permeation 
rate of the phenolic acids and their calculated radius. These data support the theory that 
the transport mechanism is transcellular passive diffusion rather than paracellular 
diffusion.
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Table 5 Permeation o f phenolic acids compared with their HPLC retention timea.
Phenolic acid RT (min) _____  Permeation rate (nmoI/cm2.min)______  Radius (À)
_________________________________ pH6_______________pH_7.4___________________
dihydrocaffeic 7.5 <3 x 10"4 <3 x 10"4 2.64
caffeic 12.2 4 x 10"4 +1 x 10"5 3 x 10"4 ± 1 x 10"5 2.56
dihydroferulic 14.5 3 x 10 2 ± 1 x 10"3 1 x 10"2 ± 8 x 10"3 2.75
ferulic_____________ 22.6 4 x 10'2 ± 2 x 10'3 2 x 10'2 ± 4 x 10~3 2.67
a The co-cultures, grown on semi-permeable membranes, were exposed to each phenolic acid 
(30 pM) for 1 h(n = 3). The results are the mean ± SD (n = 3).
4.8 Ca pa c it y  o f  Ca c o -2/H T29-M TX  c o -c u l t u r es  to  m e ta b o l iz e
FERULIC ACID
All the experiments cited above measured the transport of the free form of ferulic acid 
by the cultures under different conditions, samples being analyzed after liquid-liquid 
extraction, without any enzymatic de-conjugation. However, it was of importance to 
determine to what extent the co-culture model used was also competent for conjugation 
and metabolism. In order to focus the experiment on metabolism rather than on 
transport, Caco-2 and HT29-MTX cells were seeded on dishes and incubated with 
ferulic acid for 3 h. Supernatants of cultures analyzed by LC-MS in the negative ion 
mode contained three ferulic acid metabolites: 2 conjugates, feruloy 1-sulphate (m/z = 
273) and feruloyl-glucuronide (m/z = 369), and a reduced form of ferulic acid, 
dihydroferulic acid (m/z =195; Annex 2). Identity of the compounds was confirmed by 
fragmentation of the parent ions, which gave the expected daughter ions, with mass to 
charge ratio 193 for the glucuronide and sulphate, and 136 for dihydroferulic acid (Fig. 
32).
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Figure 32 Identification of the ferulic acid metabolites by MRM (multiple reaction 
monitoring).
Supernatants o f  Caco-2 and HT29-MTX cultures, grown on dishes fo r  6 days, were collected  
after 3 h incubation with 100 juM ferulic acid in HBSS, pH  adjusted to 6. Supernatants were 
analyzed by MRM in the negative ion mode, fo r  the follow ing pairs o f  parent and daughter ion 
masses: 273 > 193 (feruloyl-sulphate), 195 > 136 (dihydroferulic acid) and 369 > 193 
(feruloyl-glucuronide). TIC, total ion count.
The conjugation reactions of ferulic acid are hypothesized to be on the free hydroxyl 
group, on the 4 position of the phenyl ring. The presence of dihydroferulic acid and 
feruloyl-4-O-p-D-glucuronide was also confirmed by comparing their retention time 
and fragmentation pattern with the characteristics of the standard compounds. There 
was a difference in the capacity of Caco-2 and HT29-MTX cells to metabolize ferulic 
acid when grown separately, especially for glucuronidation which was not detected with 
the Caco-2. Since the amount of metabolites was much lower than the free form of 
ferulic acid, it was not possible to detect any increase in the amount of ferulic acid free 
form after enzymatic de-conjugation. Therefore, only feruloyl-4-O-p-D-glucuronide and 
dihydroferulic acid, for which standards were available, were quantified, while the
relative amount of the sulphate was evaluated by measuring the area under the peak.
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Protons (pH 6 ) favoured the production of dihydroferulic acid compared with feruloyl- 
4-(9-f3-D-glucuronide, which was more abundant at pH 7.4 (Table 6 ). Moreover, the 
area under the peak obtained for feruloyl-sulphate was also slightly lower at pH 6  for 
both types of cells, reflecting a lower production of conjugates in the presence of a 
higher concentration of protons (data not shown). While HT29-MTX seemed to be more 
competent than Caco-2 cells to conjugate ferulic acid with sulphate and glucuronide 
groups, there was no major difference in the production of dihydroferulic acid between 
the two types of cell lines.
Table 6 Metabolism of ferulic acid by Caco-2 and HT29-MTX cells0.
M etabolite production 
(pmol/min.mg protein)
____________________________ pH  Caco-2 HT29-M TX
6  NDb 61.3 + 5.8
7.4 NDb 109.4 ± 8.9
6  6 .8 + 0.8 7.1 +0.1
7.4 3.6 + 0.8 2.3 + 0.4
a The cultures were incubated with ferulic acid (100 fiM) for 3 h before analysis of the 
supernatant by LC-MS for quantification of metabolites. The results are the mean ±SD (n = 3). 
b ND, not detected in the samples.
4.9  E f f e c t  o f  d if f e r e n t  c u l t u r e  c o n d it io n s  o n  m e t a b o l it e
PRODUCTION
The production of ferulic acid metabolites was also investigated in cultures grown on 
inserts. Although most of the ferulic acid transported was as the parent compound, a 
small proportion was metabolized into dihydroferulic acid, found in equivalent amounts 
on apical and basal sides of the cultures, and conjugated to feruloyl-4-0-(3-D-
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feruloyl-glucuronide 
dihydroferulic acid
glucuronide, released more abundantly on the basal side (Table 7). Feruloyl-sulphate 
was also detected on both sides but more abundantly on the basal one. As the results 
suggested the involvement of MCT1 and S-MCT in the transport of up to 20 % of free 
ferulic acid, I tested if inhibitors of MCT1 and S-MCT also had an effect on the 
production of ferulic acid metabolites. Inhibitors of potential efflux by P-gp/MDRl 
(cyclosporine A) and by MRP 1/2 (MK571) were also tested. Results show that 
ibuprofen and MK571 significantly reduced the release of feruloy 1-4-O-^-D- 
glucuronide while only MK571 inhibited the release of dihydroferulic acid (Table 8 ). 
However, cyclosporine A significantly stimulated the basal production of both 
metabolites.
Table 7 Release o f ferulic acid metabolites from differentiated Caco-2/HT29-MTX co­
cultures0.
Metabolite production 
(pmol/cm2.min)
pH gradient Apical Basal
feruloyl-glucuronide 6 /7 .4 1.4 ±0.1 24.9 ±4 .7
7.4/7.4 1.6 ±0.3 15.4 ±1.1
dihydroferulic acid 6/7 .4 3.0 ±0.1 3.2 ± 0.4
7.4/7.4 2.0 ± 0.3 1.7 ± 0 .2
a The cultures were incubated with ferulic acid (1 mM) for 1 h before analysis of the samples by 
LC-MS for quantification of metabolites. The results are the mean ±SD (n = 3).
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Table 8 Inhibition o f metabolite production on the basal side by different treatments.
_______________ feruloyl- glucuronide3 dihydroferulic acid*
ibuprofenb 37.7 ± 6.3* 95.1 + 17.3
CHCb 114.7 + 20.7 111.3 + 10.0
MK571C 40.9 + 3.6* 64.6 + 4.8*
cylcosporin Ac_______117.5 + 5.3*__________128.5 + 6.3*
a Metabolites (in percentage of control), released on basal side after 1 h of incubation of the 
apical compartment with ferulic acid at ImM. The results are the mean ±SD (n = 3). 
b 150 pM  of inhibitor on the apical side 
c 50 pM  of inhibitor on the basal side
* Significantly different from the control value (P < 0.05, t-test)
4.10 EX  VIVO FERULIC ACID UPTAKE AND METABOLISM BY EVERTED SACS OF 
RAT COLON
In order to compare the in vitro model of Caco-2/HT29-MTX co-cultures with colonic 
tissue, ferulic acid uptake and metabolism were studied using an ex vivo model of 
colonic epithelium consisting of everted sacs of ascending and descending colon. The 
use of everted sacs has already been reported in the literature, describing different 
techniques with different transport solutions, among which, the often reported Krebs- 
Ringer bicarbonate buffer. The culture medium T C I99 has been demonstrated to 
improve cell viability and maintenance of structural integrity compared with older 
systems (Barthe et al., 1998). In order to determine which transport vehicle was the 
most appropriate, permeation of FD4 was studied using co-cultures grown on inserts for 
21 days using the culture medium T C I99 and comparing the results with Krebs-Ringer, 
supplemented or not with 1.8 mM calcium, since the commercial Krebs-Ringer buffer 
used did not contain calcium. The permeation of FD4 over 30 min of incubation with 
the co-cultures was 47 + 10 % higher in basic Krebs-Ringer buffer than in calcium 
supplemented one. Interestingly, the permeation of FD4 in T C I99 was 133 + 15 % 
higher than in the calcium supplemented Krebs-Ringer buffer. As a consequence, the
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further studies with everted sacs were performed using calcium supplemented Krebs- 
Ringer buffer as transport vehicle. Moreover, addition of dextran did not change the 
osmolarity of the transport solution as determined by calculation (data not shown).
All the ferulic acid metabolites identified using the in vitro model were detected in the 
content of the everted sacs. Their identity was confirmed by multiple reactions 
monitoring (MRM), fragmenting the parent compounds and looking for pairs of 
daughter and parent ions (Fig. 33). Interestingly, a second peak was observed with mass 
spectral and fragmentation behaviour identical to that obtained for the rrans-feruloyM- 
0-(3-D-glucuronide standard. An equivalent compound was detected in culture 
supernatants but in very low quantities. This second peak might plausibly be either a 
feruloyl ester of glucuronic acid or the cis isomer of femloyl-4-O-p-D-glucuronide. It 
has been shown that phenolic esters and isomeric phenolic glycosides fragment quite 
differently (Clifford et ah, 2007b) but that the cis and trans isomers of cinnamic acids 
have identical fragmentation patterns (Clifford et a l ,  2008). Accordingly, this second 
peak is tentatively assigned as as-feruloyl-4-O-P-D-glucuronide. However, the putative 
cis isomer could not be detected after incubation of the tranls,-femloyl-4-0-(3-D- 
glucuronide standard in the experimental conditions but in absence of everted sacs, 
suggesting that the second form of glucuronide does not result from instability of the 
trans isomer as produced by the cells.
The free form and putative trans-feruloyM -OP-D-glucuronide (RT = 11.12), for which 
standards were available, were quantified, but dihydroferulic acid was below the limit of 
quantification. Results are summarized in Table 9. The amount of ferulic acid 
glucuronide as a percentage of total amounts of free form and feruloyl-glucuronide
144
appearing in the rat colon sacs was 16.9 ± 2.8 for the ascending and 20.6 ± 2.1 for the 
descending part of the colon.
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Figure 33 Confirmation by MRM of the identity of the metabolites produced in everted sacs 
from the transport of ferulic acid.
Contents o f  everted sacs o f  ascending and descending colon incubated with ferulic acid were 
analyzed by MRM in the negative ion mode, with static parent and daughter ion masses: 193 > 
134 (ferulic acid), 273 > 193 (feruloyl-sulphate), 195 > 136 (dihydroferulic acid) and 369 > 
193 (feruloyl-glucuronide). TIC, total ion count.
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Table 9 Transport of ferulic acid and efflux o f its glucuronide by ascending and descending 
rat colon everted sacs0.
Segment of 
the colon
Concentration
(liM)
Rate
(pmol/cm2.min)
Ascending
free form 23.3 + 7.4 83.0 +31.7
glucuronide 4.7 + 1.4 15.4 + 5.2
Descending free form 23.8 ± 8.9 196.2 + 89.3
glucuronide 6.1 ± 1.9 50.7 + 23.8
0 Everted sacs of colon were incubated for 30 min with 500 pM  ferulic acid and the content of 
the sacs analysed by LC-MS.
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5 Discussion
5.1 T r a n sc e l l u l a r  d if fu sio n  o f  f e r u lic  a c id
The aim of the present study was to better understand the mechanisms of ferulic acid 
absorption and metabolism by the colonic epithelium since this is its major site of 
absorption after consumption of foods containing conjugated ferulic acid, which is by 
far the major form in the diet. Use of co-cultured human enterocytes and goblet-like 
cells, as an in vitro model for colonic epithelium, showed that ferulic acid was mainly 
transported as the free form. This uptake was linear over time and not saturable at the 
highest concentrations which could be obtained in physiological buffers (2 mM), both in 
the presence and absence of a proton gradient. These results show, as already suggested, 
that ferulic acid is mostly transported by a non-saturable facilitated transport (Adam et 
a l ,  2002) or by passive diffusion (Silberberg et a l ,  2006), which is mainly transcellular 
rather than paracellular, since ferulic acid permeation does not seem to be restricted by 
tight junctions nor dependent on their tightness. Phenolic acid permeation seen through 
the intestinal epithelium by transcellular diffusion could also occur in other tissues, such 
as the gastric mucosa, shown to be a site of absorption of ferulic, caffeic, 5 -0 - 
caffeoylquinic, p-coumaric and gallic acids (Konishi et a l ,  2006). Passive diffusion, by 
the paracellular or transcellular pathway, is governed by different parameters such as 
pKa, partition coefficient, molecular radius and charge of the molecules (Pade & 
Stavchansky, 1997). For transcellular diffusion, the law of non-ionic diffusion is applied, 
suggesting that a dissociable substance permeates through a membrane in the non­
ionized form, the ratio between the ionized and non-ionized forms being dependent on 
the pH of the solution and on the pKa of the compound. This would explain why ferulic 
acid, whose pKa is 4.44 ± 0.03 (Maegawa et a l ,  2007), is more transported at pH 6  than 
at 7.4. Moreover, permeation rate would also be expected to be proportional to the 
hydrophobicity of the phenolic acid, and this hypothesis was tested by comparing the
permeation rates of caffeic, ferulic, dihydrocaffeic and dihydroferulic acids. As clearly 
indicated by their retention time on reversed phase chromatography, caffeic and 
dihydrocaffeic acids (with two hydroxyl groups on the phenyl ring) are respectively less 
hydrophobic and absorbed than ferulic and dihydroferulic acids (a methoxyl group 
replacing one of the hydroxyls); similarly, dihydrocaffeic and dihydroferulic acids (both 
with a saturated side chain) are also respectively less hydrophobic and absorbed than 
caffeic and ferulic acids (both with an unsaturated side chain). pKa values of these 
phenolic acids, very similar (Maegawa et a l ,  2007), and their estimated radius (~ 2.6 A), 
lower than the size of the smallest pore (3 Â) formed by tight junctions in the 
intercellular space (Sawada et a l ,  1989), cannot explain the permeation differences 
obtained.
5.2 F a c il it a te d  tr a n spo r t  o f  f e r u lic  ac id
The pH dependency of ferulic acid permeation due to ionization does not exclude an 
involvement of a facilitated mechanism of transport coupled to a proton pump. Indeed, 
phenolic acids have been earlier proposed to be transported by a monocarboxylic acid 
transporter (MCT) (Konishi et a l ,  2002; Konishi & Shimizu, 2003; Konishi et a l ,  
2003a; Konishi et a l ,  2003c; Konishi & Kobayashi, 2004a; Konishi & Kobayashi, 
2004b), recently suggested to be an isoform different from MCT1 (Watanabe et a l ,  
2006), such as MCT 3, 4, 5 or 6 , which have been reported to be expressed by Caco-2 
cells (Hadjiagapiou et a l ,  2000). In the work reported by Konishi et a l  in 2003 
(Konishi & Shimizu, 2003), ferulic acid transport was Na+-independent in either the 
presence or absence of a proton gradient, which did not support work previously 
reporting that ferulic acid inhibited the permeation of cinnamate across the jejunal brush 
border in rats in the presence but not in the absence of Na+ (Wolffram et a l ,  1995). 
Protons and energy have also been shown to be necessary for the transport of some
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drugs possessing a carboxylic acid moiety such as ketoprofen, gemfibrozil or ibuprofen 
(Legen et a l ,  2003), the latter being the best transported. First suggested to be MCT 
related (Tamai et a l ,  1995), ibuprofen permeation was later shown to be MCT1- 
independent (Legen & Kristi, 2003), and more recently clarified as being driven by a 
sodium monocarboxylate co-transporter (S-MCT) (Coady et a l ,  2004), found expressed 
at the apical surface of the colonocytes and absent from the surrounding goblet cells 
(Paroder et a l ,  2006). From the data obtained in the present report, I propose that only a 
small percentage of the free ferulic acid permeating would be transported via an energy- 
dependent system, which could be MCT1 and/or S-MCT.
5.3 E f fe c t  o f  t h e  m u cu s  l a y e r  o n  f e r u lic  a c id  pe r m e a t io n
It has long been proposed that adjacent to the mucosa of the gastrointestinal tract is a 
layer whose pH is maintained around neutrality (McNeil et a l ,  1987). As the non­
ionized diffusion rule suggests that the pH of a solution has a strong effect on the 
permeation of ionisable molecules, it was also hypothesized that the microclimate 
present at the surface of the epithelium could play a role in ferulic acid transport, as 
shown for another weak electrolyte, nicotinic acid (Elbert et a l ,  1986). The mucus layer 
present on the intestinal epithelium has been demonstrated to play a key role in the 
maintenance of the pH microclimate, since DTT treatment significantly reduced the 
proton concentration close to the cell surface of excised rat proximal jejunum (Shimada, 
1987). DTT treatment of the co-cultures slightly, but significantly, increased the 
permeability of ferulic acid in the presence of a proton gradient. This suggests that the 
mucus layer may create a micro-environment of neutral pH, even though the pH of the 
chamber is lower, thereby increasing the number of ionized molecules and lowering the 
effective concentration of molecules that can cross the membrane. However, because it 
has only a slight effect, the mucus layer is not a rate-limiting step in ferulic acid
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transport across the intestine, as shown for the lipophilic drug testosterone, by using a 
similar Caco-2/HT29-MTX co-culture model (Pontier et a l ,  2001).
5.4 M e ta b o l ism  o f  f e r u lic  a c id
In the supernatant from co-cultures, three different ferulic acid metabolites were 
identified: dihydroferulic acid, feruloyl-sulphate and rra«5-feruloyl-4 -0 -p-D-
glucuronide, the latter being only released by HT29-MTX cells. Caco-2 cells have 
already been used for studying ferulic acid transport and metabolism. Grown as tri­
dimensional cultures, they were unable to conjugate ferulic acid (Konishi & Shimizu, 
2003), whereas grown as monolayers, they exported ferulic acid as sulphate but not 
glucuronide conjugates (Kern et a l ,  2003b). The results obtained, showing free ferulic 
acid as the major form transported followed by its glucuronide, and also the presence of 
sulphate and dihydroferulic acid in lower amounts, were also seen with everted sacs of 
rat colon. These results are consistent with earlier in vivo studies showing considerable 
excretion of feruloyl-glucuronide in human urine after intake of tomato (Bourne & 
Rice-Evans, 1998) and its appearance in significant amounts, but lower than un­
conjugated form, on the serosal side of rat small intestinal segments perfused with 
ferulic acid (Spencer et a l ,  1999). However, two other studies reported no free form 
detected in un-hydrolyzed plasma after ferulic acid in situ perfusion of rat small 
intestine and after ferulic acid intake from a semi-purified diet (Adam et a l ,  2002), and 
free ferulic acid and glucuronide detected in plasma but with sulphate and 
sulphoglucuronide as the most abundant forms after ingestion of a diet enriched with 
ferulic acid (Rondini et a l ,  2002). In the former study, the blood was collected at the 
end of the perfusion period, allowing absorbed free ferulic acid to reach the liver for 
further metabolism. In the work reported by Rondini et a l ,  ferulic acid was present as 
the free form in the diets and therefore part of it could have been absorbed directly from
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the stomach and later conjugated in the liver. Feruloyl-sulphoglucuronide, proposed 
earlier as one of the metabolites (Rondini et a l ,  2002; Zhao et a l ,  2003a; Zhao et a l ,  
2003b; Rondini et a l ,  2004; Zhao et a l ,  2004), was neither detected in vitro nor with 
everted sacs but could in vivo result from the hepatic metabolism of the feruloyl- 
glucuronide secreted by the intestinal epithelium. Dihydroferulic acid has been detected 
in urine following coffee consumption (Rechner et a l ,  2001b) or artichoke extract 
ingestion (Rechner et a l ,  2001a), and proposed to derive from ferulic acid, itself a 
metabolite of caffeic acid. Dihydroferulic acid was firstly proposed to result from the 
microbial metabolism of ferulic acid (Scheline, 1968), but it was later suggested that 
mammalian enzymes had also the ability to perform the reduction of an unsaturated 
bond, after the detection of tetrahydrocurcumin in rat bile after curcumin intravenous 
injection to rats (Holder et a l ,  1978) and more recently shown that hepatocytes were 
able to convert ferulic acid to dihydroferulic acid (Moridani et a l ,  2002). However, this 
is the first time that intestinal cells are proposed to display such activity.
5.5 E ffl u x  of  m e ta bo lites
In the three-dimensional co-cultures, the concentration of conjugates was higher in the 
basal chamber whereas dihydroferulic acid was equally present on both sides of the 
epithelium. The results obtained in the presence of MK571 suggest that an MRP 
transporter could contribute to a major part of the efflux of feruloyl-glucuronide and 
dihydroferulic acid to the serosal side. The strongest candidate for this function is 
MRP3 (ABCC3), since it has been shown to be expressed on the basolateral side of 
Caco-2 cells (Prime-Chapman et a l ,  2004). MRP6  (ABCC6 ), localized to the 
basolateral side of cells in kidney and liver (Kool et a l ,  1999), should also be 
considered since Caco-2 cells express the gene corresponding to ABCC6  (Taipalensuu 
et a l ,  2001). Cyclosporine A increased the release of glucuronide and dihydroferulic
151
acid in the basal compartment, suggesting that these two metabolites could also be 
effluxed to some extent to the apical side through the P-gp protein, localized on the 
apical side of enterocytes (Thiebaut et a l ,  1987). In addition to its active efflux, 
dihydroferulic acid could diffuse transcellularly, as shown for ferulic acid, until 
equilibrium is reached. Ibuprofen strongly inhibited the release of feruloyl-glucuronide 
either by competition with ferulic acid for the transport via S-MCT and/or by 
competition for glucuronidation by UDP-glucuronosyltransferase. In both cases, it is of 
interest to mention that non-steroidal anti-inflammatory drugs could compete for 
bioavailability, meaning absorption and/or metabolism, with food-derived phenolic 
acids.
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6 Conclusion
The data reported in this chapter suggest that ferulic acid is absorbed through the 
colonic epithelium by a combination of mechanisms, passive transcellular diffusion and 
facilitated transport (MCT1 and S-MCT), as summarized in the Figure 34. Both these 
mechanisms give free ferulic acid on the serosal side with only a small amount of 
conjugated forms; efflux of the conjugates is also transporteras) dependent. The form 
available to the body after passage across the intestinal barrier would be mainly the free 
form but also a small percentage of conjugates, feruloyl-glucuronide being the major 
metabolite, followed by the sulphate and dihydroferulic acid. Both free and conjugated 
forms could then be further metabolized by the liver. However, source, form and 
amount of ferulic acid ingested will influence the ratio of the different forms available 
in blood for further uptake by the tissues.
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Figure 34 Summary of the absorption and metabolism of ferulic acid by intestinal cells.
[  ]AS, concentration o f the metabolite present on the apical side; [  ] BS, concentration o f  the 
m etabolite present on the basal side; -4-G, glucuronide conjugate on the 4-OH; -4-S, sulphate 
conjugate on the 4-OH; DHFA, dihydroferulic acid; FA, ferulic acid.
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1 Abstract
The antioxidant dihydrocaffeic acid is a dietary constituent and a microbial metabolite 
of flavonoids. Orally administered to rats, dihydrocaffeic acid was very rapidly 
absorbed, most probably by the gastric or duodenal epithelium, and excreted in urine as 
the free form. LC-MS2 analysis of plasma and urine samples allowed confident 
identification of the dihydrocaffeic acid metabolites. The parent compound was 
glucuronidated, sulphated or methylated, on one of the hydroxyl groups present on its 
phenyl ring. All the dihydrocaffeic acid metabolites peaked in plasma within the first 30 
min following ingestion, suggesting a metabolism possibly by the gastric or duodenal 
cells and by the liver. Using in vitro and ex vivo models of the intestinal epithelium and 
the liver, the identity and source of the metabolites detected in vivo were examined. The 
data obtained suggest that, in rats, intestinal cells are more able to glucuronidate 
dihydrocaffeic acid, whereas liver favours sulphation. Moreover, glucuronidation, 
sulphation and méthylation seem to be regio-selective, preferably on the 3-OH of 
dihydrocaffeic acid. The methyle conjugate, dihydroferulic acid, was shown to be 
oxidized into ferulic acid by intestinal and hepatic cells, which were also able to 
perform the reverse reaction, the reduction of ferulic acid into dihydroferulic acid. As a 
conclusion, the main form of dihydrocaffeic acid circulating in plasma after its ingestion 
is a mixture of different primary and secondary metabolites.
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2 Introduction
Even though not one of the most commonly found hydroxycinnamic acids (Clifford, 
2 0 0 0 ), dihydrocaffeic acid is present in various foods, but also in traditional herbal 
medicines and supplements. It is found in urine and plasma as a microbial metabolite of 
polyphenols rich food and beverages such as coffee (Goldstein et a l ,  1984), artichoke 
leaf extracts (Wittemer et a l ,  2005), chocolate (Rios et a l ,  2003) or red wine extract 
(Gonthier et a l ,  2003a).
Dihydrocaffeic acid is one of the major phenolic acids found in human faecal water 
(Jenner et a l ,  2005) and results from the microbial hydrogenation of caffeic acid 
(Peppercorn & Goldman, 1971) and from the microbial degradation of catechin 
(Gonthier et a l ,  2003b) and procyanidins (Groenewoud & Hundt, 1986; Deprez et a l ,  
2000). It is probable that microbial cinnamoyl esterases would be able to release 
dihydrocaffeic acid from feruloylpodospermic acid or any ester of dihydrocaffeic acid 
present in food, as has been proposed for ferulic acid (Couteau et a l ,  2001). Since 
caecum and colon contain the highest amount of bacteria of the gastrointestinal tract 
(Hooper et a l ,  2002), dihydrocaffeic acid is mainly expected to be released in this 
region of the intestine.
As for many other hydroxycinnamic acids, dihydrocaffeic acid possesses potent 
antioxidant properties, free radical scavenging properties being higher than the ones of 
(±)-cc-tocopherol (Silva et a l ,  2000), even more than caffeic acid (Roche et a l ,  2005). 
Dihydrocaffeic acid was shown to enhance the antioxidant power of PBS (Phosphate 
Buffer Saline) and plasma and the ability of erythrocytes to reduce the transmembrane 
oxidant stress generated by extracellular ferricyanide (Lekse et a l ,  2001) and it 
protected against oxidative stress in endothelial cells by increasing eNOS activity
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(Huang et a l ,  2004). As a microbial metabolite of catechins and procyanidins, 
dihydrocaffeic acid could conceivably be partly responsible for some biological effects 
observed after consumption of green tea or chocolate (Cos et a l ,  2004; Cabrera et a l ,  
2006).
However, the potential biological activity of dihydrocaffeic acid depends on its 
absorption and further metabolism. Thus, the present work was performed in order to 
better understand the absorption and metabolism of dihydrocaffeic acid, firstly by 
identifying the main metabolites resulting from its ingestion and secondly by 
determining the sites of production of these metabolites. The first site of metabolism 
investigated was the epithelium of the colon, where dihydrocaffeic acid is more likely to 
be absorbed. Since the second detoxifying organ encountered by xenobiotics is the liver, 
its capacity to metabolize dihydrocaffeic acid was also tested.
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3 Materials and methods
3.1 M a t e r i a l s
RPMI 1640, fetal calf serum (PCS), penicillin-streptomycin, L-glutamine, L-ascorbic 
acid, Hanks’ Balanced Salt solution (HBSS), Earle’s balanced salt solution (BBSS), 
methionine, insulin, hydrocortisone 21-hemisuccinate, Krebs-Ringer bicarbonate buffer, 
sodium bicarbonate, calcium chloride, D-glucose and fluorescein isothiocyanate-dextran 
4000 (FD4) were purchased from Sigma (Buchs, Switzerland). Gentamicin was 
purchased from Gibco (Basel, Switzerland). Ethyl acetate, sodium acetate anhydrous, 
HPLC grade water, acetonitrile, formic and glacial acetic acids were purchased from 
Merck (Dietikon, Switzerland). Isoferulic, ferulic, caffeic and dihydrocaffeic acids were 
obtained from Extrasynthese (Genay, France). Dihydroferulic acid was provided by 
Alfa Aesar (Karlsruhe, Germany). Dihydrocaffeoyl-3-0-(3-D-glucuronide, 
dihydrocaffeoyl-4-OP-D-glucuronide and feruloyl-4-6>-(3-D-glucuronide as HPLC 
standards, were from the Nestlé Research Centre collection of standard compounds.
3.2  M e t a b o l i s m  e x p e r i m e n t s
HT29-MTX or Caco-2 were seeded at 6  x 104 cells/cm2 in 3.8 cm2 wells and grown 
over a period of six days in 10 % PCS supplemented DMEM, the medium being 
changed every second day. Metabolism was studied by incubating each well with 100 
pM  dihydrocaffeic acid in a volume of 1.5 ml. After 3 h of incubation at 37 °C, 
supernatant was collected, acidified with acetic acid to obtain a final concentration of 1 0  
mM and stored at -2 0  °C until analysis.
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3.3  I n  v it r o  t r a n s e p i t h e l i a l  t r a n s p o r t  s t u d i e s
Caco-2 and HT29-MTX were prepared for transport studies as detailed in Chapter II. 
The integrity of the monolayers was evaluated by measurement of the transepithelial 
electrical resistance (TEER) using a Millicell®-ERS device (Millipore, Zug, Switzerland) 
before and after the treatments. To evaluate transepithelial permeability, medium was 
removed from the apical and basal chambers and replaced by 2  ml of the transport 
solution consisting of HBSS containing 1.8 mM calcium and dihydrocaffeic acid (apical 
side) at 1 mM, the pH being adjusted to 6  or 7.4. After incubation at 37 °C, apical and 
basal solutions were collected, acetic acid added to obtain a final concentration of 1 0  
mM and samples stored at -2 0  °C until further analysis.
3.4  A n i m a l s  f o r  t h e  e x  v iv o  s t u d i e s
Male Sprague Hawley rats (six week-old) were adapted to the laboratory conditions 
(normal 1 2  h dark/ 1 2  h light cycles) with free access to tap water and to a conventional 
diet for one week, and then to a polyphenol-free semi-synthetic diet (AIN 93M type, 
composition in Annex 3) for another week. Rats were sacrificed randomly by 
decapitation.
3.5  T r a n s p o r t  s t u d y  u s in g  e v e r t e d  s a c s
A part of the jejunum as well as the ascending and the descending colon were quickly 
excised after the sacrifice, everted and rinsed in room temperature Krebs-Ringer 
bicarbonate buffer, prepared according to the manufacturer’s recommendations, 
supplemented with 1.8 mM calcium, and gassed with 95 % CVS % CO2 for 60 min 
prior to use. The segments were then mounted at one extremity on a 1 ml plastic syringe 
which contained 0.7 ml of Krebs-Ringer bicarbonate buffer, pre-warmed to 37 °C and
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supplemented with 1 mg/ml FD4, while the other extremity was sealed with surgical 
linen. The content of the syringes was emptied into the sacs, which were then incubated 
in chambers filled with 30 ml of Krebs-Ringer bicarbonate buffer pre-warmed to 37 °C 
and containing dihydrocaffeic acid (500 pM). The everted sacs were incubated for 30 
min in the chambers maintained at 37 °C and continuously gassed with 95 % CVS % 
CO2. At the end of the incubation, the content of the sacs was recovered by filling back 
the syringe, further acidified with acetic acid to a final concentration of 10 mM and 
stored at -2 0  °C until analysis. The content of the chambers was recovered in order to 
control the integrity of the sacs by evaluating the amount of FD4 released by the sacs by 
spectrophotometry (excitation at 490 nm and emission at 520 nm).
3.6  L iv e r  m e t a b o l is m
After sacrifice, the livers were immediately excised, placed in ice cold BBSS, which
had been previously supplemented with 25 mM D-glucose and gassed with 95 % (V S
% CO2 for 1 h. Cores of liver were prepared using a hand-held coring tool of 8  mm
diameter (Vitron, Tucson, USA). Liver slices of 200-250 pm thickness were prepared
using a Krumdieck tissue sheer (Alabama Research and Development Corp., Munsford,
AL, USA). The slices were preconditioned by incubating them for 30 min into culture
medium made of RPMI 1640 supplemented with 5 % fetal calf serum, 0.5 mM
methionine, 1 pM  insulin, 50 pg/ml of gentamicin and 0.1 mM hydrocortisone 21-
hemisuccinate and pre-warmed for 16 h at 37 °C under an atmosphere of 5 % CCV95 %
air. After adaptation of the liver slices to the culture conditions, they were transferred to
preconditioned medium containing 50 pM  of dihydrocaffeic acid and 50 pM of ascorbic
acid. Liver slices were incubated at 37 °C under an atmosphere of 5 % C(V95 % air for
different times. At the end of each incubation time, supernatants of cultures were
collected, acidified to a final concentration of 10 mM acetic acid and stored at -2 0  °C
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until analysis. The same experimental procedure was used to study the metabolism of 
feruloy 1-4- 0 - fi-D-glucuronide.
3.7 I n  v i v o  s t u d y  o f  d i h y d r o c a f f e i c  a c i d  m e t a b o l i s m
Eight week-old male Sprague Dawley rats were adapted to laboratory conditions 
(normal 1 2  h dark/ 1 2  h light cycles) with free access to tap water and to a conventional 
diet for one week and then to a polyphenol-free semi-synthetic diet (AIN 93M type, 
composition in Annex 3) for another week. The rats were adapted to metabolic cages for 
48 h and food was withheld 16 h before the experiment. The rats were randomly orally 
administered, by gastric gavage, either 1 0 0  pmol/kg of dihydrocaffeic acid prepared as 
a 20 mM solution in water or water as control. 400 pi of blood were collected into 
heparinized tubes after incision of the tail vein before and at different time points 
following administration of the treatment (30 min, 1, 2, 4, 6 , 8 , 10 and 24 h). Plasma 
was obtained by centrifugation of the blood samples for 5 min at 3000 g. Urine was also 
collected from the metabolic cages before and 6 , 12 and 24 h after administration of 
dihydrocaffeic acid. Plasma and urine were acidified with acetic acid to a final 
concentration of 10 mM and stored at -  80 °C until analysis.
3.8 S a m p le  p r e p a r a t i o n  a n d  LC-MS a n a l y s i s  f o r  t h e  i n  v i t r o  a n d  e x
VIVO STUDIES
Room temperature defrosted samples (150 pi) were mixed with an equal volume of 0.1 
mM sodium acetate buffer pH 5. HPLC grade water (150 pi) and 200 mM 
HCl/methanol (300 pi) were added. After sonication, the mixture was vortexed and 
extracted 3 times with ethyl acetate. After each centrifugation for 5 min at 5000 g,
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organic phases were collected, pooled and dried under nitrogen. The dried extracts were 
re-suspended into 50 pi 5 % acetonitrile in water containing 0.1 % formic acid and 
injected onto an Acquity UPLC™ BEH Shield RPig column (2.1 x 100 mm, 1.7 pm; 
Waters, Rupperswil, Switzerland). For MRM analysis, two ethyl acetate extracts per 
sample were pooled and re-suspended into 30 pi of solvent. Elution was performed with 
a flow rate of 0.3 ml/min and a gradient of solvent A (water) and B (acetonitrile), both 
acidified with 0.1 % formic acid. HPLC analysis was started with 3 % of solvent B. 
This condition was maintained for 1 min and then the percentage of solvent B was 
linearly increased to 5 within 1 min, to 10 within 18 min, to 15 within 10 min and 
finally to 100 within 1 min. 100 % solvent B was maintained for 3 min, then initial 
conditions were reached within 1 min and the column equilibrated in 3 % solvent B for 
5 min. The HPLC system (Acquity UPLC system. Waters, Rupperswil, Switzerland) 
was connected to a triple Quadrupole Micromass Quattro micro API mass spectrometer 
(Waters, Rupperswil, Switzerland), with an electrospray ionization (ESI) interface. The 
LC eluent was introduced directly from the absorbance monitor (Photo Diode Array, 
PDA) into the ESI probe without flow splitting. A nebulizing gas flow of 150 L/h and a 
drying gas flow of 550 L/h were applied for ionization using nitrogen in both cases. 
Samples were analyzed using the negative ion mode. ESI-MS parameters were as 
follows: voltage, 3 kV; capillary temperature, 90 °C. The results obtained for the 
amount of the phenolic acids were normalized using an internal standard, syiingic acid, 
added at a known concentration to the samples to be extracted.
3.9 S a m p le  p r e p a r a t i o n  a n d  LC-MS a n a l y s i s  f o r  t h e  i n  v i v o  s t u d y
Room temperature-defrosted plasma (50 pi) or urine (200 pi) was mixed with an equal 
volume of 0.1 mM sodium acetate buffer pH 5 and of HPLC grade water. Twice the 
initial volume of sample in 200 mM HCl/methanol was added. After sonication, the
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mixture was extracted 3 times with a volume of ethyl acetate corresponding to 6  times 
the initial volume of sample. After each centrifugation at 5000 g for 5 min, organic 
phases were collected, pooled and dried under nitrogen. Dried extracts were re­
suspended into 100 pi 15 % acetonitrile in water. The extracts were analysed by 
reverse-phase HPLC (10 pi) using an Atlantis TM dC18 column (4.6 x 100 mm, 3 pm; 
Waters). Solvent A (5 % acetonitrile) and solvent B (100 % acetonitrile) were run at a 
flow rate of 300 pl/min using the following gradient: starting at 100 % solvent A, 
solvent B was increased to 6 6  % in 25 min, to 100 % in further 2 min and maintained at 
1 0 0  % for 2  min, returned to initial conditions within 1 min, and maintained for 1 0  min. 
The eluent was monitored by UV with a DAD system set up at 280 nm and the 
metabolites identified by their m/z value using an MS/MS detection system (LCQ Deca 
XP+, Thermofinnigan, Cambridge, UK). The identity of the different compounds was 
estimated with reference to the ratio mass to charge by general scan (MS1) and to the 
daughter ions by fragmentation of the parent ions (MS2). ESI-MS parameters were as 
follows: voltage, 5.5 kV; capillary temperature, 365 °C.
3 .10  D a t a  a n a l y s is
Data are shown as mean ± SD. Differences between test and control conditions were 
assessed by Student’s f-test and differences with value of P < 0.05 were considered as 
significant.
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4 Results
4.1 I n  v iv o  s t u d y  o f  t h e  d i h y d r o c a f f e i c  a c i d  f a t e
In order to better understand its absorption and metabolism, dihydrocaffeic acid was 
orally administered to rats. The study was designed for the identification of metabolites 
using a high dose of dihydrocaffeic acid (100 pmol/kg). Blood and urine samples were 
collected and analyzed by LC-MS using an ion trap for optimal compound identification. 
The approach was firstly to detect the major peaks by total ion scan of the samples. The 
preliminary analyses were performed using acetic acid to acidify the solvent of 
migration for the chromatographic separation. However, adducts between phenolic 
acids standards and acetic acid were formed. For instance, by M S1 analysis of the peak 
at the retention time corresponding to dihydrocaffeic acid (16.55-16.99 min), three 
peaks were detected, in addition to the peak of dihydrocaffeic acid (m/z 181), with mass 
to charge ratios of 59, 119 and 241, assigned respectively to ionized acetic acid, ionized 
adduct of two molecules of acetic acid and ionized adduct of acetic acid with 
dihydrocaffeic acid (Fig. 35). In the case of ferulic acid structure, the adduct formation 
with acetic acid led to the suppression of the ionization and as a consequence of the MS 
signal obtained for isoferulic acid, as described in (Clifford et a l ,  2007a). In order to 
avoid such adducts to form during the detection and identification of the compounds, 
addition of acetic acid to the solvents was avoided.
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Figure 35 Example of MS chromatogram obtained with acetic acid present in the solvent of 
migration.
The standard fo r  dihydrocaffeic acid was analysed by LC-MS (full MS scan and MS1 at the 
retention time corresponding to dihydrocaffeic acid, 16.55-16.99 min) with a LC solvent 
containing acetic acid.
Specific metabolites, predicted to be present in the blood and urine after dihydrocaffeic 
acid ingestion and for which mass to charge ratio of the respective [M-H]~ ions could 
be calculated such as the glucuronide (m/z 357), sulphate (m/z 261), sulphoglucuronide 
(m/z 437), methyl (m/z 195) and glycine (m/z 238) conjugates, but also derivatives of 
dihydrocaffeic acid with an unsaturated or truncated side chain, were looked for (Annex 
1). The identity of the compounds detected was confirmed by studying the MS2 
fragmentation profile and using the corresponding standards if available. Full scan 
analysis of plasma samples collected after dihydrocaffeic acid administration showed no 
presence of the ion corresponding to the ingested compound (m/z 181).
However, two [M-H]- ions at m/z 357 and two at m/z 261 were detected, suggesting 
that dihydrocaffeic acid was glucuronidated or sulphated on either the 3- or 4-hydroxyl 
groups of the phenyl ring. Their identity was confirmed by MS2 fragmentation of the
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parent ions producing both a [M -H]- daughter ion at m/z 181 corresponding to 
dihydrocaffeic acid (Fig 36 A and B). Moreover, the [M -H]- ion at m/z 357 produced 
two additional [M -H]- ions at m/z 175 and 113, respectively identified as the glucuronic 
acid moiety and its daughter ion [M -H -H 2O -C O 2]- . However, neither double 
sulphate/glucuronide, nor sulphoglucuronide, of dihydrocaffeic acid was detected in the 
plasma samples. In addition to conjugation with glucuronide or sulphate, dihydrocaffeic 
acid was also methylated, but only one peak was detected for this mass to charge ratio 
(195). The identity of dihydroferulic acid was confirmed by MS2 analysis, the 
fragmentation of the [M -H]- ion at m/z 195 producing the main daughter ions 
[M -H -C O 2]- {m/z 151) and [M -H -C H 3-C O 2]- {m/z 136), as obtained for 
dihydroferulic acid standard. In addition, two [M -H]- ions at m/z 193 were detected in 
plasma, which upon fragmentation gave three different ions at m/z 149, 178 and 134, 
corresponding respectively to the [M -H -C O 2]- , [M -H -C H 3]-  and [M -H -C H 3-C O 2]-  
daughter ions of 193. The identity of the two compounds at m/z 193 was confirmed 
using standards of ferulic and isoferulic acids. Interestingly, dihydroferulic, ferulic and 
isoferulic acids were also found as sulphated forms, the respective parent ions at m/z 
275 and 273 producing, by MS2 analysis, daughter ions at mlz 195 and 193, the un­
conjugated forms. All the metabolites circulating in plasma reached a maximum within 
the first 30 min following the oral administration of dihydrocaffeic acid, their area under 
the peak decreasing between 30 and 60 min and being completely cleared after 120 min, 
except for the dihydrocaffeoyl-sulphates. The parent compound dihydrocaffeic acid was 
present in urine collected 6  h (but not 12 and 24 h) after its oral administration. All the 
dihydrocaffeic acid metabolites present in plasma (see above) were also detected in 
urine collected at 6 , 12 and 24 h, except for the sulphate and glucuronide conjugates of 
dihydrocaffeic acid, which were not found at the 24 h time point.
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Having identified the potential metabolites circulating in plasma and excreted in urine 
(summarized in Table 10), dihydrocaffeic acid absorption and metabolism were studied 
using ex vivo and in vitro models of colonic epithelium where dihydrocaffeic acid is 
most likely expected to appear from ingested food. Samples were analysed by LC-MS 
using a Triple Quadrupole, allowing quantification of the metabolites in addition to their 
identification.
Table 10 Summary o f the metabolites appearing in plasma and urine from the ingestion o f 
dihydrocaffeic acid.
Detection in plasma after 
ingestion (min)
Detection in urine after 
ingestion (h)
30 60 120 6 12 24
dihydrocaffeic acid X
dihydrocaffeoyl-sulphate (2 forms) X X X X X
dihydrocaffeoyl-glucuronide (2 forms) X X X X
ferulic acid (2 forms) X X X X X
feruloyl-sulphate (2 forms) X X X X X
dihydroferulic add (1 form) X X X X X
dihydroferuloyl-sulphate (1 form) X X X X X
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Figure 36 Chromatograms of plasma samples collected 30 min after oral administration of 
dihydrocaffeic acid.
Dihydrocaffeic acid ( 100 p  mo I/kg) was orally administered to rats. Plasma was collected after 
30 min, liquid-liquid extracted and analysed by LC-MS. M S1 and MS2 analyses were perform ed  
looking fo r  the ions at m/z in the range o f 356.5 - 357.5 (A) and 260.5 - 261.5 (B),
corresponding respectively to the expected m/z o f the glucuronide and sulphate conjugates o f  
dihydrocaffeic acid. The arrows indicate the presence o f the peaks o f interest.
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4.2 In  v i t r o  m e t a b o l i s m  o f  d i h y d r o c a f f e i c  a c id  b y  t h e  c o l o n i c
EPITHELIUM
Hydroxycinnamic acids, including dihydrocaffeic acid, have been proposed to permeate 
through the colonic epithelium mainly by transcellular diffusion (Chapter IV). However, 
the capacity of intestinal cells to metabolize dihydrocaffeic acid was not investigated at 
that time. Caco-2 (enterocyte-like) and HT29-MTX (goblet-like) cells were separately 
grown on dishes in order to identify metabolites produced from dihydrocaffeic acid (100 
pM). LC-MS analysis of the HT29-MTX culture supernatants (Fig. 37A) revealed the 
presence of two peaks for the m/z at 357 (dihydrocaffeoyl-glucuronide), one peak for 
the m/z at 371 (dihydroferuloyl-glucuronide), one broad peak for the m/z at 261 
(dihydrocaffeoyl-sulphate) and one peak for the m/z at 195 (dihydroferulic acid). No 
other compounds could be detected. A slightly different profile of metabolism was 
observed with Caco-2 cells, since the glucuronides were absent from their supernatant 
(Fig 37B), as already observed for ferulic acid (Chapter IV). The use of dihydrocaffeic 
acid glucuronide standards clearly confirmed peaks as dihydrocaffeoyl-4-(9-|3-D- 
glucuronide (RT = 7.3 min) and dihydrocaffeoy 1-3-O-(3-D-glucuronide (RT = 8.0 min). 
Multiple reactions monitoring (MRM), fragmenting the parent compounds and looking 
for pairs of parent > daughter ions, revealed the presence of two resolved but close 
peaks for the pair of m/z 261 > 181 (daughter > parent ions), at RT = 12.1 and 12.8 min. 
These peaks were unresolved by simple M S1 analysis, the first one being much smaller 
than the second one and indicating that one of the hydroxyl groups may be favoured for 
sulphation. Only one methyl conjugate of dihydrocaffeic acid was detected, suggesting 
a preference for the méthylation on one of the hydroxyl groups. However, caffeic acid, 
which also possesses two hydroxyl groups on the phenyl ring, when incubated with 
HT29-MTX and Caco-2 cells, was methylated into ferulic and isoferulic acid in not 
significantly different amounts (P > 0.05), indicating that the preference for méthylation
is substrate-dependent. The identity of the ion with m/z at 371 was confirmed as 
dihydroferuloyl-glucuronide by incubating the cultures directly with dihydroferulic acid 
which they were able to glucuronidate.
Transport and metabolism of dihydrocaffeic acid (1 mM) was also studied using the co­
cultures of Caco-2 and HT29-MTX cells grown together on semi-permeable membranes 
as a model for the colonic epithelium. The main compound detected in the basal 
chamber was the parent compound dihydrocaffeic acid. The permeation rate of 
dihydrocaffeic acid was 1.9 ± 0.2 pmol/cm2.min, 0.5 ±0.1 % of the initial quantity 
being transported over 1 h. Dihydroferulic acid, above the limit of quantification, was 
effluxed to the apical and basal sides at rates which were not significantly different, 
respectively 0.65 ±0.16 and 0.50 ± 0.06 pmol/cm2.min (P > 0.05).
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Figure 37 Chromatograms of the culture supernatants of HT29-MTX and Caco-2 cells 
incubated with dihydrocaffeic acid.
HT29-MTX (A) and Caco-2 (B) cells were separately incubated with dihydrocaffeic acid  (100  
pM ) fo r  3 h and supernatants analysed by LC-MS in the negative ion mode, searching fo r  
different mass to charge ratios. The detected peaks were identified as dihydrocaffeic acid  (181 ), 
dihydrocaffeoyl-glucuronide (357), dihydroferuloyl-glucuronide (371 ), dihydrocaffeoyl-sulphate 
(261) and dihydroferulic acid (195).
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4.3 EX VIVO STUDY OF DIHYDROCAFFEIC ACID TRANSPORT AND 
METABOLISM USING EVERTED SACS
In order to support the results obtained in vitro, transport and metabolism of 
dihydrocaffeic acid were studied using an ex vivo model of rat colonic epithelium 
consisting of everted sacs of ascending and descending colon and the results were 
compared with data obtained with a segment of jejunum. The main compound 
transported to the serosal compartment was free dihydrocaffeic acid. Table 11 shows 
that the amount of dihydrocaffeic acid transported to the serosal side of the jejunal 
epithelium was not significantly different from the amount transported by the colonic 
epithelium.
Table 11 Rate of dihydrocaffeic acid transport to the serosal side of everted sacs0.
Transport
___________________ (pmol/cm2.min)
jejunum 38.8 ±18.5
ascending colon 58.2 ± 25.7
descending colon_____60.2 ± 31.4
a E verted  sa cs w ere  incubated  w ith  d ihydrocaffeic a c id  (500  p M ) f o r  30  min a t 3 7  °C, sero sa l 
side  buffer ex tracted  and  an a lysed  by  LC-M S, w ith  detec tion  o f  the [M -H ]~  ion a t m /z 181. The 
values are  the m ean  ± SD.
In parallel with its transport as the free form, dihydrocaffeic acid was also metabolized, 
as seen in vitro, and the metabolites effluxed to the serosal side of the epithelium 
analysed. Dihydrocaffeic acid was conjugated with glucuronide or sulphate, but also 
methylated into dihydroferulic acid, which was itself found as glucuronidated and 
sulphated forms. The identity of the different metabolites was confirmed by MRM (Fig. 
38) and by using the corresponding standards if available. As shown in vitro, the first 
peak obtained for m/z 357 (RT = 7.2 min) was dihydrocaffeoyl-4-O-P-D-glucuronide,
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the other one being its isomer, dihydrocaffeoyl-3-0-(3-D-glucuronide. Only one large 
peak was apparent by M S1 analysis for dihydrocaffeoyl-sulphate, but 2 peaks were 
resolved by MS2, suggesting that dihydrocaffeic acid can be sulphated on one or the 
other hydroxyl groups of the phenyl ring, with a preference for one hydroxyl group, as 
proposed from the in vitro work reported above. Dihydroferulic acid, but not its isomer 
dihydroisoferulic acid, was detected. Dihydroferulic acid was itself further sulphated 
{m/z 275) or glucuronidated {m/z 371), possibly on the remaining free hydroxyl group 
on position 4. Other metabolites of dihydrocaffeic acid were looked for, but were absent, 
such as glycine {m/z 238) and sulpho-glucuronide conjugates {m/z 437).
Synthesized standards of dihydrocaffeoyl-glucuronides allowed quantification and 
showed a higher rate of glucuronidation and/or efflux by the colon compared with the 
jejunum (Table 12). Dihydrocaffeoyl-4-0-(3-D-glucuronide was only detected in some 
everted jejunum samples in contrast to its isomer, which was the major form of 
glucuronide found in the serosal content of all the segments (P < 0.05). Whereas no 
difference was seen for dihydrocaffeic acid permeation through the epithelium of the 
different segments, dihydroferulic acid efflux by the colonic epithelium was 
significantly higher than by the jejunal epithelium (Table 13), indicating that the rat 
colon displays a higher catechol-O-methyl transferase activity for dihydrocaffeic acid 
compared with the small intestine. Moreover, it is interesting to notice that 
dihydrocaffeoyl-3-O-P-D-glucuronide was effluxed in significantly higher amounts than 
dihydroferulic acid (P < 0.05), suggesting that the main metabolism performed by 
intestinal cells on dihydrocaffeic acid is the glucuronidation, followed by the 
méthylation and then the sulphation.
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F igu re 38  C h rom atogram  o f  ever ted  a scen d in g  co lon  con ten t (serosa l side) a n a lysed  by  M S 2.
Everted sacs were incubated with dihydrocaffeic acid (500 jjM) fo r  30 min at 37  °C and their 
content analyzed by LC-MS looking fo r  pairs o f  parent and daughter ions: 181 > 137
(dihydrocaffeic acid  >  parent minus C 0 2), 357 > 181 (glucuronide > free  dihydrocaffeic acid), 
371 > 195 (glucuronide > free  dihydroferulic acid), 261 > 181 (sulphate > free  dihydrocaffeic 
acid), 195 > 136 (dihydroferulic acid > parent minus CH3 and C 0 2), 275 > 195 (sulphate > 
free  dihydroferulic acid).
Table 12 Efflux of dihydrocaffeoyl-glucuronides to the serosal side of everted sacsa.
Efflux of glucuronides
_______ (pmol/cm2.min)______
_______________________Gluc-4 b Gluc-3 b
jejunum 4 . 9  ± 7.3 3 2 . 2  ±  7.7
ascending colon 2 2 . 4  ±  8 . 3  c 1 0 1 . 9  ±  3 1 . 2  c
descending colon 5 0 . 8  ±  1 8 . 8  c 2 0 3 . 2  ±  8 4 . 4  c
a Everted sacs were incubated with dihydrocaffeic acid (500 pM ) fo r  30 min a t 37 °C, se rosed 
side buffer extracted and analysed by LC-MS, with detection o f  the [M -H ]~  ion at m/z 357. The 
values are the mean ± SD.
b, Gluc-3 and Gluc-4: glucuronidation respectively on the 3 and 4-OH
c, significantly different from  the jejunum and Gluc-3 significantly different from  Gluc-4  
glucuronide (P < 0.05).
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Table 13 Efflux o f dihydroferulic acid to the serosal side o f everted sacs".
Efflux
___________________ (pmol/cm2.min)
jejunum 8.1 ±2.2
ascending colon 21.1 ± 5.6b
descending colon_____26.6 ± 8.9 b
a Everted sacs were incubated with dihydrocaffeic acid (500 nM) for 30 min at 37 °C, serosal 
side buffer extracted and analysed by LC-MS, with detection of the [M-H]~ ion at m/z 195. The 
values are the mean + SD.
b, significantly different from dihydroferulic acid present in the jejunum sac (P <0.05)
4.4 EX VIVO METABOLISM OF DIHYDROCAFFEIC ACID BY THE LIVER
Even though not detected in the samples collected, dihydrocaffeic acid must be present 
at some point as the free form in plasma after crossing the gastric and/or intestinal 
epithelium, according to the results obtained with the in vitro and ex vivo models for the 
colonic epithelium. However, it must be rapidly cleared from plasma by further 
metabolism in the liver and excretion in urine. Therefore, the capacity of the liver to 
metabolize dihydrocaffeic acid was of interest. In order to stabilize dihydrocaffeic acid 
for the long incubation periods in culture medium, ascorbic acid (50 pM) was added to 
dihydrocaffeic acid (50 pM), which was as a consequence stable at 100 % over 8 h of 
incubation. No peak was detected by searching the mass to charge ratio corresponding 
to the glucuronide (m/z 357) or the glycine (m/z 238) conjugates. However, two 
resolved peaks were detected for the m/z at 261, corresponding to two forms of 
dihydrocaffeoyl-sulphate and supporting the idea that dihydrocaffeic acid can be 
sulphated on either the 3 or the 4 hydroxyl groups of the phenyl ring (Fig. 39).
Dihydroferulic acid (m/z 195) and its sulphate conjugate (m/z 275) were also found, but 
only one peak was detected for each mass to charge ratio, indicating that neither
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dihydroisoferulic acid nor its sulphate could be detected. Dihydroferulic acid was 
detected after 30 min of incubation of dihydrocaffeic acid with the liver slices, and was 
quantifiable after 2 h. The amount of dihydroferulic acid produced after 8 h was 2.12 ± 
0.33 nmol/mg protein (n = 3), corresponding to 5.3 ± 0.8 % of the initial concentration 
of dihydrocaffeic acid. Moreover, two peaks were found at m/z 193, the first and major 
one (RT = 22.25 min) being ferulic acid and the second one (RT = 23.3 min) being 
isoferulic acid. From these results, I hypothesize that the first and major peak found for 
m/z 273 could be feruloy 1-sulphate whereas the second and minor one could be 
isoferuloy 1-sulphate. Ferulic acid concentration increased over time to reach 0.37 ± 0.11 
nmol/mg protein (0.9 ± 0.3 % of the initial quantity of dihydrocaffeic acid). 
Interestingly, no caffeic acid (m/z 179) could be detected in the supernatant of the liver 
slice cultures. This finding supports the hypothesis that, in the cascade of dihydrocaffeic 
acid metabolism, ferulic and isoferulic acids must respectively result from the oxidation 
of the side chain of dihydroferulic acid and its isomer, rather than from a méthylation of 
one or the other hydroxyl groups of caffeic acid. However, caffeic acid can be 
methylated into ferulic and isoferulic acid by intestinal cells, as seen using the in vitro 
model for colonic epithelium (data not shown). In order to confirm that dihydroferulic 
acid was the source of ferulic acid from dihydrocaffeic acid, dihydroferulic acid was 
incubated with liver slices. Ferulic acid was detected after 30 min of incubation and was 
quantifiable after 2 hours, its concentration increasing over time and reaching 8.0 ±1 .8  
% of the initial amount of dihydroferulic acid (50 pM) after 8 hours. Interestingly, liver 
slices were also able to reduce the double bound of the side chain leading to the 
production of dihydroferulic acid from ferulic acid. However, no isoferulic acid could 
be detected from dihydroferulic acid, supporting the idea of the méthylation on the 4- 
hydroxyl group of dihydrocaffeic acid as the route to isoferulic acid production, rather 
than a de-methylation and re-methylation on the other hydroxyl group. Liver slices
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mainly produced the sulphated form of ferulic acid, followed by its reduced form (2.2 ± 
0.4 % of the initial concentration of ferulic acid). However, ferulic acid was 
glucuronidated by the liver although no glucuronide of dihydrocaffeic and 
dihydroferulic acids could be detected.
Papers have reported the presence in plasma and/or urine of double conjugations of 
ferulic acid with one glucuronide and one sulphate (Rondini et a l ,  2002; Zhao et a l ,  
2003a; Zhao et a l ,  2003b; Rondini et a l ,  2004; Zhao et a l ,  2004). Since no glucuro- 
sulpho conjugates were detected from intestinal metabolism of ferulic acid (Chapter 
IV), one could hypothesize that the glucuronide or sulphate conjugates of ferulic acid 
produced by intestinal cells could reach the liver for further metabolism. To investigate 
this hypothesis, feruloyl-4-0-[3-D-glucuronide was incubated with liver slices as 
performed with dihydrocaffeic acid. However, no further metabolism could be detected.
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Figure 39 Chromatogram of the supernatant of liver slices cultures incubated with 
dihydrocaffeic acid and analysed by LC-MS.
Supernatants o f  liver slices cultures were collected after 8 h o f incubation with dihydrocaffeic 
acid (50 pM ) in the culture medium. Supernatants were analyzed by single ion recording o f  the 
ions with mass to charge ratio: 261 (dihydrocaffeoyl-sulphate), 195 (dihydroferulic 
acid), 275 (dihydroferuloyl-sulphate), 273 (feruloyl-sulphate) and 193 (ferulic acid).
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5 Discussion
5.1 P o s s i b l e  a b s o r p t i o n  a n d  m e t a b o l i s m  o f  d i h y d r o c a f f e i c  a c id  b y
THE STOMACH
After gavage to rats, dihydrocaffeic acid was very rapidly absorbed and/or cleared from 
the plasma, since it was only found unconjugated in the urine and not in blood. This 
suggests that dihydrocaffeic acid absorption must have taken place in the stomach or in 
the upper part of the small intestine. In addition to transport, it is likely that gastric cells 
could also metabolize part of the dihydrocaffeic acid absorbed, since absorption from 
the stomach has already been proposed for flavonoids (Piskula et a l ,  1999; Crespy et a l ,  
2002) and phenolic acids (Zhao et a l ,  2004; Konishi et a l ,  2006). However, the first 
study reporting ferulic acid absorption by the stomach suggested only further 
metabolism by the liver (Zhao et a l ,  2004). The second report mentioned a possible 
metabolism of ferulic acid in parallel to its absorption by the gastric cells, since 
conjugates were detected in plasma from the portal vein only 5 min after the intake. 
However, taking into account their previous findings, the authors came to the 
conclusion that there was rather a metabolism of ferulic acid by the liver and/or re­
absorption by the enterohepatic circulation than a metabolism by the stomach (Konishi 
et a l ,  2006). The presence of UDP-glucuronosyltransferases, as well as 
sulphotransferases, has been detected in stomach (Grams et a l ,  2000; Nishimura & 
Naito, 2006; Teubner et a l ,  2007), indicating that gastric cells could be involved in a 
pre-systemic detoxification of compounds absorbed by the stomach, even before 
reaching the liver.
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5.2 G l u c u r o n id a t io n  o f  d ih y d r o c a ffe ic  acid
The transport of dihydrocaffeic acid to the serosal side of the ^astro-intestinal tract was 
supported by the results obtained with the in vitro and ex vivo models for the colonic 
epithelium, which were able to transport but also to glucuronidate and sulphate the 
hydroxycinnamic acid. In contrast to the HT29-MTX cells, the Caco-2 cells do not 
appear to express a UDP-glucuronosyltransferase activity towards dihydrocaffeic acid 
as shown for epicatechin (Vaidyanathan & Walle, 2001), even though able to 
glucuronidate different flavones (Ng et a l ,  2004) and resveratrol (Sabolovic et a l ,  
2006). Moreover, Kern et al. reported the production of glucuronides by Caco-2 cells 
from methyl-ferulate, -sinapate, -caffeate and -p-coumarate but not from the 
corresponding free acids (Kern et a l ,  2003b). Taken together, all these findings suggest 
that different UGTs must have different specificities for substrates and that the isoform 
involved in the glucuronidation of dihydrocaffeic acid must be absent from Caco-2 cells. 
In addition, metabolism of dihydrocaffeic acid using rat intestine suggests that the UDP- 
glucuronosyltransferase activity, favouring glucuronidation of the 3-OH over the 4-OH, 
is higher in the colonic than in the jejunal epithelium and is almost absent in the rat liver.
Previous reports suggested that a substrate preference or specificity may exist for 
glucuronidation by the different UDP-glucuronosyltransferase isoenzymes. For instance, 
human isoenzymes UGT1A1, UGT1A8 and UGT1A9 have been shown to be especially 
active in conjugating quercetin and luteolin, whereas UGT1A4, UGT1A10, UGT2B7 
and UGT2B15 were less efficient (Boersma et a l ,  2002). Even though relatively less 
expressed in the lower part (caecum, colon, rectum) than in the upper part (duodenum, 
jejunum, ileum) of the rat gastrointestinal tract, UGT1A7 gene expression is higher in 
the colon than in the liver (Grams et a l ,  2000; Shelby et a l ,  2003). However, it must be 
mentioned that the gene expression may not reflect the protein activity, which could still
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be higher in the colon, even though the gene expression is lower than in the small 
intestine. Interestingly, transcripts of the isoform UGT1A7 have not been detected in 
Caco-2 cells (Gregory et a l ,  2004) whereas the gene is expressed by HT29 cells 
(Cummings et a l ,  2004), the precursor of the HT29-MTX cells. Moreover, UGT1A7, is 
ubiquitously expressed in human with trace to low levels in the gastrointestinal tract 
(Basu et a l ,  2004), being more abundant in the stomach (Gregory et a l ,  2004). All 
these findings would suggest that the isoform UGT1A7 is a potential candidate for the 
glucuronidation of dihydrocaffeic acid, and probably of other hydroxycinnamic acids. If 
the UGT1A7 is the only isoform involved in the glucuronidation of dihydrocaffeic acid, 
in humans, this conjugation would occur mainly in the stomach but at much lower 
levels, or not at all, in the lower part of the gastrointestinal tract and in the liver. 
However, these hypotheses do not exclude that, rather than an absence of a specific 
UDP-glucuronosyltransferase activity for dihydrocaffeic acid in Caco-2 cells, there 
could be a deficiency in the efflux system of the glucuronide in these cells compared 
with HT29-MTX cells and that this efflux mechanism would be more expressed in the 
colon than in the jejunum of the rat.
5.3 SULPHATION OF DIHYDROCAFFEIC ACID
An opposite profile of activity has been shown for the sulphation of dihydrocaffeic acid 
compared with glucuronidation, which was favoured in the liver compared with the 
intestine of rat. Caco-2 have also been shown to express SULT1A1 and SULT1A3 at 
identical levels (Tamura et a l ,  2001) and are able to produce sulphate conjugates of 
epicatechin (Vaidyanathan & Walle, 2001), indicating that the SULT activity is present 
in the Caco-2 cells. In rats, the highest amount of SULT mRNAs is detected in the liver 
with significant expression of SULT1A1 and SULT1B1, the latter being more expressed 
than the former in the intestine (Dunn & Klaassen, 1998). In humans, SULT1A1, A3
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and B 1 are expressed in all the gastrointestinal tract, as seen by immunohistochemistry 
and immunoblotting, the levels being the highest in the ileum, and SULT1A1 being 
more expressed in the ileum than the liver (Teubner et a l ,  2007). SULT1A3, higher 
than SULT1A1, is absent in the liver and SULT1B1 is ten times higher in the ileum 
than in the liver. In addition to these isoforms was the SULT1C1 present in the stomach. 
According to all these findings, tissue distribution of SULT activity would be different 
in human and in rats, in human the gastrointestinal tract being more potent whereas in 
rats it would be the liver, supporting the present data.
5 .4  O t h e r  t y p e s  o f  c o n ju g a t io n
5.4.1 With glutathione
Dihydrocaffeic acid, together with chlorogenic and caffeic acids, was shown to be 
conjugated with glutathione (Moridani et a l ,  2001). However, no peak for the mass to 
charge ratio corresponding to the glutathione conjugate of dihydrocaffeic acid could be 
detected in the cultures of liver slices. If conjugated with glutathione, it must have been 
under the limit of detection.
5.4.2 Méthylation and regio-selectivity
Dihydrocaffeic acid, in addition to glucuronidation and sulphation, was also methylated 
but only one form was detected and identified as dihydroferulic acid. As previously 
shown, the mass spectral signal from phenolic acids with a 3-hydroxyl (such as 
isoferulic acid) can be severely suppressed when the HPLC solvent contains an acid 
modifier to ensure good chromatography (Clifford et a l ,  2007a). The LC-MS 
conditions used in this study were adjusted so as to ensure that isoferulic acid could be 
detected, albeit with a lower sensitivity than for ferulic acid. Because no standard of
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dihydroisoferulic acid was available, it was not possible to investigate the susceptibility 
of this compound to ion suppression during LC-MS, but it is assumed that it would be 
very similar to isoferulic acid, and it is possible that if only a small amount of 
dihydroisoferulic acid was produced during metabolism, then its presence may not have 
been detected. Moreover, only one sulphated or glucuronidated form of dihydroferulic 
acid could be detected. The ion suppression is not expected to impair the detection of 
conjugated forms, suggesting that, if the conjugates of dihydroisoferulic acid were 
present in the samples in amount above the limit of detection, they would have been 
detected. The lack of detection of dihydroisoferulic acid was more due to low 
production, under the limit of detection, rather than to ion suppression. Nevertheless, it 
is hypothesized that both méthylation, on the 3- and 4-hydroxyl groups of 
dihydrocaffeic acid, must occur since 2 compounds, ferulic and isoferulic acids, appear 
after ingestion of dihydrocaffeic acid in vivo or when incubated with colonic epithelium 
or liver slices, although one being favoured over the other. These data support the fact 
that catechol-O-methlyl-transferase (COMT) strongly favoured the 3- compared with 
the 4-hydroxyl group of dihydrocaffeic acid for méthylation, leading to the formation of
3-methoxy-4-hydroxy-phenylpropionic acid (dihydroferulic acid). A study on 
understanding of the COMT regio-selectivity towards the hydroxyl groups of 
norepinephrine (Thakker et a l ,  1986) suggested that there is a link between the pKa of 
the hydroxyl groups and the regio-selectivity for méthylation of norepinephrine by the 
COMT. According to the authors, the 4-0-methylation requires a pre-ionization of the 
hydroxyl group, whereas the 3-0-methylation is assisted by a base present in the COMT, 
allowing méthylation to occur at a lower pH than the pKa. Whereas only one form of 
methyl conjugate was detected from dihydrocaffeic acid, caffeic acid was metabolized 
into ferulic and isoferulic acids in similar amounts, indicating that there was not as 
much regio-selectivity for caffeic acid méthylation as there was for dihydrocaffeic acid.
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These data support the hypothesis of pKa-dependent méthylation of the 4-OH. Indeed, 
caffeic and dihydrocaffeic acids both possess a 3-OH pKa of 11.38 ± 0.02 whereas the
4-OH of caffeic acid at 8.48 ± 0.05 is closer to neutral pH than is the one of 
dihydrocaffeic acid (9.24 + 0.02) (Silva et a l ,  2000) and as a consequence, more liable 
for méthylation.
5.5  I n t e r c o n v e r s io n  b e t w e e n  p h e n o l ic  a c id s
Dihydrocaffeic and caffeic acids were methylated respectively into dihydroferulic and 
ferulic acids by intestinal and hepatic cells. However, the reverse reaction was not 
observed in contrast to what was shown previously using CYP1A1/2 induced liver 
microsomes and a ten times higher substrate concentration than used in the present work 
(Moridani et a l ,  2002). This conversion may have happened during my experiments but 
the amount of the resulting compounds must have been under the limit of detection, 
suggesting that, in vivo, de-methylation must be a secondary metabolic pathway, the 
expected aim of the liver being to detoxify by neutralizing hydroxyl functions rather 
than liberating them. However, hepatic and intestinal cells were also able to reduce 
ferulic acid into dihydroferulic acid, and catalyse the reverse reaction, but no 
interconversion between dihydrocaffeic and caffeic acids was detected in contrast to 
reports by Moridani et a l  using isolated hepatocytes (Moridani et a l ,  2002).
5.6  M e t a b o l is m  o f  p h e n o l ic  a c id s  b y  t h e  l iv e r
Metabolism of phenolic acids by the liver was firstly studied by using HepG2 cells, the 
best characterized human hepatoma cell line. They express a variety of enzymes 
involved in the metabolism of xenobiotics by the liver, such as SULT activity, but these 
are passage-dependent and are expressed at low levels, although usually enough to
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study biotransformation of drugs (Brandon et a l ,  2005). Several culture and treatment 
conditions were tried, but metabolites of dihydrocaffeic acid could not be detected in the 
culture supernatant of HepG2 cells, because dihydrocaffeic acid was not a substrate for 
the metabolic enzymes of HepG2, because the metabolites were under the limit of 
detection, or because the cells did not express the transporters involved in the efflux of 
its metabolites. Neither were detected metabolites of ferulic acid. HepG2 cells have 
been reported to metabolize caffeic, ferulic but not chlorogenic acids (Mateos et a l ,  
2006). Nevertheless, the time of incubation which was necessary to Mateos et al. to 
detect hydroxycinnamic acid metabolites in the culture supernatant of HepG2 cells was 
much higher (18 h) than the one I tried (3 h maximum) and would explain why I could 
not detect any metabolite of ferulic and dihydrocaffeic acids. Moreover, from ferulic 
acid, Mateos et a l  only detected glucuronide conjugate whereas from caffeic acid, they 
obtained methyl, methylglucuronide, glucuronide and sulphate conjugates. These data 
suggest that, depending on the chemical structure, the type of conjugation will be 
different, méthylation being favoured for caffeic acid whereas sulphation will be the 
conjugation for ferulic acid, at least in human hepatocytes and/or in HepG2 cells. An ex 
vivo model of liver slices reported to allow the total metabolism of 7-ethoxycoumarin in 
a time dependent manner for at least 10 h (Hashemi et a l ,  1999) was used instead of the 
HepG2 cells. With this model, ferulic acid was sulphated and glucuronidated, whereas 
caffeic and dihydrocaffeic acids were not, but it was also reduced. The discrepancies 
observed between the present results and the data reported by Mateos et a l  could 
originate form the type of model used (explant of liver versus carcinoma derived cell 
line) or from the species origin of the model (human versus rat). Liver slices, as well as 
HepG2 cells, are interesting models but results should be considered with care.
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6 Conclusion
In summary, the results indicate that dihydrocaffeic acid is absorbed and extensively 
metabolized, although some free form is found in urine. The present findings suggest 
that rat intestinal epithelium favours the glucuronidation of dihydrocaffeic acid, whereas 
the liver favours sulphation, both the conjugations and méthylation favouring the 3-OH 
position (summarized in Fig. 40). The metabolic profile proposed here is based on 
results found with rat tissues. This profile could be different in other species, and 
especially in human, due to probable different rates of expression and/or tissue 
distribution of the metabolizing enzymes. However, the metabolism of dihydrocaffeic 
acid obtained with the human intestinal cells (HT29-MTX) also suggests a possible 
higher rate of glucuronidation than sulphation in the human intestine. The results show 
the pathways of absorption and metabolism of dihydrocaffeic acid, an important 
bioactive substance, and will facilitate future in vivo studies in humans.
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Figure 40 Proposed metabolic fate of dihydrocaffeic acid in rats.
Depending on the food  source or delivery, dihydrocaffeic acid may be absorbed by: the stomach, 
duodenal or jejunal cells, if  given as the free  form ; or rather by the ileum or the colon after 
metabolism by the microflora, if  given as an esterified form  (e.g. as present in many foods) or if  
given as a precursor (e.g. catechins). The unbroken arrow s indicate that the perm eation or 
efflux may be by transcellular diffusion and, to a sm aller extent, by facilita ted  transport. The 
dotted arrows represent a potential facilita ted  transport. 3 ’ or 4 ’-G/S, glucuronidation or  
sulphation on the 3'- or 4 ’-OH; DHCA, dihydrocaffeic acid; (iso)DHFA, dihydro(iso)ferulic 
acid; (iso)FA, (iso)ferulic acid.
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1 Abstract
Such as other phenolic acids, dihydrocaffeic acid, a dietary constituent and a microbial 
metabolite of flavonoids, is an antioxidant, but few biological effects have been 
examined. After its production by microflora in the colon, dihydrocaffeic acid is 
absorbed and found in plasma as a combination of free and metabolized forms. Excess 
of solar UV radiation provokes damages and initiates immune response and 
inflammation in skin, sometimes leading to cancer. Dihydrocaffeic acid reduced the 
cytotoxicity and pro-inflammatory cytokine production (IL-6 and IL-8) in a keratinocyte 
model (HaCaT cells) following UV radiation. The effect of dihydrocaffeic acid may 
result from a combination of a radical scavenging of the ROS formed in kératinocytes 
after UV exposure or a reinforcement of the antioxidant potential of the kératinocytes, 
together with an interference with the pathway involved in cytokine stimulation. The 
minimum structure required for such effect appears to consist in a propionic side chain 
attached to a phenyl ring substituted with a catechol moiety, as indicated by the efficacy 
obtained with caffeic acid but not with the methyl and glucuronide conjugates of 
dihydrocaffeic acid. The data obtained suggest that dihydrocaffeic acid is a potential 
candidate for photo-protection by interfering with the events initiated after UV exposure 
in kératinocytes. Dihydrocaffeic acid was also able to protect erythrocytes against 
damaging effects caused by a free radical generator, suggesting that it could exert 
beneficial effects as soon as entering the blood circulation, even before reaching target 
tissues.
190
2 Introduction
Based on the results obtained on the mechanisms of absorption of phenolic acids with a 
chemical structure similar to ferulic acid (Chapter IV), it was hypothesized that 
dihydrocaffeic acid could enter any type of cells mainly by transcellular diffusion, 
dependent on the pH and on its pKa, and partly by a facilitated transport (S-MCT, 
MCT1), providing the target cells expressed these transporters. This could happen in 
kératinocytes, the main cells which compose the epidermis.
Several phytochemicals, with antioxidant properties, have been associated with photo- 
chemoprevention, displaying anti-inflammatory, anti-cancer and anti-ageing properties 
(Svobodova et ah, 2003; Afaq & Mukhtar, 2006). Despite the abundance of its food 
source, since it is one of the major microbial metabolites of flavonoids, and its 
antioxidant properties, the photo-protective effect of dihydrocaffeic acid has never been 
investigated. It was of interest to determine if dihydrocaffeic acid could, similarly to 
ferulic and caffeic acids, protect kératinocytes from damages and inflammation caused 
by UV radiation. The model used to study dihydrocaffeic acid effect on kératinocytes 
was the human HaCaT keratinocyte cell line, a spontaneously immortalized human 
epithelial cell line (Boukamp et a l ,  1988), which displays specific p53 mutations 
(Lehman et a l ,  1993).
Dihydrocaffeic acid, such as caffeic acid, has been shown to enter erythrocytes and 
enhance their ability to reduce the transmembrane oxidant stress generated by 
extracellular ferricyanide (Lekse et a l,  2001). It was interesting to investigate whether 
dihydrocaffeic acid could also protect erythrocytes from lysis provoked by a water- 
soluble free radical initiator.
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3 Materials and methods
3.1 M a te r ia l s
Fetal calf serum (FCS), penicillin-streptomycin, L-glutamine, Hanks’ Balanced Salt 
solution (HBSS), RPMI 1640 and hydrogen peroxide (H2O2) were purchased from 
Sigma (Buchs, Switzerland). Plastic dishes were obtained from Coming (Wohlen, 
Switzerland). Ethyl acetate, sodium acetate anhydrous, HPLC grade water, acetonitrile 
and glacial acetic acid were purchased from Merck (Dietikon, Switzerland). Ferulic, 
caffeic and dihydrocaffeic acids were obtained from Extrasynthese (Genay, France). 
Dihydroferulic acid was provided by Alfa Aesar (Karlsruhe, Germany). 
Dihydrocaffeoyl-3-O-P-D-glucuronide and dihydrocaffeoyl-4-O-p-D-glucuronide were 
from the Nestlé Research Centre collection of standard compounds.
3.2 Ce ll  c ultur e
The spontaneously immortalized human keratinocyte HaCaT cell line was cultured at 37 
°C in RPMI 1640 medium supplemented with 584 mg/L of L-glutamine, 100 U/ml of 
penicillin-streptomycin and 10 % heat inactivated FCS. For the chemical and UV 
treatments, HaCaT cells were seeded at 75 000 cells/cm2 and grown in RPMI containing 
10 % FCS for five days, medium being changed every other day.
3.3 M e ta b o l ism  e x pe r im en t s
For the phenolic acid metabolism experiments, the cells were seeded at 25 000 cells/cm2 
and grown for four days. Then, the medium was changed for RPMI without FCS and 
supplemented with 100 pM  of the phenolic acids tested (0.1 % from a stock solution at
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100 mM in EtOH). After 3 h at 37 °C, supernatant was collected, acidified with acetic 
acid to obtain a final concentration of 10 mM and stored at -2 0  °C until analysis.
3 .4  S a m p l e  p r e p a r a t io n  a n d  L C -M S  a n a l y s is
Room temperature defrosted samples (150 pi) were mixed with an equal volume of 0.1 
mM sodium acetate buffer pH 5. HPLC grade water (150 pi) and 300 pi 200 mM 
HCl/methanol were added. After 30 sec of sonication, the mixture was vortexed and 
extracted three times with ethyl acetate. After each centrifugation at 5 000 g for 5 min, 
organic phases were collected and pooled. Each sample was extracted twice, the extracts 
pooled and finally dried under nitrogen. The dried extracts were re-suspended into 30 pi 
of 5 % acetonitrile in water containing 0.1 % formic acid and injected onto an Acquity 
UPLC™ BEH Shield RPig column (2.1 x 100 mm, 1.7 pm; Waters, Rupperswil, 
Switzerland). Elution was performed with a flow rate of 0.3 ml/min and a gradient of 
solvent A (water) and B (acetonitrile), both acidified with 0.1 % formic acid. HPLC 
analysis was started with 3 % of solvent B. This condition was maintained for 1 min and 
then the percentage of solvent B was linearly increased to 5 within 1 min, to 10 within 
18 min, to 15 within 10 min and finally to 100 within 1 min. 100 % solvent B was 
maintained for 3 min, then initial conditions were reached within 1 min and the column 
equilibrated in 3 % solvent B for 5 min. The HPLC system (Acquity UPLC system, 
Waters, Rupperswil, Switzerland) was connected to a triple Quadrupole Micromass 
Quattro micro API mass spectrometer (Waters, Rupperswil, Switzerland), with an 
electrospray ionization (ESI) interface. The LC eluent was introduced directly from the 
absorbance monitor (Photo Diode Array, PDA) into the ESI probe without flow splitting. 
A nebulizing gas flow of 150 L/h and a drying gas flow of 550 L/h were applied for 
ionization using nitrogen in both cases. Samples were analyzed in the negative ion mode. 
ESI-MS parameters were as follows: voltage, 3 kV; capillary temperature, 90 °C. The
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results obtained were normalized using an internal standard, syringic acid, added at a 
known concentration to the samples to be extracted.
3.5 UV AND CHEMICAL TREATMENTS OF THE HaCaT CELLS
The sequence of the UV and chemical treatments on HaCaT cells is detailed in Figure 
4L Cells were starved from FCS for 24 h prior to TNF-a, UV or H2O2 challenges. 
Before irradiation, medium was removed from the wells and replaced by HBSS (250- 
300 pl/cm2) and cells exposed for different periods of time to UVB. The source of UVB 
radiation was delivered by three lamps (TL-40W/12 sunlamps, Philips, The 
Netherlands), with a fixed distance of 40 cm from the lamps to the surface of the cell 
cultures. These lamps emit a spectrum from 240 to 400 nm with 54, 45 and 1 % within 
the range of respectively UVB (290-320 nm), UVA (320-400 nm) and UVC (240-290 
nm). After UV irradiation, HBSS was replaced by fresh medium without FCS and 
containing, or not, the phenolic acids, which were pre-dissolved into EtOH as stock 
solutions at 100 mM. Only the standard for the glucuronides of dihydrocaffeic acid were 
dissolved into DMSO. The stock solutions were further added to the culture medium 
made of RPMI without FCS, the amount of DMSO and EtOH in the culture medium 
never exceeding 0.1 %. The control samples contained the same volume of DMSO or 
EtOH as the test samples and the calculations were always relative to the corresponding 
control. H2O2 was dissolved into RPMI without FCS after a pre-dilution into water. 
Lyophilized TN F-a was firstly dissolved into water to a final concentration of 100 ng/pl 
and further added to RPMI without FCS at 20 ng/ml.
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Figure 41 Experimental protocol showing the sequence of events for the UV or chemical 
treatments of HaCaT cells.
3.6 IL -8  AND IL -6  E L IS A
After UV or TNF-a treatments, HaCaT cells were incubated with RPMI without FCS 
(130 and 260 |ul/cm2 for the measurement respectively of IL-6 and IL-8). Supernatants 
were harvested 24 or 48 h after the treatment, centrifuged at 4 000 g for 5 min and 
stored at -80 °C until analysis. Defrosted samples were assayed for IL-6 or IL-8 by 
ELISA using the EASIA kits (Biosource, Lucerne, Switzerland), according to the 
manufacturer’s instructions.
3.7 D e t e r m in a t io n  o f  c e l l  d e a t h
To estimate the viability of adherent cells, lactate dehydrogenase (LDH), a cytosolic 
enzyme released in the supernatant of cultures by damaged cells, was measured using 
the Cytotoxicity Detection Kit (Roche Applied Science, Rotkreuz, Switzerland) 
following the supplier’s instructions. A standard curve was prepared using dilution
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series of the supernatant of cultures treated with 1 % Triton X100 (100-150 pl/cm2) for 
1 h at 37 °C, which was considered as 100 % toxicity. In the case of H2O2 treatment, 
cytotoxicity was assayed after 24 h and after 24 or 48 h for UV and TN F-a treatments.
3.8 P r o t e c t io n  of  r ed  blo o d  cells  f r o m  lysis
Blood samples were collected by cardiac puncture into heparinized tubes from six 
week-old male Sprague Dawley rats, which were adapted to laboratory conditions 
(normal 12 h dark/12 h light cycles) with free access to tap water and to a conventional 
diet for one week. 2 ml of blood were centrifuged for 10 min at 1000 g (Fig. 42). The 
resulting erythrocytes were washed 3 times with 5 corresponding volumes of PBS IX, 
centrifuging them between each wash for 10 min at 2000 g, the last centrifugation being 
at 3000 g. The pellet was re-suspended into 4 corresponding volumes of PBS IX  in 
order to obtain a hematocrit of 20 %. Cell suspension (200 pi) was mixed with an equal 
volume of PBS IX, containing or not the test compounds, and 200 pi of PBS IX 
containing 2,2’-azo-bis (2-aminopropane) dihydrochloride (AAPH). The samples were 
incubated for 3 h at 37 °C under gentle agitation, and after addition of 8 ml of PBS IX 
(or water for total lysis), they were finally centrifuged for 10 min at 3000 g. The 
remaining supernatant was read at 540 nm. The percentage of hemolysis was 
determined using the following equation:
% inhibition of lysis = {(C-D)/C} x 100 
where C is the OD540 obtained for the sample treated only with AAPH and D the OD540 
obtained for the sample treated with AAPH and the potential antioxidant.
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Figure 42 Diagram of the sequence of events for the detection of erythrocyte hemolysis.
3 .9  D a t a  a n a l y s i s
Data are shown as mean ± SD. Differences between test and control conditions were 
assessed by Student’s Mest and differences with value of P < 0.05 were considered as 
significant.
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4 Results
4.1 U pt a k e  a nd  m e t a b o l ism  o f  p h e n o l ic  a c id s  b y  k é r a t in o c y t e s
In Chapter IV and V, it was proposed that phenolic acids are absorbed, metabolized and 
effluxed by intestinal and hepatic cells. The mechanism of absorption, based mainly on 
transcellular diffusion and dependent on the hydrophobicity of the phenolic acids 
(Chapter IV), could be applied to any type of cells, including kératinocytes. Before 
testing efficacy of dihydrocaffeic acid on HaCaT cells, it was of interest to determine if 
the kératinocytes used could metabolize phenolic acids as did enterocytes and 
hepatocytes. HaCaT cells were incubated with dihydrocaffeic, caffeic or ferulic acids 
and the supernatant of cultures were analysed by LC-MS for the presence of metabolites. 
The identification of the metabolites was performed by looking for the mass to charge 
ratio of the pairs of parent > daughter ions obtained under fragmentation. After 
incubation of dihydrocaffeic acid (m/z 181 > 137) with HaCaT cells, its sulphate (m/z 
261 > 181) and methyl (m/z 195 > 136) conjugates were detected in the supernatant. 
The méthylation was mainly on one of the hydroxyl groups of dihydrocaffeic acid, as 
only one peak was detected for the m/z at 195 > 136, which was identified as 
dihydroferulic acid (Fig. 43A). Caffeic acid (m/z 179 > 135), the oxidized form of 
dihydrocaffeic acid, was methylated (m/z 193 > 134), on one or the other hydroxyl 
groups, since 2 forms were detected in the supernatant and identified as ferulic and 
isoferulic acids, owing to the availability of the corresponding standards (Fig. 43B). 
Ferulic acid was sulphated (m/z 273 > 193), presumably on its remaining free hydroxyl 
group. The unsaturated side chain of ferulic acid was also reduced by HaCaT cells since 
dihydroferulic acid (m/z 195 > 136) was detected in the supernatant of the cultures (Fig. 
43C).
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Figure 43 Chromatograms obtained by LC-MS analysis of the supernatant of HaCaT cells.
H aCaT cultures were incubated with 100 pM  dihydrocaffeic (A), caffeic (B) or feru lic (C) acids 
fo r  3 hours at 37  °C. The culture supernatants were harvested and purified by liquid-liquid  
extraction and analysed by LC-MS looking fo r  the mass to charge ratio fo r  the pa irs o f  parent > 
daughter ions in the negative ion mode: m/z 181 > 137, dihydrocaffeic acid; m/z 261 > 181, 
dihydrocaffeoyl-sulphate ; 195 > 136, dihydroferulic acid; 179 > 135, caffeic acid; 193 > 134, 
ferulic acid; 273 > 193, feruloyl-sulphate.
4 .2  D i h y d r o c a f f e i c  a c i d  a t t e n u a t i o n  o f  k é r a t i n o c y t e s  U V - i n d u c e d
CYTOTOXICITY
The protective effect of dihydrocaffeic acid against UV-induced cytotoxicity was tested 
by incubating HaCaT cells with dihydrocaffeic acid (100 pM) for 24 h before and 24-48 
h after UV treatment. Cytotoxicity was evaluated by LDH measurement. As shown in 
Figure 44, dihydrocaffeic acid slightly but significantly (P < 0.01) protected 
kératinocytes against UV induced cytotoxicity. For the following experiments, times of 
exposure of 40 (7.5 mJ/cm2) and 50 (9.2 mJ/cm2) sec were chosen for studying the 
effect on HaCaT cells of dihydrocaffeic acid, respectively, 24 and 48 h following UV 
treatment.
199
A B
25  -,
20  -
20  -
80 10 20 30 40 50 7060
T im e  o f  e x p o s u r e  ( s e c )
Figure 44 Dihydrocaffeic acid reduces the kératinocytes cytotoxicity induced by UV.
H aCaT cells were firs t treated with (m) or without ( ♦ )  100 /j M  dihydrocaffeic acid fo r  24 h and  
then exposed to different UV doses o f  5.8, 7.5, 9.2, 11.04 and 12.5 mJ/cm2, corresponding 
respectively to 30, 40, 50, 60 and 70 sec o f  exposure to the lamps. A 100 % LDH release was 
prepared  by incubating cells with 1 % Triton X I00 fo r  1 h at 37  °C fo r  the 24 and 48 h 
conditions. LDH released was measured after 24 (A) or 48 (B) h o f  further incubation with 100 
p M  dihydrocaffeic acid. The values are the mean ± S D  (n = 3).
Time dependence of the effect of dihydrocaffeic acid on cell viability was investigated 
by measuring the LDH release 48 h after UV treatment. When the cultures were 
incubated with dihydrocaffeic acid (100 jaM) for 24 h prior to UV treatment, the UV 
induced toxicity increased by 12.7 + 4.6 % (n = 3; P < 0.05) compared with UV 
irradiated cells not treated with dihydrocaffeic acid. However, this toxicity significantly 
decreased by 15.8 ±6.1 % (P < 0.05) when cultures were incubated with dihydrocaffeic 
acid for 48 h following the UV treatment. This lowering was not significantly different 
from the 14.8 ± 0.7 % decrease obtained with a chronic incubation with dihydrocaffeic 
acid (24 h before and 48 h after UV treatment; P > 0.05), however significantly different 
from the UV irradiated cells not treated with dihydrocaffeic acid (P < 0.01). On sham 
UV irradiated cells, a post or chronic incubation with dihydrocaffeic acid exhibited only 
a very slight cytotoxicity of 2.9 ± 0.4 % compared with untreated cells. Dihydrocaffeic 
acid (100, 50 and 25 pM), used chronically, significantly attenuated the cytotoxicity 
following UV irradiation measured after 24 and 48 h (Fig. 45; P < 0.05). However, a
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significant dose dependent effect was only visible 24 h after UV exposure between the 
concentrations 100 and 50 pM (P < 0.05).
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HaCaT cells were first treated with 100 pM  dihydrocaffeic acid fo r  24 h, exposed to UV fo r  50 
(white bars) or 40 (grey bars) sec. and further incubated with dihydrocaffeic acid (100 juM) 
respectively fo r  24 or 48 h before LDH measurement. A 100 %  LDH release was prepared by 
incubating cells with 1 %  Triton X I00 fo r  1 h at 37 °C fo r  the 24 and 48 h conditions. The 
values are the mean ± SD (n =  3); the control corresponds to cells UV treated without 
dihydrocaffeic acid treatment; * ,  significantly different from  the protection obtained with 100 
pM  dihydrocaffeic acid (P < 0.05).
4.3 E f f e c t  o f  d i h y d r o c a f f e ic  a c id  o n  U V - in d u c e d  i n f l a m m a t io n
The markers chosen to monitor inflammation in HaCaT cells after UV exposure were 
the pro-inflammatory cytokines IL-8 and IL-6. The preliminary experiments showed 
that under the present experimental conditions, IL-8 was better detected 48 h following 
UV irradiation, as already shown after UVB radiation (Singh et a l,  1995), compared 
with IL-6, which was better detected after 24 h. In order to determine if the model used 
could respond to an inhibitory signal, an anti-inflammatory drug was tested, 
dexamethasone, which is a potent synthetic member of the glucocorticoid class of
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steroid hormones and known to interfere with the pathways leading to inflammation 
(Cupps & Fauci, 1982). Dexamethasone (1 pM) significantly reduced IL-8 production 
by HaCaT cells after UV irradiation by 61.6 ± 8.2 % (n = 4; P < 0.01), when incubated 
with cells 24 h prior to and 48 h after UV treatment. Moreover, this effect was not due 
to any cytotoxic effect of dexamethasone on the cells as indicated by LDH measurement 
(data not shown). Figure 46 shows that dihydrocaffeic acid did not significantly reduce 
the production of IL-8 when pre-incubated with cells for 24 h (P > 0.05), whereas the 
inhibition was significant for the post- as well as for the chronic incubation (P < 0.05), 
which was itself significantly more efficient than the post-incubation (P < 0.01).
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HaCaT cells were incubated with 100 juM dihydrocaffeic acid (DHCA) before, after or before 
and after UV exposure (40 sec). Supernatants were collected 48 h after UV exposure and 
analysed fo r  the presence o f  IL-8. The results are mean ± SD (n = 3). The significance o f  the 
results was calculated relatively to the control (no dihydrocaffeic acid) fo r  *  (P < 0.05) and to 
the condition after UV fo r  * *  (P < 0.01).
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The inhibition of IL-8 production after UV exposure by the chronic incubation with 
dihydrocaffeic acid was dose-dependent, the results obtained with the doses 100 and 50 
pM being significantly different from the control consisting of UV irradiated cells not 
treated with dihydrocaffeic acid (P < 0.01; Fig. 47). Since dihydrocaffeic acid 
significantly protected HaCaT cells against inflammation measured 48 h after exposure, 
this effect was also investigated for the early events following UV exposure, after 24 h, 
using IL-6. As for IL-8, dihydrocaffeic acid dose-dependently reduced the production of 
IL-6 compared with the control, reduction which was significant for all the 
concentrations tested (P <0.01; Fig. 48).
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Figure 47 Dihydrocaffeic acid concentration-dependent inhibition of IL-8 production by 
HaCaT cells after UV exposure.
HaCaT cells were incubated fo r  24 h before and 48 h after UV exposure fo r  40 sec with 100 pM  
dihydrocaffeic acid. Supernatants were collected 48 h after UV exposure and analysed fo r  IL-8 
production. The results are mean ± SD (n = 3); *, P < 0.01.
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Figure 48 Dihydrocaffeic acid concentration-dependent inhibition of IL-6 production by 
HaCaT cells after UV exposure.
HaCaT cells were incubated with 100 juM dihydrocaffeic acid fo r  24 h before and after UV 
exposure (50 sec). Supernatants were collected 24 h after UV exposure and analysed fo r  IL-6 
production. The results are mean +  SD (n = 3). The P value calculated fo r  the significance o f  
the results fo r  the treatments (25, 50  and 100 pM ) relatively to the control (0 pM ) or  *, and fo r  
the 100 towards the 50 pM  or  **, were all < 0.01.
Phenolic acids are absorbed and effluxed on the serosal side of the ^astro-intestinal cells 
as the parent compound and to a lesser, but not negligible, extent, as conjugated and/or 
metabolized forms (Chapter IV and V). As a consequence, it was of interest to 
determine if some of the metabolites of dihydrocaffeic acid, dihydrocaffeoyl-3-O-p-D- 
glucuronide and dihydrocaffeoyl-4-0-(3-D-glucuronide (100 pM) could also have a 
similar effect to their parent compound on the protection of kératinocytes against UV 
exposure. None of these glucuronides significantly (P > 0.05) protected HaCaT cells 
against either the cytotoxicity or the stimulation of IL-8 production following UV 
irradiation (data not shown). This suggests that the conjugation of one of the 
dihydrocaffeic acid phenyl ring hydroxyl groups could inactivate the parent compound. 
To better understand the relationship between the chemical structure and the function of
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dihydrocaffeic acid, different other phenolic acids were tested. Dihydrocaffeic and 
caffeic acids were the only ones to show a significant protective effect (P < 0.01; Fig. 
49) against the production of IL-8 after UV exposure compared with the control 
corresponding to UV treated cells but not incubated with phenolic acids.
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Figure 49 Comparison of the effect of different phenolic acids on IL-8 production by HaCaT 
cells after UV irradiation.
HaCaT cells were incubated fo r  24 h before and 48 h after UV exposure (40 sec) with 100 jlM  
o f different phenolic acids. Supernatants were collected 48 h after UV exposure and analysed  
fo r  IL-8 production. The results are mean ± SD (n = 3). The significance o f  the results was 
calculated relatively to the control (UV treatment but no phenolic acid): *, P < 0.01.
These results indicate that the catechol moiety and the length of the side chain, but not 
its saturation/unsaturation status, are important for phenolic acids activity. In order to 
ensure that the decrease of IL-8 production was not due to cytotoxicity of the treatments,
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the release of LDH by HaCaT cells was measured. Interestingly, the IL-8 inhibitory 
effect of dihydrocaffeic and caffeic acids was combined with a significant (P < 0.01) 
protection against cytotoxicity, which decreased by 29.4 ± 3.5 and 25.3 ± 2.2 %, in the 
presence respectively of dihydrocaffeic and caffeic acids, compared with the UV 
irradiated cells but not treated with phenolic acids. Moreover, the mixture of the 8 
phenolic acids (12.5 pM  each, 100 pM  as total concentration) had no effect on IL-8 
production but significantly (P < 0.01) reduced the toxicity of UV exposure on HaCaT 
by 14.8 ± 1.3 % compared with the control. These data suggest a synergistic effect of 
the phenolic acids against cytotoxicity.
4 .4  E f f e c t s  o f  d ih y d r o c a f f e ic  a c id  o n  i n t e r m e d ia t e  m e d ia t o r s  o f
UV RADIATION IN KERATINOCYTES
In order to better understand the mechanism of dihydrocaffeic acid protection against 
inflammation, its effect on IL-6 production was monitored in cultures of HaCaT cells 
stimulated with TNF-cc, a cytokine produced by kératinocytes after UV radiation as a 
mediator of inflammation. HaCaT cells were pre-treated for 24 h with dihydrocaffeic 
acid (100 pM) and then co-incubated with TNF-cc (20 ng/ml) and dihydrocaffeic acid 
(100 pM) for further 24 h. The amount of IL-6 measured after TNF-cc treatment was 1.7 
± 0.2 times higher than after UV irradiation (50 sec). However, dihydrocaffeic acid still 
significantly reduced this production by 15 ± 4.5 % (P < 0.01), even though the 
inhibition was lower compared with the protection obtained after UV challenge (45.6 ±
7.4 %).
Dihydrocaffeic acid protection against the cytotoxic effects of H2O2 produced in 
kératinocytes after UV irradiation was investigated by incubating the HaCaT cells for
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24 h with three different concentrations of H2O2 (0.25,0.5 and 1 mM). The cytotoxicity 
of H2O2 was evaluated by LDH measurement 24 and 48 h following the treatments A 
and B. Measured 24h or 48h after the challenge, the cytotoxicity may reflect different 
events: after 24h, the measurement would show the direct cell death provoked by the 
oxidative stress and the damage caused by H2O2, whereas after 48h, the measurement 
would be more influenced by events which have happened after the treatment, such as 
the recovery of the culture by cell multiplication, the apoptosis initiated in cells which 
were too damaged, or the gene expression affected by H2O2 or by dihydrocaffeic acid. 
The schedule of incubation with dihydrocaffeic acid is detailed and the results shown in 
Figure 50. The data indicate that a pre-incubation with dihydrocaffeic acid, shortly 
before challenge, is the most efficient treatment against the H2O2 cytotoxicity measured 
at 24h, probably by preparing the cells to fight against the oxidation initiated by H2O2, 
by reinforcing the antioxidant power of the cells. For lower concentrations of H2O2, 
which will provoke lower damage, such short term pre-incubation to prepare the cells is 
not necessary and co-incubation is efficient, dihydrocaffeic acid possibly directly 
scavenging H2O2. Interestingly, the opposite profile was observed for the co-incubation 
when the cytotoxicity was measured after 48h, co-incubation which was efficient 
against the high concentrations. This may indicate that low and high concentrations of 
H2O2 will provoke different types of damage, initiating different early or late cell 
responses that dihydrocaffeic acid can influence directly by scavenging ROS or 
indirectly by helping the antioxidant status of the cells or by influencing gene 
expression. However, taken all together, the results indicate that the best protection 
obtained with dihydrocaffeic acid, in any challenge condition, is when the phenolic acid 
is present in the cells already shortly before the oxidative stress starts.
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Figure 50 Dihydrocaffeic acid protection o f HaCaT cells against cytotoxic effects of H2 O2 .
HaCaT cells were treated as indicated on the figure and the cytotoxic effects o f  H 2 O 2 evaluated  
by LDH measurement. The white, grey and black bars correspond respectively to the control 
(H2 O 2 but no dihydrocaffeic acid treatment), A and B treatments. The results are mean ± S D  (n 
= 4) and the significance o f  the results was calculated relatively to the control (*) and relatively 
to the treatment A (**), P < 0 .01 .
4.5 P r o t e c t io n  o f  e r y t h r o c y t e s  a g a in s t  h e m o l y s is  b y
DIHYDROCAFFEIC ACID
Dihydrocaffeic acid protected kératinocytes against cytotoxicity following UV and 
H2O2 treatments. This anti-cytotoxic capacity was assessed for the protection of 
erythrocytes challenged with the reagent AAPH, which produces peroxyl radicals at 
constant rate through its spontaneous thermal decomposition (Niki, 1990). To determine 
the best experimental conditions allowing the detection of a protective activity of 
dihydrocaffeic acid against erythrocyte hemolysis, different concentrations of AAPH 
and of the known antioxidant ascorbic acid were tested. The best concentration of 
AAPH to use in order to detect significant antioxidant activity and differences between 
treatments was in the range of 50 to 100 mM (Fig. 51). As shown in Figure 52, 
dihydrocaffeic acid significantly (P < 0.01), and in a concentration dependent manner,
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protected rat erythrocytes from lysis initiated by 80 mM AAPH. The effect obtained 
with protocatechuic acid, a metabolite of dihydrocaffeic acid (/2-oxidation) in the 
cascade of catechin metabolism, was not significantly different from what was obtained 
with dihydrocaffeic acid, except for the lowest concentration tested (25 pM) at which 
protocatechuic acid was less efficient than dihydrocaffeic acid, inhibiting the lysis by 
52.7 ± 1.8 % compared with 61.6 + 1.0 % for dihydrocaffeic acid (P < 0.01).
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Figure 51 Protection by ascorbic acid of erythrocytes against hemolysis.
Purified rat erythrocytes were incubated with AAPH at different concentrations to initiate their 
oxidation and the capacity o f  10 (white bars), 50 (grey bars) and 100 (black bars) p M  ascorbic  
acid to inhibit lysis o f  erythrocytes was investigated. The results are the mean ±  SD (n -  3); *, 
significantly different from  the inhibition obtained with 10 p M  o f ascorbic acid (P < 0.01); **, 
significantly different from  the inhibition obtained with 50 pM  o f ascorbic acid (P < 0.05).
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Figure 52 Dihydrocaffeic acid protection of erythrocytes from hemolysis.
Purified rat erythrocytes were incubated with 80 mM AAPH to initiate the oxidation reaction 
and the protective properties o f  dihydrocaffeic acid (DHCA) at different concentrations were 
tested. The results are the mean ± S D  (n = 3); *, significantly different from  the control with no 
dihydrocaffeic acid treatment, and significantly different from  the other concentrations (P < 
0.07 j.
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5 Discussion
The model used to perform the studies on kératinocytes was the spontaneously 
immortalized human keratinocyte HaCaT cell line (Boukamp et a l,  1988). Most of the 
laboratories working with HaCaT cells use DMEM as culture medium. However, 
DMEM is potent for the production of H2O2 in the presence of antioxidants, as shown 
for vitamin C (Clement et a l,  2001) or for epigallocatechin gallate, quercetin, gallic 
acid and, to a lesser extent, for epicatechin (Wee et a l, 2003). This oxidative potential 
of DMEM is due to the high iron ions content of this medium which promote the 
production of H2O2, shown to be lower in RPMI 1640 than in DMEM (Clement et a l, 
2001). Thus, the HaCaT cells were cultured in RPMI 1640 in order to minimize the 
potential risk of H2O2 production by dihydrocaffeic acid.
5.1 M e t a b o l is m  o f  p h e n o l ic  a c id s  b y  k é r a t in o c y t e s
Interestingly, HaCaT cells were able to metabolize the phenolic acids tested, 
conjugating them with a methyl or a sulphate group and reducing their un-saturated side 
chain. They produced ferulic and isoferulic acids from caffeic acid, with no distinction 
between the two hydroxyl groups, whereas dihydrocaffeic acid was only methylated on 
the 3-OH, giving dihydroferulic acid. In Chapter V, the preference of the catechol-O- 
methyltranferase for the méthylation of the 3 position over the 4 position of the catechol 
moiety was proposed, preference which was less marked for caffeic than for 
dihydrocaffeic acid and linked to the pKa of the 4-OH. To my knowledge, this is the 
first time that kératinocytes are shown to perform sulphation, méthylation or reduction 
of phytochemicals. It has been shown that UDP-glucuronosyltransfereases are 
constitutively expressed in normal human kératinocytes, the UGTs expressed in 
kératinocytes being different isoforms, or forms differently matured, compared with the
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enzymes expressed in the liver (Vecchini et a i,  1995). UGT1A7, the isoform 
hypothesized to be responsible for the metabolism of phenolic acids in enterocytes and 
hepatocytes (Chapter V), may not be expressed in kératinocytes and/or in HaCaT cells, 
explaining why no glucuronide of ferulic, caffeic or dihydrocaffeic acids could be 
detected. This hypothesis does not exclude the possible absence of expression on 
HaCaT cells of the transporter(s) involved in the efflux of the phenolic acid 
glucuronides. The mRNAs of SULT1A1 and SULT1A3, phenol and catechol 
sulphotranferases, have been detected in human skin (Dooley et a l,  2000) and could be 
responsible for the phenolic acid sulphation observed with HaCaT cells. In parallel to 
sulpho- and UDP-glucuronosyltranferase, expression of the CYP450 enzyme CYP1A1 
has also been detected in normal human kératinocytes, however only under induction 
(Vecchini et a l, 1995). These findings suggest that, even though dihydrocaffeic and 
other phenolic acids can circulate in plasma as the free forms for some time after their 
absorption through the gastrointestinal barrier and reach the epidermis as such, they 
may be further metabolized by kératinocytes.
5.2  P h o t o p r o t e c t io n  o f  k é r a t in o c y t e s  b y  d ih y d r o c a f f e ic  a c i d :
ANTIOXIDANT AND ANTI-INFLAMMATORY CAPACITY
H2O2 is one of the ROS generated in kératinocytes by UV radiation as shown in cultured
human fibroblasts under UVA (Vile & Tyrrell, 1995) and UVB (Masaki et a l,  1995)
exposure. From UV light exposure, an electron can be transfered to molecular oxygen
(O2), present under normal conditions in cells, and produce the free radical superoxide
anion ("O2"), which can gain another electron from UV light to generate H2O2 (Black,
1987). The cytotoxicity of H2O2 results from its reaction with iron to form the hydroxyl
radical ("OH"), the most reactive compound of the ROS, able to react very rapidly with
any type of molecule (Pugliese, 1995). Dihydrocaffeic acid significantly protected
212
HaCaT cells against the cytotoxic effects induced by UV or H2O2 exposure. This 
suggests that the protection of dihydrocaffeic acid towards the damaging effects of UV, 
which leads to keratinocyte cell death, may happen through an interference with the 
reactions initiated by reactive oxygen species such as H2O2, either by direct 
neutralization of these intermediates or by recycling of the antioxidant system of the 
cells. Indeed, UV radiation of skin is thought to deplete antioxidants involved in the 
defence of the cells such as ubiquinol, oc-tocopherol, uric and ascorbic acids (Podda et 
a l,  1998).
In parallel to the protection of HaCaT cells against the cytotoxic effects of UV 
irradiation, dihydrocaffeic acid reduced the expression of the pro-inflammatory 
cytokines IL-6 and IL-8. Dihydrocaffeic acid exhibited no preventive effect on the 
production of IL-8. However, a post, and to a higher extent, a chronic treatment of 
HaCaT cells with dihydrocaffeic acid significantly reduced the secretion of IL-8 in 
response to UV exposure, the chronic effect being dose dependent. Dihydrocaffeic acid 
also reduced IL-6 production, but to a lower extent than IL-8, with no dose dependency 
in the range of the concentrations tested, the amounts of IL-6 being not significantly 
different from each other for the doses tested. It could be hypothesized that 
dihydrocaffeic acid acts mainly during the early events following UV irradiation, 
directly or indirectly, neutralizing the reactive oxygen species produced and 
consequently, but indirectly, decreasing the production of IL-6 and IL-8. However, the 
results showed that dihydrocaffeic acid could also significantly reduce the HaCaT 
production of IL-6 in response to TN F-a stimulation. Ferulic and isoferulic acid have 
been shown to inhibit the in vitro production of IL-8 by a mouse macrophage cell line as 
well as in an in vivo mouse model, in response to Influenza virus infections 
(Hirabayashi et a l ,  1995). These results indicate that phenolic acids can modulate
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inflammation. They also suggest that, in parallel to its antioxidant effect on ROS, 
dihydrocaffeic acid could have a more direct effect on the production of cytokines. This 
could take place at different levels in the cascade of events from UV irradiation to 
cytokine production: via inhibition of NFkB activation, known to be regulated by TNF- 
cc (Baeuerle & Henkel, 1994), as shown for vitamin C in endothelial cells (Bowie & 
O'Neill, 2000); via inhibition of the phosphorylation of ERK1/2, INK and p38 proteins 
of the MARK family, as shown for grape seed proanthocyanidins (Mantena & Katiyar, 
2006) and flavonoids (Lee et a l,  2005) in kératinocytes; via the reduction of p53, p21 
and c-fos gene expression, as shown for EGCG in kératinocytes (Luo et a l,  2006); via 
the reduction of caspase 3 and 7, as shown for ferulic acid in skin (Lin et a l,  2005).
Absence of inhibitory effects on IL-8 production by the treatment of HaCaT cells with 
dihydrocaffeoyl-glucuronic, dihydroferulic and m-hydroxyphenylpropionic acids 
indicates that the catechol moiety present on dihydrocaffeic acid is required for its 
activity. As shown by the results obtained with protocatechuic acid, which possesses 
two hydroxyl groups but a truncated side chain, the catechol moiety by itself is 
necessary but not sufficient. Since caffeic acid is able to reduce IL-8 production, it 
appears that only the length of the side chain is important for the activity, whether it is 
saturated or not. It has been previously proposed that the antioxidant potential of 
phenolic acids resides solely in the catechol ring structure with little effect of the 
conjugated double bound, as indicated by a similar capacity of dihydrocaffeic and 
caffeic acids to reduce ferric iron (Lekse et a l,  2001). Nevertheless, it is not excluded 
that the failure of the glucuronide conjugates to inhibit IL-8 production by HaCaT cells 
following UV irradiation could be due to the absence of uptake of these glucuronides by 
HaCaT cells or kératinocytes in general. A synergistic effect of the phenolic acids 
against the cytotoxicity of UV radiation was shown even though most of them were not
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efficient when taken individually. This suggests that the protective effect of 
dihydrocaffeic acid may be not only due to the parent compound but also due to the 
metabolites produced by the HaCaT cells in synergy with the parent compound. 
Moreover, it can be extrapolated that, in vivo, all the microbial metabolites resulting 
from a diet rich in flavonoids will be able to synergistically have an effect on skin, even 
though circulating in plasma at lower concentrations than the amounts tested in vitro.
5.3  P r o t e c t io n  o f  e r y t h r o c y t e s
Before reaching any target tissue, one of the first cell population encountered by 
xenobiotics, once absorbed through the gastro-intestinal barrier, are the erythrocytes. 
Dihydrocaffeic acid, significantly and dose-dependently, protected rat erythrocytes 
against damaging effects initiated by AAPH, known to be able to induce lysis of 
erythrocytes (Raneva et a l,  2001). Protocatechuic acid had a similar activity to 
dihydrocaffeic acid, suggesting that the length of the side chain is not required for the 
protection of erythrocytes, contrary to what has been observed with kératinocytes, 
except for the lowest concentration tested for which the side chain appeared to be 
involved in the function. Dihydrocaffeic acid has already been demonstrated to increase 
antioxidant capacity of plasma and erythrocytes using a FRAP assay, an antioxidant 
capacity being similar to the one displayed by caffeic and chlorogenic acids (Lekse et 
a l,  2001). Epicatechin (Grinberg et a l, 1997) and procyanidins (Zhu et a l,  2002b) have 
also been shown to protect red blood cells against oxidation and subsequent lysis in 
vitro. From these results, I hypothesize that in vivo, after ingestion of 
epicatechin/catechin or procyanidins, there could be a long lasting effect against 
erythrocytes oxidation and further lysis, epicatechin/catechin or procyanidins exerting 
the early part of the effects and dihydrocaffeic acid, their microbial metabolite, being 
responsible for the later part of the effects. Moreover, the relationship between the
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structure and the function of phenolic acids, observed for the protection of erythrocytes 
and kératinocytes, indicate that, depending on the mechanism involved (direct 
scavenging, recycling of the antioxidant system of the cells or interference with gene 
expression), the minimal structure requirements for a phenolic acid to be efficient may 
differ.
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6 Conclusion
The results obtained in the present work show that dihydrocaffeic and caffeic acids are 
potential candidates for the protection of kératinocytes against the damaging effects of 
UV irradiation. It is expected that these phenolic acids will display the same effects in 
vivo, providing they reach the skin, shown to be the major tissue target of ferulic acid as 
measured 24 h following intra peritoneal administration of [2-14C] ferulic acid to rats 
(Teuchy & Van Sumere, 1971). However, it must be noted that, in vivo, the quantity of 
the active forms, the free caffeic and dihydrocaffeic acids, which will reach skin after 
ingestion of their precursors in food, will be much lower than what has been used in the 
present in vitro work. This will result from the low amount absorbed at the level of the 
gastrointestinal tract, as well as from the high rate of metabolism by the 
gastrocytes/enterocytes, the hepatocytes and finally the kératinocytes. Nevertheless, an 
activity could still be expected in vivo with lower concentrations of caffeic and 
dihydrocaffeic acids, as a result of a possible synergy with other phenolic acids and 
metabolites, which, as shown in the present report, may have no effect if taken 
individually but which could show synergistic effects when taken together. This synergy 
could even be extrapolated to other phytochemicals present in food. Further studies will 
be necessary to investigate the exact mechanisms of action of dihydrocaffeic acid.
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1 The initial purpose of investigation in the context of the literature
Phenolic acids, which have been shown to exert beneficial effects on health, can be 
found in food as the free form but are usually present as esters or precursors such as 
flavonoids, and are expected to be released in the colon where an abundant microflora is 
present. However, to exert their effect, phenolic acids need to be bioavailable.
In order to study mechanisms of absorption of molecules, in vitro studies are often 
preferred to ex vivo and in vivo studies because allow focusing on one target tissue and 
even on one cell type. Few studies reported in the literature investigated the phenolic 
acids transport mechanisms with Caco-2 cells. However, the concentrations of 
substrates used were far higher than the physiological concentrations, and the 
conclusions concerning the mechanism of transport are still unclear.
The purpose of this work was mainly to better understand the mechanisms of phenolic
acids absorption by the colonic epithelium, in the presence of mucus, and with
concentrations close to physiological ones, using ferulic acid as a model compound. The
Caco-2 cells are the most widely used for this type of investigation but are not covered
by mucus. The mucus producing cells HT29-MTX were used to add this parameter to
the Caco-2 cultures. The optimal culture and experimental conditions needed to be set
up (Chapter III) before the study of ferulic acid permeation (Chapter IV). The results
obtained for the permeation in vitro were supported by data obtained with an ex-vivo
model of everted sacs of colon and compared with results obtained with jejunal everted
sacs. The studies on the metabolism of phenolic acids described in the literature have
been mainly performed in vivo, with no clear distinction between the metabolites
obtained from the intestine and from the liver. Using the in vitro and ex vivo models of
colonic epithelium, the metabolism of phenolic acids by intestinal cells was clarified,
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with ferulic acid as a model compound. In parallel, the metabolic fate of dihydrocaffeic 
acid was investigated by studying its metabolism in vivo, ex vivo with the models of 
intestinal epithelium and liver slices, and in vitro with the co-culture model of Caco-2 
and HT29-MTX (Chapter V). Finally, dihydrocaffeic acid was investigated for potential 
photoprotective effects on skin using an in vitro model of epidermis made of a 
keratinocyte cell line (HaCaT cells), which were challenged with UV in order to induce 
cytotoxicity and inflammation (Chapter VI). Often, literature reports studies performed 
in vitro with concentrations of phytochemicals which are much higher than 
physiological ones. Moreover, the forms which reach the target tissues are often not the 
ingested phytochemical but their metabolites. Thus, the potential protection of 
dihydrocaffeic acid was compared with the effect of its circulating metabolites in order 
to better understand its in vivo activity.
2 Summary of the achievements and results
Since phenolic acids are expected to be released mainly from plant-derived food 
components in the colon by its abundant microflora, the mechanisms of absorption by 
the colonic epithelium was investigated. An in vitro model for the colonic epithelium 
was set up and characterized, and the optimal experimental conditions necessary to 
investigate the mechanisms of phenolic acid absorption were determined. In addition, 
analytical methods (liquid-liquid extraction, LC-DAD and LC-MS) were set up for the 
detection, identification and quantification of phenolic acids in biological fluids.
Using ferulic acid as a model compound, the mechanisms of phenolic acids absorption
were investigated. The results obtained suggested that phenolic acids
(hydroxyphenylpropionic and hydroxycinnamic acid derivatives) permeate through the
gastrointestinal epithelium mainly by transcellular diffusion governed by their pKa and
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their relative hydrophobicity, but also partly by facilitated transport involving MCTs 
and S-MCTs transporters. The intestinal, and possibly gastric, cells are able to 
metabolize these absorbed phenolic acids, conjugating them with glucuronide, sulphate 
and methyl groups but also reducing/oxidizing their side chain. The efflux of 
metabolites into the blood circulation appears to be partly dependent on MRP (3 or 6), 
whereas MDR1 could be involved in their efflux back to the lumen. Interestingly, 
ibuprofen was shown to compete with ferulic acid uptake by intestinal cells, apparently 
sharing the same S-MCT transporter. It is of interest to mention that there is a possible 
competition for the in vivo absorption of phenolic acids derived from food and drugs 
such as ibuprofen. This suggests that in vivo, the effect of ibuprofen could be lowered if 
taken at the same time as plant-derived food. However, the interference with drugs is 
minimized by the low amount of phenolic acids released from food compared with the 
amount of drug usually ingested. Moreover, the drugs are more rapidly released from 
their formulation and most probably absorbed from the stomach or the upper part of the 
small intestine, whereas phenolic acids are expected to be released from the food matrix 
mainly in the colon.
The circulating forms of the absorbed phenolic acids are a combination of different 
metabolites in addition to the parent compound, metabolites which are formed by 
enterocytes and hepatocytes. The parent compound is proposed to be rapidly excreted in 
urine and metabolized by the liver, as indicated by the results obtained with 
dihydrocaffeic acid using in vivo and ex vivo models from rats. It also appears that 
among all the UGT isoforms, UGT1A7 is a candidate for the glucuronidation of 
phenolic acids. In rats, the liver seems to favour sulphation whereas the intestinal cells 
rather perform the glucuronidation of phenolic acids. Moreover, the méthylation of 
phenolic acids possessing a catechol moiety, such as caffeic and dihydrocaffeic acids, is
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favoured on the 3-OH compared with 4-OH, as demonstrated with dihydrocaffeic acid, 
the méthylation of the 4-OH by COMT being dependent on the pKa of the hydroxyl 
group and the pH of the environment.
From the data obtained with HaCaT cells challenged with UVB and chemicals 
responsible for oxidative stress and inflammation, dihydrocaffeic acid appears to be a 
potential candidate for the photoprotection of kératinocytes in epidermis. It reduced the 
production of IL-6 and IL-8 by HaCaT cells after UVB exposure and IL-6 after TNF-a 
treatment. Dihydrocaffeic acid also protected the kératinocytes from the damaging 
effects of UVB and H2O2 treatments. This suggests that the mechanisms of action of 
dihydrocaffeic acid in photoprotection could be by scavenging of radicals formed from 
H2O2 and UVB treatment but also by interference with the pathways leading to the 
activation of the cytokines production, directly or indirectly inhibiting the gene 
expression or protein synthesis. Caffeic acid had a similar effect on the production of 
IL-8. However, the absence of effect of the other phenolic acids tested suggests that the 
minimum structural feature required for such beneficial effect is a catechol moiety 
present on the phenyl ring attached to a side chain of three carbons, saturated or not. 
This was supported by the absence of effect of dihydroferulic acid and of dihydrocaffeic 
acid glucuronides, which have one of the hydroxyl groups conjugated. However, it has 
not been determined if the lack of activity of these glucuronides results from their 
inability to enter the cells or from a real loss of activity by the neutralization of the 
catechol moiety.
3 The novelty of the work
Reports in the literature proposed that the transport of phenolic acids could be
paracellular or transcellular via MCTs, depending on the compounds. The present work
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allows the clarification of the mechanism of phenolic acids permeation across the 
intestinal epithelium. This mechanism is proposed to be mainly by transcellular 
diffusion (80 %) and partly (20 %) by facilitated transport involving MCTs and S- 
MCTs, but not by the paracellular pathway. Phenolic acids delivered on the apical side 
can cross the intestinal epithelium as the free form, what was originally not clear from 
the literature, but also as metabolites after glucuronidation, sulphation, méthylation or 
reduction-oxidation (of the side chain). Moreover, the quantification of conjugates 
(sulphate and glucuronide) is usually performed by de-conjugation and measurement of 
the free compound, which can be source of errors. Indeed, the de-conjugation can be un- 
complete or the incubation with the sulphatase and/or glucuronidase can lead to the 
degradation of the phenolic acids and/or to the addition of proteins and impurities to the 
samples. The use of standards allowed the quantification of the glucuronides avoiding 
such problems. Moreover, the efflux mechanism of the metabolites was not known and 
is now proposed to be possibly through MRP-3 or 6 on the serosal side and by MDR1 
on the luminal side, but also by passive diffusion when unconjugated. Usually, reports 
of the literature never mention distinctions between the isomeric forms of conjugates. 
The present report shows that phenolic acids possessing a catechol moiety can be 
conjugated on one or the other hydroxyl groups, conjugation which appears to be regio- 
selective, especially for the méthylation.
The novelty of the work was also the investigation of the role of the mucus layer by the 
use of a co-culture of enterocyte and goblet-like cells. Caco-2, compared with HT29- 
MTX, lack the ability to perform the glucuronidation of phenolic acids, probably due to 
the absence of a functional UGT, hypothesized to be UGT1A7 for phenolic acids, so far 
never suggested. The use of liver explants showed that the liver produced the same type 
of conjugates as the intestinal epithelium but, in rats, it appears to favour the sulphation
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rather than the glucuronidation, higher in intestinal cells. The metabolism of phenolic 
acids has been reported in the literature to happen in the intestine and in the liver but the 
present work proposes for the first time a possible metabolism by gastrocytes and 
demonstrates a metabolism by kératinocytes.
From the literature, ferulic and caffeic acids appear to be interesting candidates for the 
protection against UV light-induced skin damage by topical application (Lin et al., 
2005 ; Saija et al., 1999; Saija et al., 2000). The present work suggests that 
dihydrocaffeic and caffeic acids are good candidates for skin photo-protection since 
they reduced cytotoxicity and inflammation in HaCaT cells after UV exposure. 
Moreover, this is the first time that the effect of a phenolic acid is compared with the 
effect of some of its potential circulating metabolites. The present work also 
demonstrates that phenolic acids and metabolites can act synergistically for a beneficial 
effect.
Dihydrocaffeic acid, as for caffeic acid, has been shown to enter erythrocytes and 
enhance their ability to reduce the transmembrane oxidant stress generated by 
extracellular fenicyanide (Lekse et a l, 2001). The present work shows in addition that 
dihydrocaffeic acid also protects these cells against the lysis provoked by a water- 
soluble free radical initiator.
4 Future investigations
The results obtained suggested that UGT1A7 was a potential candidate for the 
glucuronidation of phenolic acids. It would be interesting to confirm this hypothesis by 
studying the potential in vitro glucuronidation of dihydrocaffeic acid and other phenolic 
acids by a human UGT1A7 recombinant protein.
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The metabolism of femlic acid into dihydroferulic acid by enterocytes and hepatocytes 
suggests the involvement of enzymes able to reduce the unsaturated side chain of femlic 
acid. This reduction could result from an incomplete /^-oxidation of femlic acid into 
vanillic acid. This ^-oxidation, similar to the /2-oxidation of fatty acids, could affect 
enzymes responsible for the metabolism of lipids. This could be investigated in order to 
see if phenolic acids could compete with the metabolism of lipids, which could have an 
impact on obesity for example.
From the results obtained, it appears that phenolic acids could be absorbed and 
metabolized by the stomach. It would be of interest to confirm this absorptive and 
metabolizing capacity of gastric cells towards phenolic acids by using an in vitro model 
of the gastric epithelium, consisting of cultures of gastrocytes on a semi-permeable 
membrane, as already performed with enterocytes.
Since dihydrocaffeic acid was metabolized by HaCaT cells, I hypothesize that 
dihydrocaffeic acid was absorbed by the kératinocytes which they further metabolized. 
However, the uptake by these cells remains to be proven. Moreover, it would be 
interesting to know if kératinocytes possess active forms of the transporters MCTs and 
S-MCTs. In addition, the efflux of the metabolites from the kératinocytes could also be 
investigated.
Because phenolic acids are proposed to be mainly absorbed by passive transcellular 
diffusion, it is hypothesized that they could permeate the cytoplasmic membrane of any 
type of cells. Any target tissue for which there is an interest for a beneficial effect of 
phenolic acids could be also investigated for its capacity to uptake these compounds and 
eventually to metabolize them.
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The photoprotective effect of dihydrocaffeic acid in skin appears to result from an 
interference of the phenolic acid with the pathways activated by UV or TNF-ct and 
leading to inflammation by stimulation of cytokine production. It would be interesting 
to deeply investigate the mechanism of action of this interference.
A way to increase the benefits from the activities of phenolic acids on health could be to 
improve their bioavailability. Because they are mainly absorbed by transcellular 
permeation, it is difficult to act on the mechanism of phenolic acids uptake. Although 
very challenging, it might eventually be considered to increase the expression of MCT 
and S-MCT transporters at the surface of intestinal cells but this could have side effects 
due to their involvement in the transport of other molecules than phenolic acids, such as 
drugs. The simplest approach that could be envisaged is to increase the amount of 
phenolic acids delivered at the luminal side of intestinal cells. This can be achieved by 
increasing the amount ingested, by concentrating the active compounds in food (use of 
enriched food with extracts), but it could also be envisaged to boost microflora or adapt 
them in order to obtain a higher release of phenolic acids from the food matrix. 
However, scientists must be careful in the future with the wish to increase the 
bioavailability of such compounds and try to firstly identify the best doses to achieve 
optimized benefits without adverse effects (Rowland, 1999).
5 General comments arising from this thesis
A wide range of in vitro studies has shown the beneficial effects of the consumption of
phytochemicals present in plant-derived food. However, it is sometimes difficult to
extrapolate to in vivo effects of the same compounds, since this is strongly affected by
their bioavailability. The latter will depend on their form in food, and chemical structure
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before and after ingestion. The compound, depending on this structure and form, will be 
released from the food matrix, pre-deglycosylated, modified by pH or digestive 
enzymes present in the lumen of the gastrointestinal tract, metabolized by microbial 
enzymes, absorbed from the gastrointestinal tract, metabolized by mammalian enzymes 
(intestine and liver), absorbed by target tissues and eventually, and finally, metabolized 
by the enzymes of the target tissues. The activity of the compound ingested can be 
increased by all these modifications but is in general decreased. That is the reason why 
it is important to investigate the activity shown in vitro using an in vivo model. 
However, in vitro models remain very good tools, which allow a first screening for a 
potential activity of the phytochemical tested, for the identification of its target tissue or 
for the understanding of the mechanism of action. However, this potential effect should 
be carefully extrapolated to the in vivo situation.
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A nnex 2: Daughter ions obtained by M S2 fragm entation o f  some phenolic acids in the 
negative ion mode. Some o f  the phenolic acids give more than two peaks which are 
from  the m ajor to the m inor ones: peak  1, 2 and 3.
Fragments obtained by MS2
Phenolic acids peak 1 peak 2 peak 3
137
dihydrocaffeic (-CO,)
136
151 (-CH3 and
dihydroferulic (-CO2) -CO,)
134
178 149 (-CH3 and
ferulic (-CH3) (-CO,) -CO,)
134
149 178 (—CH3 and
isoferulic (-CCW ( - c h 3) -COz)
152 123
vanillic (-CH3) (-CO,)
123 152
isovanillic (-CO2) ( - c h 3)
137
(-CH3 and
syringic -CO,)
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A nnex 3: Composition o f  the A IN  93M  diet used to fe e d  rats during the in vivo 
experiments.
Compounds %
Mais Oil 4.0
Mais starch 62.1
K-caseinate 14.0
Sucrose 10.0
Cellulose 5.0
Mineral mix AIN-93M 3.5
Vitamin mix AIN 93M 1.0
L-cystine 0.18
bitartrate choline 0.25
tert-butyl hydroperoxide (TBH) 0.0008
Total 100
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